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Abstract
This study evaluated the role of resident peritoneal and pleural macrophages
(M(|)) in neutrophil (PMN) recruitment in acute peritoneal and pleural inflammation.
I also investigated the role of lymphocytes (Lp) in peritoneal inflammation by
studying experimental peritonitis in mice deficient in various Lp populations.
The conditional M(t> ablation mice used in these studies are transgenic for the
human diphtheria toxin receptor (DTR) under the CDllb promoter (CDllb-DTR
mice) and exhibit >97% depletion of resident serosal Mc() following intraperitoneal
(IP) administration of diphtheria toxin (DT). I determined leukocyte numbers by
flow cytometry in peritoneal or pleural lavage exudates at various time points after
the initiation of inflammation with various agents following Mc() depletion
(peritoneum: Brewer's thioglycollate [BTG], zymosan; pleural cavity: carrageenan
and fixed staphylococci). I also induced BTG peritonitis in RAG-1 knockout (KO)
mice (mature B and T Lp deficient), NUDE mice (T Lp deficient), pMT mice (B
Lp deficient) and their respective controls.
Mcj) ablation markedly inhibited peritoneal and pleural PMN recruitment at
early time points compared to wild type (WT) controls. Administration of Mc|)-rich
resident cells, unlike Mcj)-depleted resident cells, significantly restored PMN
infiltration. Analysis of PMN C-X-C chemokines in lavage exudate showed that
Mcj)-depleted mice had significantly reduced levels of peritoneal and pleural MIP-2
and KC at the lhr time point compared to control mice with more marked MIP-2
reduction compared to KC (>90% reduction vs 25-40%). Reduced levels of
monocyte C-C chemokine and various cytokines were evident in the Mcj)-depleted
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mice at early time points. In vitro studies demonstrated that the production of these
chemokines and cytokines from peritoneal and pleural cells was M(j)-dependent.
RAG-1 KO mice exhibited increased early PMN infiltration and blunted M((>
infiltration. NUDE exhibited increased early PMN infiltration and increased M(j)
infiltration whilst pMT KO mice exhibited decreased PMN influx and a reduced M(j>
influx. Although chemokine analysis of peritoneal exudates in RAG-1 KO mice and
NUDE mice demonstrated some differences in MCP-1 levels, there were no clear
differences evident in pMT KO mice.
These data suggest that resident M(j) play a pivotal role in the orchestration of
PMN infiltration with M(j)-dependent production ofMIP-2 being important. The data
suggests that Lp can modulate leukocyte recruitment in experimental peritonitis with
T cells possibly acting as suppressor cells and B cells facilitating M(J> recruitment.
However, the exact mechanisms ofLp action remain elusive.
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Celsus (1st century AD) described a situation characterised by rubor, calor,
tumor and dolor. This was the first description of the cardinal signs of a process now
known as inflammation, from the Latin inflammare (to set on fire). Galen (3rd
century AD) proposed that inflammation was an essential part of the response to
injury but emphasised the humoral aspect of it. More than 1400 years later, Virchow
(1799-1878) saw inflammation as a consequence of an initial 'irritant' (Virchow,
1971). The aggression of the body from the 'irritant' would result in a change or
injury in the tissue known as the 'irritament' or the inflammatory stimulus as a
passive consequence of the irritant. This will subsequently affect other nearby parts
of the body not directly in contact with the 'irritant'. These distant consequences
would be an active condition relying on the intrinsic physiology of the local milieu
and represented the 'irritation' (Virchow, 1971). Virchow regarded 'irritation' as the
starting point of inflammation leading to pathological consequences that he described
as the fifth cardinal sign of inflammation: functio laesae, loss of function (Scott et
al., 2004; Virchow, 1971).
Cohnheim, Virchow's former student, proposed the 'vascular' theory as he
believed that the exudate cells were derived from the blood such that the most
important aspect of inflammation was the vessel wall lesion secondary to the
injurious agent. He proposed that the vessel walls became more permeable and were
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unable to retain leukocytes within the vessel. Any other phenomena evident were of
secondary importance to this passive leukocyte extravasation (Besredka, 1921).
Metchnikoff was one the first scientists to actually see chemotactic
movement: either positive (attraction) or negative (repulsion). He also noted that
phagocytic cells (the phagocytes) were the first cells to arrive at an inflamed site and
believed that their role was primarily 'digestive' i.e. the phagocytes were attracted
specifically to clear inflammatory material and protect the attacked organism. This
inflammatory reaction was also found in vessel-free organisms such as the larva of
the starfish, thereby indicating that a vascular lesion was not a necessary first step of
inflammation and suggesting that vessels acted to accelerate the arrival of these
phagocytes through diapedesis. The chemotactic behaviour of phagocytes was
considered to be the primum movens of the inflammatory reaction and inflammation
was considered to be a salutary reaction to protect the organism against the morbid
agent by mobilising phagocytes (Besredka, 1921). Metchnikoff described different
types of phagocytes. The "big eaters" or macrophagocytes became known as
macrophages (Mcj)) whilst the 'smaller eaters' or microphagocytes became known as
neutrophils (PMN)(Segal, 2005). With this "phagocyte armamentum, Nature had its
Natura MedicatrixV' (Besredka, 1921). The concept of 'disharmony' was at the core
of Metchnikoff s view of inflammation such that "the sentinel phagocyte was
directed to regaining disrupted harmony" (Tauber, 2003). The resident phagocyte or
M(j) thus represented a gatekeeper that functioned to maintain harmony under normal
conditions and acted to rectify the 'dysregulated disharmony' that occurs in the
context of inflammation after the injurious agent has been eliminated (Tauber, 2003).
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Inflammation is therefore a body response to injury and is usually followed
by tissue repair until tissue function is regained. This inflammatory response is
composed of altered blood flow, the recruitment and activation of leukocytes,
followed by eradication of the inflammatory stimulus and removal of tissue debris
leading to tissue repair (Henson, 2005). Acute inflammation is characterized by an
initial influx of PMN followed by inflammatory monocytes that will differentiate
into Mcf) (Serhan and Savill, 2005). Beside resident cells, PMN rapidly arrive at an
inflamed site and have a crucial role in acute inflammation. PMN are intimately
involved in host defense against microbial invasion and also play an important role
in other inflammatory disease states (Segal, 2005). When recruited PMN are
activated and produce a myriad of cytokines, reactive oxygen species and
antimicrobial enzymes and are potent phagocytes. Activated and cytokine-
stimulated PMN can secrete chemokines and other chemoattractant proteins that are
important in the recruitment of other leukocytes (Yamashiro et al., 2001). PMN are
also responsible for a large degree of host tissue destruction (Cochrane, 1968; Weiss,
1989) that may be evident at inflammatory sites. In view of the importance of PMN
accumulation in various pathophysiological states, it is crucial to understand the
mechanism of their recruitment and identify the cellular network involved in this
process. This is particularly important because an increased knowledge of the
initiation of inflammation may provide insights into preventing injury and promoting
resolution thereby reducing loss of organ function.
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1.2 Description of the serosal cavities and their resident cells:
The peritoneal, pleural and pericardial cavities are serosal or serous cavities.
They constitute a protective barrier against damage and reduce friction between the
organs and tissues within them (Mutsaers, 2004). They are constituted of
mesothelial cells (MeC), resident leukocytes and fibroblasts. All of these cells are
important as they are metabolically active and act as a barrier to invading pathogens
by generating an innate and adaptive immunological response (reviewed in (Faull,
2000)). The serosal cavities are lined by a monolayer ofMeC, which constitute the
most abundant cell type. They were originally described as the "epithelial lining of
mammalian mesodermic cavities", hence the term mesothelium (Mutsaers, 2004).
The serosal cavities also contain fibroblasts situated between the MeC lining and the
capillaries in the interstitium(Faull, 2000). These cells are also capable of cytokine
and chemokine production (Loghmani et al., 2002; Witowski et al., 2001).
The peritoneal membrane is composed of three layers: mesothelium,
interstitium and blood microvessels The peritoneal membrane exhibits a variable
thickness according to the examined area. The interstitium contains various
leukocytes and fibroblasts as well as lymphatic vessels. The peritoneal
microcirculation is derived from the systemic circulation and the vascular
endothelium is mostly continuous. The lymphatic drainage of the peritoneal cavity is
accomplished by specialized lymphatic pores called 'stomata' in the
subdiaphragmatic peritoneum as well as by milky spots predominantly located in the
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omentum. The lymphatics present in the peritneal interstitium do not contribute
significantly to drainage of fluid from the peritoneal cavity (Cameron et al., 1992).
The vasculature and lymphatics of the pleural space are rather unusual. The
capillaries of the visceral pleura in large mammals are supplied by the systemic
bronchial circulation whereas in smaller animals the blood supply comes from the
pulmonary circulation (Albertine et al., 1984). In humans, the visceral pleural
microcirculation is derived from both the systemic and pulmonary circulation
(Miserocchi, 1997). In humans, the parietal pleura is thinner than the visceral pleura
and its capillaries originate from the systemic microcirculation (Miserocchi, 1997)
and are closer to the MeC layer than the visceral capillaries (Albertine et al., 1984).
Moreover, the visceral pleura contains lymphatics that directly open into the pleural
space through specialized openings called stomata similar to those found in the
subdiaphragmatic peritoneum of the peritoneal space (Albertine et al., 1984 ;
Miserocchi, 1997).
The resident leukocytes are comprised mainly of M(j) and these cells are also
present in specialised cellular aggregates called milky-spots in the peritoneal space
(Daems and de Bakker, 1982; Takahashi, 1994). The equivalent structures in the
pleural cavity are called 'black-spots' (Boutin et al., 1996). There is, however, a
significant population of free Mc(> within the serosal cavities that are not associated
with either milky spots or black-spots. In the pleural space of CD1 mice, 82% of
leukocytes were M(j)-like cells, 15% were lymphocytes, 1-2% were PMN whilst there
were also few mast cells (Peao et al., 1992). However, different mouse strains
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exhibited significant variation in the number of M(|) and lymphocytes (Festing et al.,
1990). In rats, M()> represent around 72% of the recoverable cells from the pleural
and peritoneal cavities (5% and 13.2% lymphocytes; 19% and 12.8% PMN
respectively for the peritoneal and pleural space) (Gjomarkaj et al., 1999). In
humans, the peritoneal resident leukocyte population is composed of 45-90% Mcj),
10-47% lymphocytes [45% T (mostly memory T cells) and 2% B lymphocytes], 8%
NK cells, 2-6% dendritic cells and <5% PMN (Broche and Tellado, 2001; Kubicka et
al., 1996; Lewis and Holmes, 1991). Thus, resident leukocytes constitute the
majority of cells recoverable by lavage. A more detailed analysis of the different
constituents of the serosal membranes and their role in the initiation of inflammation
will be further discussed below.
1.2.1 Description and role of resident M<|>:
Mc() are dispersed throughout the tissues and have an important role in innate
immunity (Gordon, 2002), apoptotic cell clearance (Savill et al., 2002), development
(Gouon-Evans et al., 2000) and morphogenesis (Diez-Roux et al., 1999; Lang and
Bishop, 1993). M(J) are heterogeneous cells and can be found in tissues where they
are known as resident M(j). The local microenvironment will provide tissue-specific
signals such as apocrine secretion products from neighbouring resident cells and
extracellular matrix and this is likely to play a prominent role in the development of
the different phenotypes found in the various resident M(|) populations (Gordon,
2003). These various resident M(|) include serosal (peritoneal and pleural) M(|),
Kupffer cells in the liver, alveolar M(() in the lung, microglia in the brain and
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osteoclasts within bone (Wiktor-Jedrzejczak and Gordon, 1996). Resident Mcj) differ
from the other monocyte-derived M(j) (MDMcj)) as they are long-lived in tissue and
possess a proliferative capacity such that they may be sustained by self-renewal
(Daems and de Bakker, 1982; Lawson et al., 1992; Takahashi et al., 1996). Although
resident M(j) number was shown to be independent of the bone marrow and the level
of circulating monocytes based on studies involving strontium89 ablation (Volkman
et ah, 1983), recent evidence suggests that the situation is more complex. The
renewal of resident M()) could be derived from colony forming unit-granulocyte/M(j)
or earlier precursor cells (Naito et ah, 1996; Takahashi, 1994) in peripheral tissues or
by extravasation and differentiation of circulating monocytes (Bruno et ah, 2001;
Geissmann et ah, 2003; Lawson et ah, 1992).
Recent work has suggested that there are two distinct monocyte populations
that give rise to either resident McJ) or inflammatory Mcj) and that these monocytes
may be distinguished by their surface markers. Resident M(j) are derived from
CX3CRI111, Grl" and CCR2" monocytes whilst inflammatory M(|) are derived from
CX3CR1Lo, Grl+, CD62L and CCR2+ monocytes (Geissmann et ah, 2003). Intra¬
peritoneal migration of resident Mc|)-precursor monocytes is not prominent in the
absence of inflammation. During inflammatory peritonitis, however, there is some
recruitment of the long-lived CX3CRlHl, GrT and CCR2" monocytes (Geissmann et
ah, 2003) and this may be to replace the resident McJ) that emigrate to the parathymic
lymph nodes during and following inflammation (Bellingan et ah, 2002). The nature
of the originating cells for both monocyte subsets is not entirely clear and it is not
known if the CX3CRlHl, Grl" and CCR2" MDMcj) would be able to replenish normal
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tissue resident M(|) (Taylor and Gordon, 2003). However, a bone marrow M(j)-DC
progenitor has been recently described that may give rise to splenic and brain
resident M<j), splenic resident DC and inflammatory M(j) and DC (Fogg et al., 2006).
The osteopetrotic mouse exhibits a deficiency of the primary M(j) growth
factor colony stimulating factor (CSF)-l (Wiktor-Jedrzejczak et al., 1990). Study of
this mouse has allowed the identification of CSF-1-dependent and CSF-1-
independent M(j) populations further highlighting the complexity of the M(|) system
(Cecchini et al., 1994; Wiktor-Jedrzejczak and Gordon, 1996; Witmer-Pack et al.,
1993). Interestingly, Ly-1 positive resident peritoneal M(j) are derived from the same
precursor cells as Ly-1 positive B cells present in the peritoneum (Takahashi, 1994).
In addition, careful analysis of PU. 1 mutant mice showed that the transcription factor
PU. 1 was essential for normal differentiation of both M(|> and B cells further linking
the origins B cells and M(j) (McKercher et al., 1996).
Resident M<J) have an important role in the immune protection of their
respective organ of residence and resident tissue M<j) are regarded as sentinels of the
innate immune system. They are implicated in the clearance of pathogens and the
repair of injured tissue (Sean Eardley and Cockwell, 2005). Although resident McJ)
are heterogeneous, the comparison of the phagocytic activity and prostaglandin
release of resident peritoneal and pleural M(j) exhibit considerable similarity. In
contrast, both peritoneal and pleural M(j> are functionally and phenotypically different
from resident alveolar Mc() (Dorger et al., 2001; Gjomarkaj et al., 1999; Sestini et al.,
1984). In addition, adhesion and phagocytosis of apoptotic cells also differs between
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resident peritoneal Mcj) and alveolar M(j) (Hu et al., 2004; Hu et al., 2000).
Monocytes modify their expression of adhesion molecules as they differentiate into
monocyte-derived M(J) (MDM<j>). They downregulate various integrins [a40i, aePi,
aLP2, platelet endothelial cell adhesion molecule-1 (PECAM-l)and anbfo integrins]
and upregulate av(35 integrin reflecting their different adhesive requirements (Faull et
al., 1996). Resident M(j) and MDM(j), or elicited M(j), differ in their production of
hyaluronan (Hodge-Dufour et al., 1997) and oxygen radicals (Rugtveit et al., 1995),
caveolae formation and endocytosis (Kiss et al., 2002) and expression of laminin
(Wicha and Huard, 1983). However, these variations might reflect differences in the
activation state of the cell rather than differences between resident and elicited M(j).
Resident peritoneal M<j) are an important source of cytokines and chemokines
involved in the immune defense of the peritoneal cavity. Key players include the
cytokines interleukin (IL)-l, IL-6 and tumour necrosis factor (TNF)-a (Lewis and
Holmes, 1991; Topley et al., 1993c) and the chemoattractants IL-8, monocyte
chemotactic protein (MCP)-l (Bauermeister et al., 1998; Topley et al., 1993c;
Topley et al., 1994), prostaglandins (Topley et al., 1993c) and leukotrienes
(Kolaczkowska et al., 2002; Mackenzie et al., 1990; Mackenzie et al., 1991). It is
believed that this "cytokine network" facilitates communication between peritoneal
Mc() and MeC that act in concert to protect the peritoneum (Topley et al., 1996).
In addition, TNF-a and IL-1 (3 are key cytokines in the development of pleural
inflammation as they act to enhance IL-8 and MCP-1 production from pleural MeC
(Antony et al., 1995; Frode et al., 2001; Goodman et al., 1992; Mohammed et al.,
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1998a; Park et al., 2003). Studies using function-blocking antibodies suggest that
activated resident pleural M(|) could be responsible for this TNF-a and IL-ip
secretion (Frode et al., 2001; Park et al., 2003). To date, there has been limited study
of the role of the resident pleural M(() in the initiation of inflammation and
orchestration of PMN recruitment. Previous work has demonstrated that the pleural
eosinophil influx induced by the administration of lipopolysaccharide (LPS) was
reduced in mice previously treated with diphosphonate-containing liposomes in order
to deplete resident pleural M(}) (Bozza et al., 1994) thereby suggesting an important
role for the resident pleural M(j). In contrast, the role of resident peritoneal M(j) in the
initiation of inflammation and orchestration of PMN recruitment is more
controversial. Previous studies have produced conflicting results suggesting that the
resident peritoneal Mc() play a key role (Ajuebor et al., 1999; Knudsen et al., 2002;
Souza et al., 1988), an inhibitory role (Ajuebor et al., 1999) or no role at all (Ajuebor
et al., 1999) depending on the model used. Although these studies do suggest that
resident M(j) may play a key role in the initiation of inflammatory responses, there are
no definitive data available for PMN infiltration and pro-inflammatory cytokine
production in serosal inflammation.
1.2.2 Description and role of resident dendritic cells (DC):
Dendritic cells (DC) represent 1% of the resting resident peritoneal cells in
rats (van Vugt et al., 1991). DC are also described as the sentinel cells of the
immune system, at least with regard to their key interactions with the adaptive arm of
the immune response i.e. T and B lymphocytes (Banchereau and Steinman, 1998).
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DC can be located in non-lymphoid tissues and constantly sample their environment
to detect infectious or non-self stimuli. These immature resident DC have a limited
plasticity and life span (Foti et al., 2004). Similar to M(j>, splenic resident DC exhibit
different phenotypes and share numerous Mcj) markers and functions that highlight
the close relationship between Mcj) and DC (Leenen et al., 1998). The sensing
function of DC is mediated through various innate immune receptors such as the
Toll-like receptors (TLR). These receptors can react to different classes of infectious
agents including bacteria and viruses. Upon receptor ligation, DC can up-regulate
genes leading to expression of various cytokines and chemokines involved in the
inflammatory and immune response such as IL-1(3, IL-1 receptor antagonist (IL-
1RA), TNF- a, IL-2, IL-6, IL-12 p40, MlP-la, MIP-1(3,MlP-ly, MIP-2a, MCP-5,
macrophage migration inhibitory factor (MIF), inducible protein (IP)-10 and growth-
related oncogene (GRO)-l (Dubois et al., 1995; Granucci et al., 2001).
1.2.3 Description and role of lymphocytes:
Although lymphocytes are present in serosal cavities, their function during
inflammation has not been explored in detail (Faull, 2000). A short description of
the importance of the lymphocytes in the serous cavities will follow in the next two
sections and I will then discuss the different murine models that lack various
lymphocyte populations.
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1.2.3.1 Description and role of B lymphocytes:
B cells represent 2.3% of total cells in the human peritoneum (Hartman et al.,
1995). Peritoneal B lymphocytes are divided into 4 different subpopulations
according to their expression of CD5 (Ly-1) and MAC-1 as follows:
(i) B-la cells (CD5+, MAC-1+ and C45RALow) (Youinou et al., 1999),
(ii) B-lb cells (CD5~, MAC-1+ and C45RALow, these cells comprise 5-10 % of the
total B-l cell population) (Youinou et al., 1999),
(iii) B-lc cells (CD5+, MAC-1") (Hastings et al., 2006)
(iv) B-2 cells (CD5~, MAC-1"; comparable to normal circulating B cells) (Youinou et
al., 1999).
The B-l cells represent approximately 50% of the B cell population in the
murine peritoneum (10-20% of total peritoneal cells are B-l cells) (Hayakawa et al.,
1985). A key function of the B1 cells is the synthesis of immunoglobulins (Ig) and
natural antibodies (IgM) (Herzenberg, 2000). Peritoneal B cells are derived from
different progenitors (Herzenberg, 2000) and the B-la cells exhibit the capacity for
self-renewal (Youinou et al., 1999). The maintenance ofB-l cells in the peritoneum
depends on interactions between MeC-derived stromal cell-derived factor (SDF)-l
(Foussat et al., 2001) and constitutive IL-10 production (Balabanian et al., 2002). In
addition, CXCL13 production by peritoneal M(J> has an important role in the
peritoneal homing of B-l cells (Ansel et al., 2002). B-l cells play a role in the
initiation of the early phase of skin delayed-type hypersensitivity and are essential
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for subsequent T cell recruitment (Szczepanik et al., 2003); a finding that can also be
found in filarial models of inflammation (Ramalingam et al., 2003). B-l cell-
dependent IL-10 production can affect peritoneal M(j) phagocytosis and reactive
oxygen species production (Popi et al., 2004). B-l cells play an important role in
diseases mediated by filarial parasites (Paciorkowski et al., 2000) as well as in
autoimmunity (Boes et al., 2000), autoimmune haemolytic anemia (Watanabe et al.,
2002), atherosclerosis (Shaw et al., 2003; Shaw et al., 2000), and granuloma
formation (Bogsan et al., 2005).
1.2.3.2 Description and role of T lymphocytes:
The majority of peritoneal T cells express the a(3 T cell receptor (TcR) with
around 17% expressing the 76 TcR. The majority of T cells exhibit markers of
thymus-dependent origin and surface antigens compatible with an activation and
memory phenotype. This peritoneal T cell phenotype indicates that the peritoneum
is capable of thymus-independent differentiation of T cells (Hartman et al., 1995).
The CD4/CD8 ratio also differs from that evident in the blood where most of the T
cells are CD8+. Although the majority of peritoneal CD8+ cells secrete a Thl pattern
of cytokines such IL-2 as well as the cytotoxic mediators IFN-y and TNF-a, some
peritoneal CD8+ cells secrete the cytokines IL-4 and IL-5 that are characteristic of
Th2 cells (Birkhofer et al., 1996). These Th2-type cells are able to support B cell
differentiation and secretion of IgG and IgA (Birkhofer et al., 1996), whilst 78 T cells
would play an important role in monocyte/M(j) differentiation (Skeen et al., 2004).
These 78T cells would have an important role in regulation of the early
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inflammatory response and it is of interest that y5 T cell knock-out (KO) mice
exhibit greater pulmonary inflammation with increased numbers of PMN and M(|)
after aerosolised Bordetella per/«vsfs(Zachariadis et al., 2006). Similarly, increased
numbers of PMN and elevated cytokine levels were found in yh T cell KO after IP
Listeria inoculation (Skeen et al., 2001). This evidence suggests that y6 T cells are
important in regulating the extent of the inflammatory response in order to prevent
excessive damage. It is currently unclear why the lymphocyte population of the
peritoneal cavity is so different from the blood. However, the cytokine IL-15 may be
involved in the generation of such differences because it affects the maturation and
proliferation of NK and CD8 T cells and can be produced by M(j) and MeC
(Kobayashi et al., 2005; Rapoport et al., 1999; Tagaya et al., 1996). Pleural T cells
play an important role in eosinophil recruitment induced by LPS as selective ablation
ofT cells inhibited pleural eosinophil influx (Bozza et al., 1994).
1.2.3.3 Description of mice deficient in various lymphocyte
populations:
Different mice models to study lymphocyte functions are available. A
naturally occurring mutation in mice resulted in mice with absent hair, a congenital
absence of the thymus due to a defect of the thymic epithelium and absent T cell
development such that they are used as a model of T cell deficiency (Pantelouris,
1968; Wortis et al., 1971). There is some extrathymic T cell production present but
this is very marginal. The natural killer (NK) cells and M(j> of NUDE mice exhibit
increased cytotoxic activity (Budzynski and Radzikowski, 1994). The pMT KO
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mice were generated by disruption of one of the exons coding for the p-chain and
resulted in B cell development stopping at the stage of pre-B-cell maturation,
resulting in an absence of mature B cells (Kitamura et al., 1991). RAG-1 KO mice
were generated by mutating the RAG-1 gene involved in the V(D)J recombination
reaction of immunoglobulin and T cell receptors. RAG-1 KO lack mature T and B
cells but other immune mediators are increased such as complement activity and NK
cell activity (Mombaerts et ah, 1992; Shultz et ah, 2000).
1.2.4 Description and roie of resident mast cells:
There are two classes of mast cells in the mouse: connective tissue MC and
mucosal MC. As is the case for resident M(j), MC complete their maturation in the
tissue of residence under the influence of the local microenvironment. MC exist only
as "resident" cells and can produce inflammatory mediators such as histamine,
platelet-activating factor, prostaglandins, thromboxane, leukotriene, chymase,
cytokines (GM-CSF, TNF-a, IL-1,-3, -4 and -6) and chemokines (MCP-1 and MIP-
la) (He and Walls, 1998; Metcalfe et ah, 1997). Previous work has examined the
role of MC in the initiation and amplification of "non-immunologic" inflammation
(Wershil et ah, 1988) (Metcalfe et ah, 1997). In a model ofphorbol 12-myristate 13-
acetate (PMA)-induced cutaneous inflammation in MC-deficient W/Wv mice, MC
were involved in tissue swelling and leukocyte recruitment as adoptive transfer of
MC resulted in increased swelling and PMN influx (Wershil et ah, 1988). The
induction of BTG peritonitis in MC-deficient W/Wv mice resulted in a reduced PMN
recruitment compared to controls and this defect could be corrected with adoptive
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transfer (Qureshi and Jakschik, 1988). However, an inflammatory response was still
present in both models with PMN recruitment being reduced by 55% and 70% at 18h
in the PMA and the BTG model respectively and this suggests that MC are not the
only cell involved in the initiation of inflammation but are capable of modulating
inflammatory responses (Metcalfe et al., 1997; Qureshi and Jakschik, 1988). The
production of leukotrienes by MC is an important facet of the early PMN recruitment
in a model of infectious peritonitis (Malaviya and Abraham, 2000; Malaviya et ah,
2001). Another study examined the role of MC in PMN recruitment in three
experimental models of peritonitis after MC 'depletion' was induced by the
activating MC compound 48/80 (which induces excessive degranulation). MC
depletion had no effect upon BTG induced peritonitis, reduced PMN infiltration in
LPS induced peritonitis (though no chemokine differences were evident) and
inhibited PMN influx and chemokine secretion in zymosan induced peritonitis
(Ajuebor et ah, 1999). In addition to playing a role in zymosan peritonitis (Ribeiro et
ah, 2000), MC were essential for PMN recruitment in a cutaneous model of T cell-
mediated delayed hypersensitivity reaction (Biedermann et ah, 2000) and in an
experimental model of bullous pemphigoid (Chen et ah, 2002). In the study by Chen
et al, MC activation was crucial for the development of M(|)-dependent PMN influx
(Chen et ah, 2002). The lL-8-induced PMN recruitment into the air-pouch cavity is
MC-dependent and mediated by MC release of cytokine-induced neutrophil
chemoattractant (CINC)-l (Ramos et ah, 2003). Furthermore, PMN recruitment has
been found to be MC-dependent in zymosan-induced pleurisy (Takeshita et ah,
2003). In this context it is of interest that PMN recruitment is MC-independent in
carrageenan-induced pleurisy (Horakova et ah, 1980; Takeshita et ah, 2003). MC
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degranulation did not affect eosinophil recruitment in LPS-induced pleurisy (Bozza
et al., 1994). In summary, MC play a role in the initiation of inflammation but many
studies indicate that the prime action of MC is the modulation of the inflammatory
reaction.
1.2.5 Description and role of resident natural killer cells:
The NK cell population is enriched in the human peritoneal cavity of healthy
CAPD patients; 20% of the peritoneal lymphocytes would be NK cells whilst 4.2%
would be CD8+ NK cells (Lewis et al., 1993). In C57BL/6 mice, NK cells represent
3.2±0.8% of total unstimulated peritoneal cells whereas NK 1.1+ T cells represent
3.5±1.1% (Kawamura et al., 1999). Activated NK cells produce a spectrum of
cytokines such as TNF-a, IFN-y, GM-CSF, lymphotoxin and IL-8 (Das and Khar,
2002), whereas NK T cells can produce Thl-type cytokines (including IFN- y and
TNF- <^, as well as Th2-type cytokines (including IL-4 and IL-13) (Smyth and
Godfrey, 2000; Wilson and Delovitch, 2003). The production of IFN-y by NK T
cells is induced by M(j)-dependent IL-12 production (Kawamura et ah, 1999;
Kobayashi et ah, 1989). NK T cells can mediate cytotoxicity through Fas-Fas
Ligand and perforin/granzyme pathways (Wilson and Delovitch, 2003). NK T cells
are involved in many important biological processes including the suppression of
tissue destruction (allograft tolerance, GVHD), autoimmune responses, antitumour
responses and host defence against viral, bacterial and parasitic pathogens (Godfrey
and Kronenberg, 2004). NK T cells might be also implicated in allergy and contact
hypersensitivity (via IL-4 secretion in the latter). NK T cells may modulate B-l B
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and mast cell activation and have also been implicated in atherosclerosis (Godfrey
and Kronenberg, 2004). It remains to be determined ifNK T cells are regulators or
effectors of immune-mediated damage (reviewed in (Godfrey and Kronenberg,
2004)). Peritoneal resident NK cell activation would facilitate M(j) clearance of
bacteria (Scott et al., 2003) via IL-12 regulation (Godshall et al., 2003).
In summary, although the role ofNK cells in peritonitis or pleurisy remains
ill defined, it is likely that the modulation of the inflammatory response via IFN-y
secretion and the subsequent effects upon cytokine and chemokine production might
be of some importance.
1.2.6 Description and role of the mesothelial and stromal cells:
The mesothelial cell (MeC) lining constitutes a protective barrier to physical
and infectious injury and has a complex role in the immunity of the serosal cavity
(Mutsaers, 2004). Although peritoneal and pleural MeC may be similar in many
regards, there have been no studies that have directly compared them and therefore
their functions will be presented separately. MeC play an important role in
peritoneal inflammation (Topley, 1995b; Topley et al., 1993c; Topley and Williams,
1994) and tissue repair (Mutsaers et al., 1997; Rennard et al., 1984). In vivo and in
vitro studies have demonstrated that peritoneal MeC produce pro-inflammatory
cytokines such as IL-ip (Lanffancone et al., 1992) and IL-6 (Topley et al., 1993b),
anti-inflammatory molecules such as IL-10 and the decoy molecule IL-1 receptor
type II (IL-1RII) (Yao et al., 2004a; Yao et al., 2004b) and prostaglandins (Topley et
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al., 1994)((Jayne et al., 2000) (reviewed in (Broche and Tellado, 2001)). Stimulated
MeC increase the expression of adhesion molecules and produce chemokines [IL-8,
MCP-1 and Regulated upon Activation, Normal T Expressed and Secreted
(RANTES)] (Jonjic et al., 1992; Li et al., 1998; Topley et al., 1993a; Zeillemaker et
al., 1995) which represent essential steps in order to mount an inflammatory
response. CD40 is expressed at the MeC surface and is induced by IFN-y and CD40L
(CD 154). CD40 activation increases the expression of intercellular adhesion
molecule-1 (ICAM-1) by peritoneal mesothelial cells (Yang et al., 2004), which
facilitates ICAM-1-dependent PMN migration across the mesothelial membrane (Li
et al., 1998).
During pleural inflammation, it has been reported that MeC are
predominantly responsible for the secretion of C-X-C chemokines such as IL-8 and
C-C chemokines such as MlP-la and MCP-1 that act to recruit PMNs and
mononuclear cells (Antony et al., 1995; Mohammed et al., 1998a; Mohammed et al.,
1999; Mohammed et al., 1998b).
Fibroblasts are present in the interstitial stroma beneath the MeC layer and
are also implicated in serosal inflammation (Faull, 2000). Recent studies
demonstrated that activated peritoneal and pleural fibroblasts may be a source of C-
X-C and C-C chemokine production (Loghmani et al., 2002; Witowski et al., 2001).
In addition, resident cells, specifically fibroblasts, can play an important role in
leukocyte recruitment in the air-pouch model of inflammation (Garcia-Ramallo et al.,
2002).
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MeC involvement in the initiation of inflammation has been widely discussed
whilst the underlying population of fibroblasts may also be involved. However, most
studies involve the study of chemokine and cytokine production after the activation
of the MeC and this raises the possibility that other cells may well be involved in the
initial production of these activating cytokines. A "cytokine network" between the
resident cells is therefore essential for this initiation of inflammation (Topley,
1995a). Some studies have suggested that resident M(|)-derived pro-inflammatory
cytokines such as TNF-a would be essential for the secretion of C-X-C and C-C
chemokines from mesothelial cells and fibroblasts (Antony et al., 1995; Cuzzocrea et
al., 1999b; Frode et ah, 2001; Goodman et ah, 1992; Mohammed et ah, 1998b; Pace
et ah, 1999; Park et ah, 2003; Topley et ah, 1994; Witowski et ah, 2001). However,
there have been no definitive experiments performed to address this issue. Thl (IL-2,
IFN-y and lymphotoxin) and Th2 (IL-4, IL-5, IL-6 and IL-10) cytokines also appear
to have a role in the regulation of chemokine production, suggesting that leukocytes
other than M(j) might be involved (Kunkel, 1996; Mohammed et ah, 1999). This
provides an exciting environment to investigate the role of the resident M(J) and
lymphocytes in the orchestration of leukocyte recruitment in serosal inflammation.
1.3 Description of the M<j> ablation systems:
The simplest method to reduce Mtj) number in the peritoneal cavity is
peritoneal lavage in order to wash out M(j) from the peritoneal cavity. This has been
shown to reduce the number of recoverable M(|) number by about 80% and block
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PMN recruitment induced by various inflammatory agents (Barja-Fidalgo et al.,
1992; Souza et al., 1988). These studies therefore suggested that Mc() might be
involved in the control of PMN recruitment. In addition to these methods, various
depletion strategies have been developed to dissect M(j) function in vivo. M()>
depletion induced by the administration of liposomal clodronate is probably the most
common strategy used (Van Rooijen, 1989). Following the phagocytosis of
liposome encapsulated clodronate, the phospholipid bilayers are disrupted by the
action of lysosomal phospholipases and the clodronate is then released in the intra-
cytoplasmic compartment (Van Rooijen and Sanders, 1994). Clodronate
accumulation induces cell death by inhibiting mitochondrial adenosine triphosphate
(ATP)/adenosine diphosphate (ADP) translocase, thereby causing loss of the
mitochondrial membrane potential and direct induction of apoptosis (Green, 2003).
Clodronate released in the circulation from dead M(|) or by leakage from liposomes is
ineffective and does not kill bystander cells (Schmidt-Weber et al., 1996; Van
Rooijen and Sanders, 1994). M(|) and activated monocytes are the only cells to die
after phagocytosis of clodronate-containing liposomes as resting and activated PMN
did not undergo apoptosis despite phagocytosis of liposomes (Schmidt-Weber et al.,
1996). Resident M(|) ablation rates are high using this reagent but can be somewhat
variable. Examples of the efficacy ofmacrophage ablation in different organs include
the following; 78-88% ablation in the lung (Cheung et al., 2000), >95% ablation in
the liver and spleen, around 55% ablation of circulating monocytes (Zito et al.,
2001), 70% ablation in the eye (Pouvreau et al., 1998) and 85% ablation in the
peritoneum (Ajuebor et al., 1999). Recently, a modified version of this protocol has
been described using clodronate-loaded erythrocytes with a M(j) ablation rate of
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around 70% (Rossi et al., 2005). Using clodronate-based Mc() ablation, M(j) were
shown to be important in various situations including glomerulonephritis (D'Souza et
al., 1999), lung inflammation (Hashimoto et al., 1996), arthritis (Lawlor et al., 2005),
allograft rejection (Wyburn et al., 2005), diabetes (Jun et al., 1999), neointimal
formation (Danenberg et al., 2003), liver injury (Schumann et al., 2000),
experimental allergic encephalomyelitis (Huitinga et al., 1990), ischaemia-
reperfusion injury in the gut (Chen et al., 2004), uveitis (Baatz et al., 2001) and
pancreatitis (Shifrin et al., 2005). It is of interest that previous work using clodronate
to study the role of resident peritoneal M(|) in the initiation of experimental peritonitis
has produced conflicting results (Ajuebor et al., 1999; Knudsen et al., 2002). Ajuebor
et al showed that M(|> ablation had no effect upon PMN recruitment in the BTG and
zymosan model of peritonitis. In contrats, Knudsen et al demonstrated that M())
ablation blunted PMN influx in their casein model of peritonitis. The latter work is in
accord with a study using peritoneal lavage as a M(() depleting strategy as this
demonstrated an important role of resident Mcj) (Souza et al., 1988). Table 1
summarises the details and conclusions of various studies that have examined the
role of resident Mc|).
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A conditional M()> ablation strategy has advantages over the available
naturally occurring and induced M())-deficient mutant mice as the timing of Mc|)
elimination can be chosen. Despite their limitations, non-conditional Mc()-deficient
op op
mice have proven valuable for analysis. For example, the Csfm /Csfm
(osteopetrosis) mouse is a naturally occurring mutant of the colony stimulating
factor-1 gene and exhibits a M(|) deficiency at a level that permits viability in
homozygotes (Cecchini et al., 1994). These mice have provided significant insight
into M(|> function during development (Gouon-Evans et ah, 2000) as well as
inflammation (Lenda et ah, 2003). In addition, mice targeted at the PU.l locus
exhibit multiple defects in development of hematopoietic lineages including a
complete absence of tissue M(j) and B cells (McKercher et ah, 1996; Scott et ah,
1994). Although the PU.l mutation results in perinatal lethality, these mice have
been used to demonstrate that mesenchymal cells are able to clear apoptotic cells in
the absence of tissue M(j) during embryonic regression of inter-digital tissues (Wood
et ah, 2000).
Previous strategies used to eliminate specific cell types in a living organism
have included the generation of transgenic lines that express diphtheria toxin (DT)
A-chain (Breitman et ah, 1987; Pappenheimer, 1977) or the ricin polypeptide
(Landel et ah, 1988). However, even low levels of unanticipated transgene
expression can give unpredictable consequences in such mice (Breitman et ah, 1987).
The alternative ablation strategy of killing thymidine-kinase (TK) expressing cells
with gancyclovir (Heyman et ah, 1989; Minasi et ah, 1993) is useful but is limited by
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the fact that it only permits the elimination of proliferating cells. More recently,
conditional M(|) ablation has been achieved using transgenic expression of Fas under
the control of the c-fms promoter coupled with drug inducible Fas dimerization to
induce cell death (Burnett et al., 2004). Identification of the human receptor for DT
(also known as heparin-binding epidermal growth factor (hbEGF) (Naglich et al.,
1992) or referred to as DTR for diphtheria toxin receptor) created an opportunity for
a unique ablation strategy. The murine form of hbEGF binds DT poorly, but murine
cells can be rendered sensitive through transgenic expression of human hbEGF or
DTR. Richard Lang's group generated transgenic mice expressing human hbEGF
lineage specifically under the CD1 lb promoter (CD1 lb-DTR) and demonstrated that
cell ablation results from toxin injection (Cailhier et al., 2005). In addition, since DT
is a protein synthesis inhibitor this strategy results in the induction of death in both
mitotic and terminally differentiated cells. The death mechanism is apoptosis as
65% of the F4/80 positive peritoneal M(j) are Annexin-V positive 6 hours after DT
administration (Cailhier et al., 2005). The generation of CD1 lb-DTR transgenic
mice used in this study have also been used to demonstrate the importance ofM(j) in
progressive renal inflammation (Duffield et al., 2005b) and the progression of liver
injury and subsequent resolution of fibrosis (Duffield et al., 2005a). This strategy
has also been used to generate transgenic mice in which hepatocytes (Saito et al.,
2001) or dendritic cells (Jung et al., 2002) may be conditionally ablated.
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1.4 Overview of leukocyte recruitment:
Leukocytes are essential during acute inflammation and must migrate from
the blood to the site of inflammation. Circulating leukocytes migrate toward
inflammatory stimuli in response to a gradient of released chemoattractants or
chemokines. Resident cells such as M(j), MeC and fibroblasts constitute a reservoir
of such chemokines and upon cytokine activation will release them (Loghmani et al.,
2002; Topley et ah, 1996; Witowski et ah, 2001) and establish the necessary gradient
to attract leukocytes passing through the serosal vasculature (Figure 1.1 adapted from
(Luster, 1998)). The combined effects of inflammatory cytokines and
chemoattractants induce the following sequence of events:
1) Leukocyte rolling along endothelial cells,
2) Activation of leukocyte integrins,
3) Firm adhesion to the vascular endothelium (adherence),
4) Transmigration out of the vessel by passing between the endothelial cells,
5) Activation of the recruited leukocyte.
The rolling phase is mediated by the main leukocyte selectin ligand P-selectin
glycoprotein ligand-1 (PSGL-1) engaging with endothelial adhesion molecules
known as selectins (E-, L-, and P-selectin). Adherence involves the adhesive
interactions between integrins on the leukocytes (e.g. 2, 01 mP 2, a 4(3 1) and
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Figure 1.1 Overview of leukocyte recruitment
The rolling phase is mediated by the main leukocyte selectin ligand P-selectin
glycoprotein ligand-1 (PSGL-1) engaging with endothelial adhesion molecules
known as selectins (E-, L-, and P-selectin). Adherence involves adhesive interactions
between integrins on the leukocytes (e.g. a^, oufh) and members of the
immunoglobulin superfamily on the endothelial cells [e.g. intercellular adhesion
molecule (ICAM)-l and -2, vascular cell adhesion molecule (VCAM)-l], Both
ICAM-1 and VCAM-1 are induced on endothelial cells by inflammatory cytokines
(such as TNF-a) whilst integrins act as tethering molecules on the leukocyte surface.
The leukocyte transmigration is mediated by interactions between platelet
endothelial cell adhesion molecule-1 (PECAM-1) and members of the junctional
adhesion molecule family with their leukocyte counter-ligands. The final step of
diapedesis results in the leukocytes entering the extravascular connective tissue
having traversed the basement membrane with the aid of secreted matrix-degrading
metalloproteinases.
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members of the immunoglobulin superfamily on the endothelial cells [e.g.
intercellular adhesion molecule (ICAM)-l and -2, vascular cell adhesion molecule
(VCAM)-l] (Carlos and Harlan, 1994; Mclntyre et al., 2003). Both ICAM-1 and
VCAM-1 are induced on endothelial cells by inflammatory cytokines (such as TNF-
a) whilst integrins act as tethering molecules on the leukocyte surface. The
leukocyte transmigration is mediated by interactions between PECAM-1 and
members of the junctional adhesion molecule family with their leukocyte counter-
ligands. The final step of diapedesis results in the leukocytes entering the
extravascular connective tissue having traversed the basement membrane with the
aid of secreted matrix-degrading metalloproteinases (Nourshargh and Marelli-Berg,
2005).
1.5 Description of relevant cytokines:
Cytokines are a group of secreted proteins that carry a message from cell to
cell ("cyto") and induce a targeted cell to accomplish something ("kine" from the
same root as kinetics). They were called lymphokines or monokines depending of
the cell of origin. Many of these molecules are now known as interleukins (proteins
talking to leukocytes) (Sigal, 2004). Cytokines are multifunctional proteins and are
involved in cell growth and activation, inflammation, immunity and cell
differentiation (Feldmann et al., 1996). Many cytokines are secreted simultaneously
and their action can compete against each other. They can enhance or inhibit
production of cytokines or other proteins such as chemokines and can either increase
or decrease the inflammatory response (Gouwy et al., 2005). As it was discussed
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previously, cytokines are essential stimulators of resident cells in order to initiate
chemokine production. There are numerous cytokines that are grouped in different
families but I will describe only the main cytokines that have been involved in
models of peritonitis and pleurisy.
1.5.1 IL-ip and TNF-a:
IL-1|3 and TNF-a are potent pro-inflammatory cytokines produced by M([),
epithelial, NK and T cells that are systemically involved in the acute-phase response.
They increase body temperature, hepatic production of acute-phase proteins, which
play a crucial role in opsonisation, mobilise energy to allow increase in temperature,
allow PMN mobilisation and promote signal to involve adaptive immunity. They
also have an important local effect. They contribute to endothelium and leukocyte
activation (Janeway et al., 2001; O'Shea et al., 2002). TNF-a can induce production
of other pro-inflammatory cytokines such as IL-1 (3 and 1L-6 (O'Shea et al., 2002).
Furthermore, IL-1 (3 and TNF-a play a crucial role in the initiation and modulation of
the inflammatory response in serosal cavities as it was demonstrated earlier through
induction of chemokine secretion by resident cells (Antony et al., 1995; Frode et al.,
2001; Goodman et al., 1992; Lewis and Holmes, 1991; Mohammed et al., 1998a;
Park et al., 2003; Tessier et al., 1997; Topley et al., 1993c).
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1.5.2 IFN^y:
IFN-y is produced mainly by T and NK cells, its production by M(|), DC and
PMN remains ill-defined. It is a major pro-inflammatory cytokine and it has an
important role in antiviral activity but also in regulating function of innate and
adaptive immunity (Renauld, 2003; Trinchieri et al., 2003). IFN-y has been
implicated as a potent regulator of C-X-C and C-C chemokines in MeC and acts to
downregulate IL-8 and upregulate MCP-1 and RANTES (Robson et al., 2001).
Cytokine production can also be induced (Trinchieri et al., 2003). IFN-y can control
PMN recruitment and sIL-6R signalling in vivo (McLoughlin et al., 2003).
Therefore, it might be important in regulating leukocyte recruitment in experimental
peritonitis and pleurisy.
1.5.3 IL-6:
IL-6 has a more complex role and can have pro-inflammatory (Cuzzocrea et
al., 1999b; Romano et al., 1997) and anti-inflammatory proprieties (Tilg et al., 1997;
Tilg et al., 1994; Xing et al., 1998) depending on the model used. IL-6 is produced
by a variety of cells (M(j), MeC, endothelial cells and fibroblasts) in response to
inflammatory stimuli or other cytokines such as IL-ip and TNF-a. Previous work in
experimental models of pleurisy suggested that the initiation of inflammation is
dependent upon endogenous IL-6 secretion that subsequently stimulates the
additional production of TNF-a and IL-ip from resident pleural cells (Cuzzocrea et
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al., 1999b). In contrast, increased IL-1(3 levels have been reported to precede
elevated IL-6 levels (Utsunomiya et al., 1991) and this suggests that IL-1 (3 might
induce IL-6 production, so the exact temporal production of cytokines is not entirely
clear. IL-6 has also been described as an important inducer of chemokine
production. Moreover, the administration of IL-6-sIL-6R complex to cells unable to
respond to IL-6 was able to generate a pro-inflammatory response (Romano et al.,
1997). However, these complexes have been involved in down-regulation of C-X-C
chemokines and up-regulation of C-C chemokines production by MeC thereby
stopping PMN recruitment and facilitating mononuclear cell recruitment (Hurst et
al., 2001). Furthermore, IL-6 production has been linked to production of anti¬
inflammatory molecules by M(j) such as circulating IL-1 receptor antagonist (IL-lra)
and soluble TNF receptor p55, which neutralize their respective ligand (Tilg et al.,
1994).
1.5.4 IL-10:
IL-10 is produced by M(J>, lymphocytes and keratinocytes. It has an
immunomodulatory role and can inhibit Thl responses, promote Th2 responses,
down-regulate expression of activating and co-stimulatory molecules, suppress M(()
pro-inflammatory cytokine production (such as TNF-a and IL-l(3)and inhibit
chemokine production. IL-10 can downregulate IL-8 production and increase
soluble TNF-a receptor and IL-IRa and MCP-1 production by monocytes (Seitz et
al., 1995). It is considered as an anti-inflammatory cytokine, thereby representing
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the counter-balance for TNF-a and IFN-y pro-inflammatory activities (Pestka et al.,
2004; Renauld, 2003).
1.5.5 IL-12:
IL-12 is mainly produced by M((>, B and dendritic cells. It is an important
immunoregulatory and pro-inflammatory cytokine, that links innate to adaptive
immunity. It is essential for cell-mediated immunity (Thl differentiation), resistance
to infections and tumours. Many of its pro-inflammatory functions are mediated by
IL-12-induced IFN-y production (Trinchieri et al., 2003).
1.6 Description of relevant chemokines:
The presence of inflammatory stimuli will induce secretion of cytokines that
will lead to release of chemotactic cytokines that recruit leukocytes. These
chemotactic cytokines or chemoattractants are small proteins that lead to leukocyte
accumulation and are called chemokines. They are divided into four families








C-X-C chemokines are named as such because of the presence of a single
amino acid between the two cysteine residues nearest to the N-terminal position.
They are divided into ELR+ and ELR- because of the presence of a glutamate-
leucine-arginine motif before the first two cysteines. ELR+ C-X-C chemokines
attract PMN and are represented by IL-8 (CXCL8) and GRO-ain humans and
byMIP-2 and KC in mice. IL-8 can be produced by monocytes, T cells, PMN,
fibroblasts, endothelial cells and MeC. IL-8 is a potent PMN attractant but can also
attract T cells. GRO-a is a specific and potent PMN chemoattractant. IL-8 and
GRO-a acts through the receptors CXCR1 and CXCR2. There is no equivalent of
IL-8 in mice. However, KC and MIP-2 are two homologues of human GRO-a. In
murine cells, KC and the MIP-2 receptor, CXCR2, plays a major role in PMN
recruitment (McColl and Clark-Lewis, 1999) and this receptor also mediates human
IL-8 chemoattractant signal.
ELR- C-X-C chemokines attract mostly lymphocytes and are represented by
IFN-y-inducible protein (CXCL10), monokine induced by ILN- y(CXCL9), IFN-
inducible T cell a-chemoattractant (CXCL11) and stromal-derived factor (SDF)-l.
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1.6.2 C-C chemokines:
In members of the C-C chemokine family, the two final cysteines are adjacent
and these chemokines attract a broader range of cells. MCP-1 was the first C-C
chemokine to be identified. It is a potent monocyte chemoattractant but can also
attract PMN and T cells. MCP-1 (CCL2) interacts with CCR2 and this receptor is
essential for the recruitment of monocytes to the peritoneum after BTG
administration (Kuziel et al., 1997). MlP-la is included in this family and was
called macrophage inflammatory protein as it was identified from LPS-stimulated
monocytes. MlP-la attracts monocytes, but is less potent in this regard than MCP-1.
MlP-la also attracts PMN and T cells. Another important member of this family is
RANTES which can attract monocytes, T cells and NK cells. The actions of both
MlP-la and RANTES are mediated by CCR1.
1.6.3 C-X3-C chemokine:
The C-X3-C chemokine family is characterised by the presence of three
amino acids between the two cysteines and has only one member called fractalkine.
Fractalkine is an integral membrane protein that can be cleaved in order to exert its
chemoattractant effect on monocytes and T lymphocytes.
34
1.6.4 C chemokine:
The C chemokine family is named as such because of the presence of only
cysteine in the N-terminal domain. So far, the chemokine lymphotactin is the only
member of this family and this chemokine appears to be an exclusive T cell
attractant.
The most important function of chemokines is chemoattraction. Chemokine
secretion will create a chemokine gradient that will give recruitment directions to
leukocytes. They also promote the integrin activation that is an essential requirement
for firm leukocyte-endothelial interactions. Furthermore, chemokines are involved
in degranulation and mediator release from attracted leukocytes. They also have a
role in lymphoid organ development, metastasis, angiogenesis and angiostasis
(Mackay, 2001; Rossi and Zlotnik, 2000). Chemokines are therefore crucial to the
development of inflammation and their differential regulation will affect the nature
of the inflammatory cells present at sites of inflammation. It is therefore important
to determine and understanding the temporal sequence of chemokine secretion in
order to fully appreciate the complexity of this cellular ballet.
1.7 Other inflammatory mediators:
Leukocytes can metabolise arachidonic acid (AA) into prostaglandins (PG),
thromboxanes (Tx), leukotrienes (LT) and prostacyclins and all of these members of
the eicosanoid family are key regulators of inflammation (Harizi and Gualde, 2005;
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Stenson and Parker, 1980). The name is derived from the characteristic twenty
carbon fatty acid derivatives, eicosa or twenty in Greek (Funk, 2001). PGs mediate
several of the cardinal signs of inflammation including vasodilation, oedema and
pain (Morley, 1974). McJ) can produce all the AA metabolites upon different stimuli
(Stenson and Parker, 1980) and represent a major source of PGs (Ferraris and
DeRubertis, 1974). Vascular permeability has usually been associated with mast
cells, but recent data suggest that M(|)-derived LT may represent important mediators
of vasopermeability (Kolaczkowska, 2002; Kolaczkowska et al., 2002). LTB4 has
been shown to be present in pleural effusions and has important chemotactic
properties for PMN. Pleural M(J> appear to be an important source of LTB4 (Pace et
al., 2004). LTB4 also appears to play a role in peritonitis but exerts more marked
effects upon eosinophils compared to other leukocytes (Tager et al., 2000).
Although the complement system was initially considered as an additional
weapon or 'complement' to humoral immunity, it now clear that it is also associated
with cellular immunity. Complement can enhance innate immunity by promoting
phagocytosis of apoptotic cells (Mevorach et al., 1998) and bacteria (Brown et al.,
1983; Brown et al., 1982) as well as bridging innate to adaptive immunity and
regulating the adaptive arm by enhancing B and T cells responses (reviewed in
(Carroll, 2004)). Complement production is mostly hepatic and is upregulated by IL-
6 as part of the acute phase response. Some of the early components, such as Clq,
are also produced locally by Mcj) (Loos et al., 1980; Rabs et al., 1986). Peritoneal
resident and BTG-stimulated M(|) have been showed to increase their production of
Clq following IL-6 stimulation whereas IL-1 and IFN-y inhibited Clq production
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(Faust and Loos, 2002). Production of the initial members (CI, C2, C3 and C4) of
the complement system by cells of the innate immune system is crucial to the
formation of the membrane attack complex. An additional role includes the
opsonisation of both bacteria and apoptotic cells as well as enhancement of adhesion
molecule expression on the endothelial cell surface (Kishore et al., 2004; Kishore
and Reid, 2000). Furthermore, complement also plays a crucial role in inflammation
per se. For example, the tissue damage and inflammation induced by the reperfusion
phase following ischemia is complement-dependent (Barrington et al., 2001). The
activation of C3 and C5, which are key members of the complement pathway,
liberates the fragments C3a (Bokisch et al., 1969) and C5a (Kay et al., 1973) that are
also called anaphylotoxins as a result of their important pro-inflammatory functions.
Mc|) are able to generate these two fragments (Huber-Lang et al., 2002; Taylor-
Robinson et al., 1978). The production of anaphylotoxins is common to all three
activation pathways of complement and underscores their importance in the
inflammatory reaction. They play an important role in the initial PMN (Snyderman
et al., 1971) and monocyte recruitment (Zwirner et al., 1998), modulate
cytokine/chemokine release from M()) (Goodman, 1984; Guo and Ward, 2005) and
exert immunomodulatory effects (Chenoweth et al., 1982) by ligation to their
respective surface receptors, C3aR and C5aR (Ames et al., 1996; Gerard and Gerard,
1991; Kildsgaard et al., 2000). An increased expression of the anaphylotoxin
receptor C5aR was found at the surface of peritoneal resident M(|) and PMN
compared to the surface of BTG-recruited Mcj) (Chenoweth et al., 1982). This could
demonstrate the importance of 'C5a awareness' in the gate-keeping leukocytes such
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as resident Mcj) in the initiation of inflammation secondary to anaphylotoxin
production.
Thus these two classes of inflammatory mediators, eicosanoids and
complement proteins, can play an adjuvant role to cytokines and chemokines in order
to promote an adequate inflammatory response to any type of tissue insult.
1.8 Inflammation Models:
The models described in these studies were used as tools to assess the 'gate-keeper'
functions of serosal resident leukocytes. Although the models of thioglycollate and
zymosan peritonitis have been extensively used to study inflammatory processes,
such models may not accurately reflect the clinical situation in patients with infection
or inflammation of the peritoneal space. For example, in the clinical context, patients
undergoing chronic ambulatory peritoneal dialysis develop peritonitis following the
exogenous introduction of bacteria or yeast. It is therefore apparent that these
experimental models do have significant limitations such that the findings must be
interpreted with some caution in extrapolating to the clinical situation. Despite this,
it is undoubtedly the case that these experimental models have provided great
insights into the biology ofperitoneal inflammation.
A similar criticism of the model of carrageenan pleurisy may be made as clinical
pleural inflammation is generally seen in association with pulmonary infection.
However, clinical situations do arise where intra-thoracic or intra-mediastinal tubes
38
are inserted e.g. following a pneumothorax or cardiac surgery and in such
circumstances pleural inflammation can originate from a defect in the thoracic wall
without a primary lung lesion. Therefore, the administration of exogenous
Staphylococcus aureus into the pleural space does recapitulate some aspects of such
a situation.
1.8.1 Brewer's thioglycollate peritonitis:
Brewer's thioglycollate (BTG) peritonitis is frequently used as a model of
leukocyte recruitment. It has been used for over 40 years as a source of recruited M(j)
(Gallily and Feldman, 1967; Gallily et al., 1964) and for over 20 years as a source of
recruited neutrophils (PMN) (Baron and Proctor, 1982). It is a resolving model and
is characterised by an initial influx of PMN peaking at 6-12h, which resolves by 24-
36h (Baron and Proctor, 1982). Subsequently, monocytes are recruited by 24h and
the inflammation has subsided by day 7-10 (Melnicoff et ah, 1989). The exact
nature of the innate inflammatory stimulus in this model is unknown. It has been
described as 'non-specific' (Li et ah, 1997) and to involve complement-independent
pathways (White et ah, 2002). The fact that thermically aged BTG induces an
increased leukocyte recruitment compared to fresh BTG led Li et al to suggest that
the accumulation of advanced glycation end-products (AGEs) induced by
autoclaving might mediate the inflammatory stimulus (Li et ah, 1997). Therefore,
the inflammation may be mediated through the AGE receptor, RAGE (Chavakis et
ah, 2003). In this study, however, Chavakis et al looked at RAGE-Mac-1 interactions
and not at the induction of inflammation. It is therefore difficult to be sure whether
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RAGE is involved in peritonitis induction by BTG. It is generally accepted as an
'LPS-like' model of inflammation without exhibiting full M(j) activation or the full
bactericidal potential of the M([) (Eichner and Smeaton, 1983; Leijh et al., 1984).
1.8.2 Zymosan peritonitis:
Zymosan is a derivative of the fungal cell wall from Saccharomyces
cerevisiae. As with BTG, this model is a resolving model and is characterised by an
initial PMN influx that is followed by monocyte recruitment. The pro-inflammatory
signals can be mediated directly to the M<j) through binding of zymosan to TLR-2
(Sato et al., 2003) or indirectly by secretion of various pro-inflammatory mediators
(recently reviewed in (Volman et al., 2005)). The phagocytic receptor dectin-1 has
been shown to interact with TLR-2 in response to zymosan (Gantner et al., 2003).
Resident M(|>, along with MC, have been reported to play an important role in
inducing PMN recruitment in a zymosan peritonitis model through TNF-a, IE-1 (3
and IL-8 secretion (Ribeiro et al., 2000). However, as for the BTG model, there are
still unresolved issues (Ajuebor et al., 1999).
1.8.3 Carrageenan pleurisy:
Carrageenan is an Irish sea-moss and induces complement dependent inflammation.
Carrageenan-induced pleurisy is a well-established model of acute inflammation
(Murai et al., 2003) and is characterized by a rapid influx of neutrophils (PMN)
followed by mononuclear cell infiltration (Ackerman et al., 1980; Harada et al.,
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1996). This model is often used to assess the anti-inflammatory effects of
pharmaceutical agents that will eventually be used clinically (Cuzzocrea et al.,
1999a; Cuzzocrea et al., 2000b; Cuzzocrea et al., 2004; Frode-Saleh and Calixto,
2000; Salvemini et al., 2001) and to assess the in vivo importance of established
inflammatory mediators (Cuzzocrea et al., 2000a; Gilroy et al., 1999; Gilroy et al.,
2004). Although the neutrophil influx evident in this model is generally used as an
experimental readout of acute inflammation, there are data indicating that neutrophils
are involved in the release of injurious enzymes and modulation of vascular
permeability in carrageenan-mediated pleural inflammation (Dalmarco et al., 2002;
Saito et al., 2002). Carrageenan has been referred to as a 'M(|)-depleting agent' but,
in the only specific paper on the subject, the authors were using i-carrageenan
(Ishizaka et al., 1989). However, despite one paper showing reduced splenic M(|)
after i.p. X-carrageenan treatment (Goldmann et al., 2004), the evidence only implies
functional modifications and no alteration in macrophage viability following X-
carrageenan administration (Vijayakumar and Muthukkaruppan, 1990; Vijayakumar
et al., 1989).
1.8.4 Formalin Fixed Staphylococcus aureus pleurisy:
Staphylococcus aureus (S. aureus) is a Gram positive coccus that may cause
severe infections (Caksen et al., 2000). The inflammatory reaction is mediated by
peptidoglycan and lipoteichoic acid from the bacterial cell wall. The immune
response against S. aureus leading to cytokine production is TLR-2- and MyD88-
dependent (Takeuchi et al., 2000; Takeuchi et al., 1999; Texereau et al., 2005). S.
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aureus stimulates TLR-2, which induces Racl GTPase activation that leads to
nuclear factor (NF)-kB transactivation (Arbibe et al., 2000). Recent data indicate
that CD36 mediates phagocytosis of S. aureus and facilitates direct interactions with
TLR-2 and -6 in order to induce NF-kB activation and this is similar to the
interaction of CD14-TLR-4 with LPS (Stuart et al., 2005). On the other hand, S.
aureus is able to secrete a chemotaxis inhibitory protein that is able to blunt the
leukocyte response to pro-inflammatory compounds secreted by S.aureus (de Haas et
al., 2004).
1.9 The Aims of this Study
This thesis will evaluate the role of the resident M(j) in both peritoneal and pleural
cavities in orchestrating PMN recruitment and look into the cytokine/chemokine
network involved in this process. These studies will be accomplished using a
recently described conditional M(|) ablation murine model. The contribution of
lymphocytes in early leukocyte recruitment will be also looked at with the use of
mice exhibiting various deficiencies in lymphocyte populations. This work was
designed to address the following hypotheses:
1) The resident peritoneal and pleural M()) are key sentinel cells and
orchestrate the initiation of inflammation by directing the generation of
chemokines.
2) Resident peritoneal lymphocytes are capable of modulating innate immune
responses.
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In particular the questions addressed by the work include:
1) Are resident M(|) responsible for the initiation of inflammation in
peritonitis and pleurisy?
2) What are the key cytokines and chemokines involved in this process?
3) Can the in vivo cellular network between leukocytes initiated by M(j) be
studied in vitro?
4) How do the resident lymphocytes modulate leukocyte recruitment in
peritonitis? In this regard I hypothesise that the lymphocytes are
modulating innate immune processes.
5) What are the chemokines involved in lymphocyte-mediated modulation of
leukocyte recruitment?





The following experimental animals were used in these studies:
1) Homozygous CDllb-DTR mice on the FvB/N background were bred at the
University of Edinburgh. In experiments involving homozygous CD1 lb-DTR mice,
either FvB/N wild-type (WT) (Harland, UK) treated with DT or CDllb-DTR mice
treated with vehicle served as eontrols.
2) RAG-1 KO mice were obtained from Charles River UK and exhibit a deficiency
ofmature B and T cells. The RAG-1 KO mice were on the C57BL/10 background
and C57BL/10 mice (Charles River UK) were used as controls.
3) NUDE mice were obtained from Charles River UK and exhibit a deficiency in T
cells. NUDE mice were on the CD1 background and CD1 mice (Charles River, UK)
were used as controls.
4) (iMT mice were a kind gift of Prof D. Gray (University of Edinburgh) and exhibit
a deficiency in B cells. The pMT mice were on the C57BL/6 background and
C57BL/6 mice (bred in-house at the University ofEdinburgh) were used as controls.
2.2 Conditional Macrophage ablation:
Resident peritoneal and pleural M(J) were ablated in homozygous CDllb-
DTR mice by intraperitoneal (IP) injection ofDT (25ng/g body weight) 24 h prior to
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the administration of pro-inflammatory agents (see below). In the majority of
experiments DT-treated FvB/NWT mice served as controls.
2.3 Induction of experimental peritonitis:
The well-established models of Brewer's thioglycollate or zymosan peritonitis were
used to induce peritoneal inflammation. Mice were injected IP with 1 ml of 3%
Brewer's thioglycollate (BTG) (DIFCO, Detroit, MI) or 0.2mg of zymosan (Sigma,
St. Louis, MO) and underwent peritoneal lavage at various time points following the
initiation of inflammation. Peritonea were lavaged at different time points with 5ml
of cold PBS (Sigma, Dorset, UK). The undertaking of a peritoneal lavage is an
invasive procedure and so called 'bloody lavages' were occasionally encountered.
Peritoneal lavages were excluded from subsequent analysis if they exhibited gross
contamination with blood that was evident on macroscopic inspection as circulating
blood cells could affect the assessment of the recruited leukocyte number.
Furthermore, serum or plasma may also interfere with the analysis of peritoneal
cytokines or chemokines. Three peritoneal lavages were excluded in experiments
involving BTG peritonitis after macrophage ablation. In addition, one lavage derived
from a RAG-1 KO mouse, two lavages from CD 1 mice and one lavage derived from
a NUDE mouse were excluded.
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2.4 Induction of experimental pleurisy:
The agents used to induce pleural inflammation included 1% carrageenan (a
kind gift from Marine Colloids Inc, Philadelphia, USA) and formalin-fixed
fluorescently labelled Staphylococcus aureus (Sigma, Dorset, UK). Mice were
anaesthetised with halothane and a small incision was made between the 6th and 8th
intercostal muscles. The pro-inflammatory agent was then injected intra-pleurally
(IP1) with a blunted 21G needle and the wound closed with a Michel clip. Animals
were subsequently killed by a rising concentration of C02 at various time points after
pleurisy induction in order to prevent bleeding in the pleural cavity.
Mice underwent pleural lavage at various time points following inflammatory agent
injection. Pleural lavage was performed lavaging the pleural cavity with 1 ml of
3.15% (weight/volume) sodium citrate (Sigma, Dorset, UK) in saline.
Macroscopically 'bloody' pleural lavages were excluded for reasons similar to those
mentioned in the previous section. Three pleural lavages were excluded in the
carrageenan induced pleurisy time course for this reason.
2.5 Cell processing and flow cytometry analysis:
For flow cytometric analysis, peritoneal or pleural cells were incubated for 30
minutes in PBS containing 10% mouse serum. Conjugated antibodies at
concentrations suggested by the supplier were then added and the mixture incubated
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at 4 C for 30 minutes. The cells were then washed before undergoing flow cytometry
analysis. Circulating numbers of leukocytes were also determined from samples of
whole blood. 25pi ofwhole blood was obtained by tail vein bleed into 3.9% sodium
citrate. The blood was aliquoted into flow cytometry tubes, blocked with PBS
containing 10% mouse serum and stained as for cells retrieved by pleural or
peritoneal lavage. 2 ml of FACSLysis buffer (BD, UK) was then added to lyse
erythrocytes and samples were spun and processed by flow cytometry. The following
antibodies were used: anti-CDllb fluorescein isothiocyanate (FITC), anti-GRl
phycoerythrin (PE) and anti-c-kit PE (all from eBiosciences, UK), anti-B220 (mouse
CD45R) PE and FITC and mouse anti-CD3 PE (both from Pharmingen, San Diego,
CA) and F4/80 allophycocyanin (APC) and F4/80 PE (both from Caltag, UK). A
known amount of fluorescent Flow-check fluorospheres (Beckman and Coulter,
USA) was added to each sample prior to analysis and the ratio of cells to beads used
to calculate the absolute number of any cell type in experimental fluid. Analyses
were performed using a FACScan or FACScalibur instrument and analyzed using the
FlowJo software (Treestar, Oregon, USA). Comparisons were made between
different mice at each time point.
Flow cytometric assessment of leukocyte numbers was performed as it is an
objective and rapid technique for counting cells (Backteman et al., 2002; Bono et al.,
1999; Burgess and Davison, 1999; Deneys et al., 1994; Derer et al., 1983) compared
to the analysis of more traditional cytospin smears where only a relatively small
number of cells can be counted. It has been previously used in the literature to assess
leukocyte number in inflammation (Henderson et al., 2003). Also, the use of flow
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cytometry has been compared to analysis of cytospin smears to assess cell numbers
and similar results were reported (Schweppe et al., 1992; van Zaanen et al., 1995)
thereby suggesting that both techniques are valid. However, flow cytometry was
better than cytospin smears if leukocyte numbers were low (van der Meer et al.,
2001). Flow cytometry also has its limitations as antibody specificities and
reactivities can be variable and the assessment of cell number is dependent upon the
positioning of the gates. For this reason, I used the same gates for each time points
in order to minimise variation due to this potentially confounding issue. Cytospin
smears are also subject to technical difficulties such as distortion of cell morphology
secondary to centrifugation that can prevent adequate cell identification. Flow
cytometry plots of typical time course peritonitis patterns are depicted in Figure 2.1.
2.6 Adoptive transfer of resident peritoneal and pleural cells:
Cells derived from the lavage of serosal cavities of groups of naive FvB/N
control mice were pooled, centrifuged and either underwent positive or negative
selection for macrophages. Peritoneal lavage samples from groups of FvB/N control
mice were pooled, spun and either plated on tissue culture plastic for 90 minutes in
order to deplete M(j) by adhesion (M<j)-depleted peritoneal cells) or resuspended in
sterile PBS (M(|)-rich peritoneal cells). M<|> depletion by adhesion resulted in removal
of 97±2.8% of Mc|) from the cell suspension. The M<j)-depleted peritoneal cell
population or the M(j)-rich peritoneal cell population were subsequently adoptively
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Figure 2.1- Representative flow cytometry plots of typical time course
in peritonitis.
1 ml of 3% BTG was administered in C57BL/6 mice and peritoneal lavages
performed at different time points.
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Pleural lavages from groups of naive FvB/N control mice were resuspended in
PBS with 0.5% mouse serum and 2mM ethylenediaminetetraacetic acid. Cells
were then incubated for 10 minutes with PE-conjugated anti-F4/80 antibody to label
M((>. Cells were then washed and spun at 350G for 10 minutes. The PE-conjugated
anti-F4/80 labeled M(j) were then incubated for 15 minutes with anti-PE conjugated
MACS magnetic beads (Miltenyi Biotech Ltd, UK). Cells were then washed, spun
for 10 minutes and M<f> subsequently removed by passing the cells over a magnetic
MACS column. As a control, pleural cells were incubated with an isotype control
antibody and then processed exactly as for F4/80 labeled cells. This method of M(|)
depletion removed 98.2±0.7% M(|). This Mcj)-depleting strategy was also used once
with peritoneal cells and yielded similar results to the M(|) depletion by adhesion
method. In addition, resident pleural M(() were purified by negative selection
following incubation of pleural cells with anti-B220, anti-c-kit and anti-CD3
antibodies (all antibodies were PE conjugated) for 15 minutes in order to label B cell,
mast cells and T cells. This was followed by incubation with anti-PE conjugated
MACS magnetic beads and passage through the magnetic MACS column. The M(|)
purified by negative selection were >90% pure as assessed by F4/80 labelling. In
experiments studying the effects of the reconstitution of Mc|> ablated mice by the
adoptive transfer of non-transgenic FvB/N M<|), the purified Mcj) (purified by negative
selection) as well as the Mc()-depleted and M<j> rich pleural cell populations were
resuspended in 1% carrageenan and administered into the pleural cavity of each
mouse.
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Approximately 20% of the initial pleural resident Mcf) are lost following the
passage of resident pleural cell populations over the MACS column irrespective of
whether the cells had been stained with antibodies and this presumably reflects non¬
specific cell loss. The expression of the M(() marker F4/80 was compared between
Mcj) that had been through the column to Mcj) that have been bound to the column and
later eluted. F4/80 expression was comparable between these two groups (Figure
2.2). I did not undertake more extensive phenotyping.
2.7 Adoptive transfer of T cells into NUDE mice:
Resident peritoneal T cells were purified by negative selection. Peritoneal
lavage cells from CD1 mice were pooled and the cells were incubated for 15 minutes
with anti-B220, anti-c-kit and anti-F4/80 antibodies (all antibodies were PE
conjugated) in order to label B cell, mast cells and M(j). This was followed by
incubation with anti-PE conjugated MACS magnetic beads and passage through the
magnetic MACS column. Approximately 50,000 T cells (a purity of 22% was
obtained) were then transferred into NUDE mice at the same time as the
administration of BTG and peritoneal lavages were performed 8h afterwards.
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Figure 2.2- F4/80 expression of pleural resident M(j> after passage
through the magnetic column.
Pleural resident cells were incubated with a PE-conjugated isotype control antibody
followed by incubation with anti-PE conjugated magnetic beads. Cells were then
passed over a magnetic column with cells that bound to the column being
subsequently eluted. Macrophages that either passed through or were bound in the
column were then stained with F4/80 APC in order to analyse F4/80 expression.
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2.8 Supernatant transfer studies:
NUDE and CD1 mice were injected with BTG and peritoneal lavage was
performed after 3h with 3ml of PBS in order to reduce the dilution of
chemoattractants. The peritoneal lavage fluid was centrifuged (1000G for 15
minutes) to remove cells and debris. The peritoneal supernatant fluid was then
injected IP into NUDE and CD1 mice in a cross-over fashion in order to evaluate the
capacity of the various mediators within the supernatant fluid to induce PMN
recruitment. Peritoneal lavage and tail vein blood sample was performed 8h
following the injection of peritoneal supernatant fluid and cells were stained for the
PMN marker GR1 and counted by flow cytometry as previously described.
2.9 In Vitro and In Vivo Chemokine and Cytokine Studies:
Mice underwent peritoneal or pleural lavage at various time points following
the administration of BTG or carrageenan in order to determine the levels of
chemokines and cytokines. Lavage fluid supernatant was centrifuged and stored at -
80°C until analysed by specific ELISA for MIP-2, KC, MIP-lcx, MCP-1 and TNF-a,
TGF-p (R&D, UK). The concentrations of IL-6, IL-10, IL12p70, IFN-y and MCP-1
in lavage fluid or cell culture supernatant were determined using a Cytometric Bead
Array (CBA) (BD Biosciences, UK). Cytokine-specific-antibody-coated beads were
incubated with a fixed volume of experimental lavage fluid and followed by addition
of the PE detection reagent. Samples were then washed and analysed by flow
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cytometry to determine the cytokine concentrations according to the shift in
fluorescence generated by the beads.
In order to dissect the role of various cells present in the peritoneum or
pleural space in the generation of pro-inflammatory mediators, peritoneal cell
populations that had been depleted of either M(|), MC, B cells or T cells was
stimulated in vitro. Peritoneal cells were incubated for 15 minutes with either PE-
conjugated anti-F4/80, PE-conjugated c-kit (CD117)(Pharmingen, UK) or an
antibody to B-220 or CD3 in order to label M(|), MC, B or T cells respectively.
Peritoneal cells were then incubated with anti-PE conjugated MACS magnetic beads
and the M(|), MC, B or T cells removed by passing the cells over a magnetic MACS
column (Miltenyi Biotech Ltd, UK). As a control, total peritoneal cells were
incubated with an isotype control antibody followed by magnetic beads and
subsequently passed over the magnetic MACS column. This method resulted in
>97% depletion of the cell type of interest. Figure 2.3 illustrates flow cytometry
analysis of the peritoneal cell populations obtained after magnetic immunodepletion.
Pleural cells were only incubated with an anti-F4/80 antibody in order to deplete M(j)
and this depleted over 98% of M(j). Chemokine and cytokine production by intact
control peritoneal/pleural cell populations or peritoneal/pleural cell populations
depleted of M(j), MC or lymphocytes and subsequently stimulated with BTG or
carrageenan in vitro was determined. In control experiments, cells were exposed to
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Figure 2.3- Peritoneal cells were selectively immunodepleted.
Peritoneal cells were depleted of either M(j), MC, B or T cells by incubation with PE-
conjugated anti-F4/80, anti-c-kit, anti-B220 and anti-CD3 respectively followed by
incubation with anti-PE conjugated magnetic beads and passage over a magnetic




cell types were then plated in 48 well plates (5x10s cells per well) and exposed to 1%
BTG or LPS (10ng/ml)(Sigma, Dorset, UK) for 3h and 6h. Control pleural cells and
M(j)-depleted pleural cells were plated in 48 well plates (6xl05 F4/80 negative cells
per well) and exposed to 0.25% carrageenan for 6h. Cell culture supernatant was
centrifuged and stored at -80°C until analysed by specific ELISA for MIP-2, KC,
MlP-la, MCP-1 and TNF-a, TGB-p (R&D, UK). The concentrations of IL-6, IL-
10, IL12p70, IFN-y and MCP-1 in cell culture supernatant were determined using a
Cytometric Bead Array (CBA) (BD Biosciences, UK). Cytokine-specific-antibody-
coated beads were incubated with a fixed volume of experimental lavage fluid or cell
culture supernatant and followed by addition of the PE detection reagent. Samples
were then washed and analysed by flow cytometry to determine the cytokine
concentrations according to the shift in fluorescence generated by the beads.
Intracellular TGF-(3 staining was performed on peritoneal cells in selected
experiments. Peritoneal cells were fixed and permeabilised in paraformaldehyde
3%/sucrose 5%, washed and then preincubated with 5% bovine serum albumin in
PBS for 1 hr. After washing, the cells were stained with either an anti-TGF-
(3 antibody (R&D, UK) or a chicken Ig isotype control (R&D, UK) overnight. Cells
were then washed and stained with an Alexa-633-conjugated anti-chicken antibody
(Molecular Probes, Netherlands) and F4/80 PE for 1 hr. After washing, cells were
processed by flow cytometry.
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2.10 Statistical Analysis
Experimental data were analysed using a one-way ANOVA with Bonferroni multiple
comparison post hoc test with a 95% confidence interval or a Student's T-test as
appropriate. Statistical analysis including correlation analysis was performed using
graph pad prism software. The significance level was set at p <0.05. Data are
presented as mean ± standard error from the mean (SEM). Values that were outside 2
standard deviations were suspected as 'outliers'. Such outliers may results from
infrequent experimental problems such as unsuccessful peritoneal injections where
the needle inadvertently hits the bowel such that the injected substance does not enter
the peritoneal space. In order to confirm the true nature of 'outliers' the extreme
studentized deviate (ESD) test or Grubb's test was performed on the data set in
question. If the 'outliers' was identified as an outlier by a p value of less than 0.05, it
was then excluded from subsequent analysis (Barnet and Lewis, 1998).
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Chapter 3: The role of resident peritoneal macrophages in experimental
inflammation
3.1 Introduction
MeC are important cells in peritoneal inflammation. However, many studies
have used cytokines typically derived from M(j) in order to stimulate MeC chemokine
production (Robson et al., 2001; Topley et ah, 1993a; Topley et ah, 1993b).
Therefore, it is likely that the resident peritoneal M<)) may play an important role in
the initiation of inflammation. Although, previous studies have examined the role of
peritoneal M(j) in the initiation of peritoneal inflammation, the generated data differed
substantially between studies such that there was no consensus regarding the exact
involvement of the peritoneal M(|). For example, previous work suggested that
peritoneal M<f> could either play a key role (Ajuebor et ah, 1999; Knudsen et ah,
2002; Souza et ah, 1988), an inhibitory role (Ajuebor et ah, 1999) or no role at all
(Ajuebor et ah, 1999) depending on the experimental model used. The CD1 lb-DTR
mice developed by Richard Lang's group (Cailhier et ah, 2005) provided an
excellent resource to dissect the role of the resident peritoneal M(j) in peritoneal
inflammation and resolve these issues. M([) ablation is a useful technique in itself but
also allows M(J> repletion studies that can further demonstrate M(j> function in
inflammation. A complex 'cytokine network' (Topley et ah, 1993c) is present in the
peritoneal cavity and it is still incompletely understood. In this chapter I describe the
results of a combination of in vivo and in vitro analysis of cytokine and chemokine
production that facilitates the identification of the cells involved in
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cytokine/chemokine production as well as the kinetics of secretion of
cytokines/chemokines during peritoneal inflammation.
3.2 Results
3.2.1 The administration of DT to CD11b-DTR mice ablates
transgenic M<)> in vivo.
Previous work from Richard Lang's laboratory indicated that the
administration ofDT at a dose of 25 ng/g mouse body weight effectively ablated McJ)
systemically (Richard Lang, personal communication). Thus, flow cytometric
analysis of peritoneal cells was performed 24 h following the injection of DT (25
ng/g mouse body weight). CD1 lb-DTR transgenic mice exhibited almost complete
ablation of F4/80 positive peritoneal M(|) (98.4%±0.9 M(|) ablation, p<0.00001) after
a single dose of DT with M<j) numbers being compared to those evident in the
peritoneal cavity of non-manipulated control CD1 lb-DTR mice (Figure 3.1). A dose
titration was then performed with the administration of DT doses of 6.25 and 12.5
ng/g mouse weight and this resulted in M(|) ablation of approximately 72% and 82%
respectively whilst lower doses resulted in <50% ablation. 25ng/g body weight was
therefore used for the in vivo studies as it induced marked M(j) ablation.
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Peritoneal Mty number (106)
Pre-DT Post-DT
Figure 3.1 - The administration of DT ablates resident peritoneal M<|).
DTR mice underwent peritoneal lavage in order to establish the number of M<j)
present under normal non-manipulated conditions. Histogram of peritoneal M<b
number in CD1 lb-DTR 24h after DT administration (25ng/g body weight) compared
to the M(|> number in the normal peritoneum (*=p<0.00001 vs pre-DT; n=7 per
group).
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3.2.2 Specificity of M<j> elimination in vivo.
The CDllb-DTR model was generated to allow the selective ablation of
CDllb+ cells especially monocytes and M(f). In order to investigate the specificity
of cell ablation, CD1 lb-DTR mice were treated with either DT or PBS. Peritoneal
lavage was performed and blood was obtained 24h after treatment with DT (25ng/g
body weight) for cell count analysis. This demonstrated that, in addition to potent
M<f> ablation, DT administration significantly reduced the number of B cells and mast
cells within the peritoneal cavity (Figure 3.2A). However, the numbers of peritoneal
T cells were unaffected. DT administration did result in an increased number of
PMN in the peritoneal cavity. This may be a consequence of the inevitable
secondary necrosis of M(J> that will occur under conditions promoting the widespread
apoptosis of the professional resident phagocyte although some dying M<j) may be
cleared by 'amateur' phagocytes (Kurosaka et al., 2001; Misawa et al., 2001) as the
resultant release of intracellular contents would be predicted to be pro-inflammatory
and recruit PMN. Interestingly, review of the kinetics of pleural M({> ablation
indicate that M([) depletion is almost complete 6h after DT administration at which
time no significant difference in the number of B lymphocytes or MC was evident
(for B cells: 2.8x105±0.7xl05 vs 4.6X105±0.2xl05; for MC: 1.10xl04±0.09xl04 vs
1.4x104±0.25x104; DT treatment vs PBS; p>0.05, n=4 per group). Although a
significant subset of B lymphocytes and MC may express CD lib (Chevallier et ah,
1998; Howell et ah, 2002; Rosenkranz et ah, 1998) this suggests that the loss of B
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Figure 3.2 - Specificity of DT induced cell death: DT induces M<|> ablation
but also reduces B and mast cell numbers in the peritoneum.
A) DT or PBS was administered IP to CD1 lb-DTR mice and peritoneal lavage was
performed 24h later. The number ofMcj), PMN, B, T and mast cells was determined
by flow cytometry (*=p<0.01 vs CD1 lb-DTR+DT; n=6). B) DT was administered
IP to CD 1 lb-DTR or FvB/N mice and peritoneal lavage was performed 24h later
(*=p<0.01 vs CD1 lb-DTR; n=6 per group).
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types but is mainly a consequence of the secondary necrosis of apoptotic M<j) that
occurs in the absence of a population of viable phagocytic M(() to ingest the dying
cells.
To further address the specificity of the conditional ablation system, the
differential effect ofDT in CD1 lb-DTR and non-transgenic control FvB/N mice was
examined. There was no difference in the baseline number of peritoneal M(()
between CD1 lb-DTR and FvB/N control mice although CD1 lb-DTR mice exhibited
an increased number of B and T cells. The administration of DT to CD 1 lb-DTR
mice resulted in a marked reduction in peritoneal Mcji together with reduced numbers
of B cells and mast cells (Figure 3.2B) compared to FvB/N mice. In addition, a mild
influx of PMN was evident but there was no difference in T cell numbers (Figure
3.2B).
3.2.3 Circulating and recruited PMN are unaffected by DT
administration.
Since CD lib is also expressed on granulocytes, I performed experiments to
evaluate whether PMN were sensitive to DT. Flow cytometric analysis of whole
blood performed 24 hours following DT administration indicated a significant 80%
reduction in circulating monocyte numbers (Figure 3.3A). However, no reduction in
the number of circulating PMNs was evident 24hr following DT administration
(Figure 3.3A). In fact, an increased number of circulating PMN were evident at the
24 hr time point post DT. In addition, no reduction in circulating PMN number was
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Figure 3.3 - The administration of DT reduces circulating blood
monocytes but circulating PMN numbers are not reduced.
CDllb-DTR mice received either DT or PBS. Blood was obtained at 6, 24, 48 and
72h later and analysed by flow cytometry. A) Circulating monocytes and PMN
numbers are compared at 24h. B) PMN kinetic following administration of DT or
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evident at 6, 48 or 72 hr following the administration of DT indicating an absence of
any initial neutropenia or delayed effects of DT treatment (Figure 3.3B)
To determine whether recruited PMN were sensitive to DT, CDllb-DTR
mice were injected with BTG in order to recruit a significant influx of PMN. DT (25
ng/g BW) or PBS was then injected 8 h after the initiation of peritonitis with
peritoneal lavage being performed 12h later. Despite 90% ablation of recruited
monocytes and recruited/resident Mcj) (0.5xl06±1.5xl05 vs 4.8xl06±2.3xl05; DT
treatment vs PBS; p<0.005) there was no difference in PMN number between
experimental groups (2.3xl06±2.2xl05 vs 1.6xl06±3.9xl05; DT treatment vs PBS;
p>0.05).
3.2.4 Repopulation of monocytes and M<|> in blood and the peritoneal
cavity following DT administration.
Circulating monocyte numbers remained markedly reduced for 48 hr
following the administration ofDT compared to administration of PBS with almost a
complete recovery of circulating monocyte numbers evident at 72 hrs (Figure 3.4A).
In contrast, peritoneal M<j) depletion persisted over this 72h period and this is likely
to reflect the route of administration as the local intraperitoneal levels of DT may be
higher than those in the systemic circulation (Figure 3.4B).
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Figure 3.4 - Repopulation of monocytes/ M(|> following DT administration
CD1 lb-DTR mice received either DT or PBS. Blood sampling and peritoneal lavage
was performed at various time points to determine the repopulation kinetics of
circulating monocytes (A) and peritoneal Mc() (B). Cell numbers were determined by
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3.2.5 Resident M(j> ablation reduces PMN influx during experimental
peritonitis induced by BTG.
The conditional ablation strategy was used to investigate the role of resident
peritoneal M(|) in sensing perturbation of the microenvironment and subsequent
initiation of acute peritoneal inflammation and PMN recruitment in experimental
peritonitis. DT treated FvB/N control mice exhibited a marked PMN influx that
peaked 8h following the administration of 3% BTG (Figure 3.5). The ablation of
resident peritoneal M(j) markedly attenuated PMN infiltration following the
administration of 3% BTG with significant differences being evident at both the 8h
and 24h time points (Figure 3.5).
3.2.6 Adoptive transfer of non-transgenic resident peritoneal M<|> to
DT treated CD11b-DTR mice restores PMN recruitment in BTG
peritonitis.
In light of the fact that the administration of DT did exert effects upon other
cells within the peritoneum including B cells and MC, I went on to perform M(()
repletion studies. In these experiments, I adoptively transferred either M())-rich or
M(j)-depleted peritoneal cells derived from DT insensitive non-transgenic control
FvB/N control mice. FvB/N control and 3 groups of CDllb-DTR mice were








Figure 3.5 - Resident M<|> ablation attenuates peritoneal PNN influx.
FvB/N and CDllb-DTR mice were injected IP with DT (25 ng/g body weight) in
order to deplete resident peritoneal M(|). 1 ml of 3% BTG was injected IP 24h later
with mice undergoing peritoneal lavage at various time points. Peritoneal cells were
stained for the PMN marker GR1. Resident peritoneal M(|) ablation induced a marked
blunting of PMN infiltration of the peritoneal cavity (*=p<0.001 vs CD1 lb-DTR;
n=7 per group at each time point).
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ablate peritoneal M(]>. Two groups of M(|)-depleted CDllb-DTR mice were then
reconstituted with either:
(i) Mc()-rich peritoneal cells (M(|)R) i.e. all peritoneal cells retrieved from the
peritoneum (7.9xl05±2.7xl05 M(|) were transferred per mouse in these
experiments),
(ii) M(|)-depleted peritoneal cells (M(j)D) i.e. peritoneal cells that had been
depleted ofM(|) by adhesion to tissue culture plastic prior to instillation into the
peritoneal cavity of recipient mice.
These various cell populations were adoptively transferred 4h prior to the
administration of BTG whilst the other groups (FvB/N and control M(j>-ablated mice)
received an identical volume of PBS IP in order to control for the IP injection. Mice
were then injected with 3% BTG and underwent peritoneal lavage 8 hours later.
Reconstitution ofM(|)-ablated mice with M<))-rich peritoneal cells fully restored PMN
infiltration (Figure 3.6). In this experiment, the transfer of a Mcji-rich peritoneal cell
population alone was an important control as the transfer of M(j) that have been
manipulated ex vivo may have been inherently pro-inflammatory. However, the
adoptive transfer of M(j)-rich peritoneal cells to Mcj) ablated CDllb-DTR mice did
not result in a significant PMN infiltrate (Figure 3.6) thereby highlighting the non¬
inflammatory nature of the adoptive transfer of cells and indicating that the cells
were unlikely to have been significantly activated by the ex vivo manipulation.
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FvB/N CD1 lb-DTR CDllb-DTR CDllb-DTR CDllb-DTR
+ BTG +M<j)R+BTG +M(|>D+BTG +M(|)R +BTG
Figure 3.6 - Adoptive transfer of peritoneal M<j> restores PMN influx in
M(|> ablated mice.
FvB/N control and 3 groups of CD1 lb-DTR mice were injected with DT (25 ng/g
body weight) 24 hr prior to BTG injection. 2 groups of M(j)-depleted CDllb-DTR
mice were reconstituted with either (i) M(()-rich peritoneal cells (M(|)R), (ii) M(J>-
depleted peritoneal cells (McJ)D) 4h prior to BTG injection whilst the other groups
received PBS. Mice underwent peritoneal lavage 8 hours after the induction of
inflammation. Reconstitution of Mc))-ablated mice with a M(j)-rich peritoneal cell
population fully restored PMN infiltration. The adoptive transfer of M(j)-rich
fTi
peritoneal cells alone in the 4 group ofDT treated CD1 lb-DTR mice did not induce
significant PMN infiltration highlighting the non-inflammatory nature of the
adoptive transfer (*=p<0.05 vs CD1 lb-DTR+BTG; n=4-14 per group).
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The reconstitution of DT-treated M(j) ablated CDllb-DTR mice with Mc))-rich
peritoneal cells 4 hours prior to BTG treatment resulted in complete restoration of
peak PMN infiltration at the 8 h time point; the time point exhibiting maximal PMN
infiltration in this model and mouse strain. In contrast, the administration of M(J>-
depleted peritoneal cells was ineffective and resulted in levels of PMN recruitment
directly comparable to that evident in the control M(J> ablated CDllb-DTR mice.
These data suggested that B cells and mast cells were not critically involved in
orchestrating the PMN influx (Figure 3.6).
3.2.7 Resident M<|> ablation reduces PMN influx during experimental
peritonitis induced by zymosan.
Previous work suggested that the nature of the inflammatory stimulus may be
a key factor in determining the involvement of M(() in experimental peritonitis
(Ajuebor et al., 1999) and I therefore performed Mcj) depletion studies in the model of
zymosan peritonitis. The depletion of resident peritoneal M(j) resulted in a significant
reduction in PMN infiltration 8 hours following the induction of zymosan peritonitis
(Figure 3.7). Although I did not perform extensive time course studies or repeat the
adoptive transfer experiments in the model of zymosan peritonitis, these data do
suggest that resident M(|) play an important role in the initiation of PMN infiltration







Figure 3.7 - Resident M(|> ablation attenuates PMN influx in zymosan
peritonitis.
FvB/N control and CD1 lb-DTR mice were injected with DT (25 ng/g body weight)
24 hours prior to the IP administration of zymosan. Peritoneal lavage was performed
8 hr following the administration of zymosan and PMN number assessment by GR1
staining flow cytometry. M<|) ablation reduced the PMN influx (* p<0.05 vs CD1 lb-
DTR; n=6 per group).
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3.2.8 Peritoneal resident M<{> ablation reduces secretion of key
chemokines/cytokines in vivo.
In this model, peak levels of the PMN C-X-C chemokines MIP-2 and KC
were found at the 1 h time point with levels being low at later time points. Resident
peritoneal M<j) ablation prior to the initiation of BTG peritonitis markedly reduced
the elevation in MIP-2 levels (Figure 3.8A). There was a slight, albeit statistically
significant, difference between DT-treated CD1 lb-DTR mice and DT-treated FvB/N
control mice in the much lower levels of MIP-2 evident at 3 hours (Figure 3.8A).
There were no differences in the MIP-2 levels at later time points between both
groups as levels were low. This result strongly suggests that the production ofMIP-
2 in vivo is predominantly McJ) dependent. In addition, a 50% reduction in the level
of KC was evident in Mcj)-depleted mice at the 1 h time point. Interestingly, the
levels of KC at 3h are higher in M(J)-depleted mice compared to control mice thereby
suggesting a source of KC other than resident M(j) (Figure 3.8B). The mildly
elevated levels of KC at the initiation of inflammation (24 hrs post DT treatment)
may reflect the inflammatory reaction secondary to M(|) ablation, which does result in
a mild PMN influx (Figure 3.2B).
The C-C chemokines peaked at 8h in this model of peritoneal inflammation.
Mcj) ablation completely inhibited the increased level ofMlP-la evident at 8h and
reduced the level of MCP-1 at 8h by 55% (Figure 3.9A and 3.9B). However, there






Figure 3.8 - Modulation of MIP-2 and KC production following M<|>
ablation in BTG peritonitis.
CDllb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to administration of BTG. Peritoneal lavage was performed at various
time points after the induction of peritonitis as indicated. The levels of MIP-2 (A)
and KC (B) were determined in the peritoneal lavage supernatant by specific ELISA.
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Figure 3.9 - Modulation of MIP-1a and MCP-1 production following M(|>
ablation in BTG peritonitis.
CD1 lb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to administration of BTG. Peritoneal lavage was performed at various
time points after the induction of peritonitis. The levels ofMlP-la (A) and MCP-1
(B) were determined in the peritoneal lavage supernatant by specific ELISA. (*=
p<0.05 vs CD1 lb-DTR group, n= 4-6 mice per group at each time point).
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Interestingly, MCP-1 production was higher in M(|)-ablated CD1 lb-DTR mice 24h
after BTG administration (Figure 3.9B). Similar to the data for KC production, these
data suggest that late MCP-1 production is probably derived from a source other than
resident M(j). The MCP-1 difference at Oh is presumably a reflection of the pro¬
inflammatory milieu generated by the Mcj) ablation and subsequent secondary
necrosis of the apoptotic M<j).
The levels of various cytokines were measured in the peritoneal fluid by
ELISA or CBA. M(J) ablation completely inhibited the increased level of TNF-a
evident at 3h after BTG administration (Figure 3.10) with TNF-a levels being
undetectable at late time points. However, there were no differences between
CD1 lb-DTR mice and FvB/N controls for any of the other cytokines analysed (IL-6,
IL-10, IL12p70 and IFN-y) at the 8, 24 and 72h time points and the cytokine levels
were relatively low compared to chemokine levels. The shorter time points were not
looked at.
The level of the anti-inflammatory and reparative cytokine TGF-(3 was also
analysed at various time points. A 70% reduction in TGF-(3 levels at 24h was
observed in Mc|)-ablated CD1 lb-DTR mice compared to FvB/N control mice
(113.3±21.8 pg/ml vs 424.9±48.3 pg/ml; DT-treated CD1 lb-DTR mice vs DT-
treated FvB/N mice; p<0.0001). Intracellular staining indicated that TGF-(3
production was likely to be from differentiated MDM(() as positive cells expressed a




Figure 3.10- Modulation of TNF-a levels following M(j> ablation in BTG
peritonitis.
CD1 lb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to administration of BTG. Peritoneal lavage was performed at various
time points after the induction of peritonitis. The levels of TNF-a were determined
in the peritoneal lavage supernatant by specific ELISA. (*= p<0.05 vs CD1 lb-DTR
group, n= 4-6 mice per group at each time point).
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low monocytes were TGF-(3 negative (Figure 3.11A and 3.1 IB).
3.2.9 C-X-C chemokine responses are M<j> dependent in vitro.
Previous studies of peritoneal and dermal inflammation have implicated the
MC as playing an important role in the initiation of PMN infiltration (Ajuebor et al.,
1999; Chen et ah, 2002). I therefore performed additional in vitro studies to
determine the production of C-X-C chemokines by BTG-stimulated peritoneal cell
populations that had been depleted of either Mcj) or MC. Control non-depleted
peritoneal cells produced significant levels of MIP-2 and KC following 3h
stimulation with BTG (Figure 3.12). Chemokine production was completely
unaffected by the specific immunomagnetic depletion of MC. In contrast,
chemokine levels were dramatically reduced following the depletion of Mcj> thereby
indicating that chemokine production was completely Mcj) dependent in vitro with no
discernible involvement ofMC (Figure 3.12).
I also investigated the production of MCP-1 in vitro. Although, MCP-1
levels obtained after in vitro BTG stimulation were much lower than those found in
vivo, there was a complete absence of MCP-1 generation following Mcj) depletion
whereas MC depletion had no effect (10.38±1.1 pg/ml vs 0±0 pg/ml vs 12.1±1.2
pg/ml; All cells vs Mcj)-depleted vs MC-depleted; p<0.05). These data suggest that
MC do not significantly modulate chemokine production. It should also be stated
that the low level ofMCP-1 evident in these assays suggests that other cells such as
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Figure 3.11- Differentiated monocyte-derived M<{> express intracellular
TGF-p 24h after administration of BTG.
Intracellular TGF-|3 staining was performed on peritoneal cells obtained from lavage
24h after the induction of BTG peritonitis. Peritoneal cells were fixed, permeabilised
and stained with either an anti-TGF-|3 antibody or an isotype control. Cells were
stained with an Alexa-633-conjugated secondary antibody and F4/80 PE. F4/80
analysis by flow cytometry revealed an F4/80 Hi and F4/80 Lo M(j) populations (A).
Subsequent TGF-|3 analysis demonstrated that F4/80 Hi monocyte-derived M(j)
strongly expressed TGB-P whereas F4/80 Lo monocytes did not (B).
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Figure 3.12 - C-X-C chemokine production in response to BTG
stimulation is M<)> dependent and MC independent in vitro.
Peritoneal cells were depleted of either M(j) or MC by incubation with PE-conjugated
anti-F4/80 or anti-c-kit (CD 117) antibodies followed by incubation with anti-PE
conjugated magnetic beads and passage over a magnetic column (>97% depletion of
M([) or MCs achieved). Incubation of total peritoneal cells with an isotype control
antibody followed by magnetic beads and passage over the magnetic column served
as control. Cells were then plated in 48 well plates (5xl05 cells per well) and exposed
to 1% BTG for 3h. Peritoneal cell conditioned supernatants were harvested, spun





The CDllb-DTR mice are a potent experimental conditional M(|> ablation
system with DT inducing >98% depletion of resident peritoneal M(|) 24h after
administration. However, I noted that B and MC numbers are also reduced
following DT treatment. In contrast, neither circulating nor recruited PMN exhibit
significant sensitivity to DT. Using these transgenic mice, I was able to demonstrate
that M(|> ablation significantly blunted the recruitment of PMN that follows BTG-
induced and zymosan-induced peritonitis. Importantly, M(j) repletion studies
demonstrated that the adoptive transfer of M(j)-rich peritoneal cells fully restored
PMN influx whereas Mc()-depleted cells exhibited no significant effect upon PMN
recruitment. This experiment reinforced the role of resident M(|) in the initiation of
inflammation. In addition, since both B cells and MC were present in the ineffective
M(j)-depleted peritoneal cell population, the adoptive transfer studies excluded a
major contributing role of these cells despite their reduced numbers following DT
administration.
The analysis of cytokine levels in peritoneal exudates revealed that TNF-a
production in vivo was M(j) dependent and was reduced following M0 ablation.
Similar analysis of chemokine levels revealed that Mcj)-dependent in vivo production
of MIP-2 plays a crucial role in PMN recruitment. In contrast, KC production was
less affected by M(j) depletion thereby suggesting a non-M(j) origin in vivo.
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Additional in vitro studies demonstrated M(j)-dependent production of both C-X-C
chemokines with no discernible role for MC evident.
In conclusion, these data suggest that the resident peritoneal M(j) plays a
crucial role in the initiation of inflammation and PMN recruitment in peritoneal
inflammation.
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Chapter 4: The role of resident pleural macrophages in experimental
inflammation
4.1 Introduction
In the last chapter, it was demonstrated that resident peritoneal Mcf) are
important for the initiation of inflammation. Despite the fact that both peritoneal and
pleural M(j) are similar functionally and phenotypically (Dorger et al., 2001;
Gjomarkaj et al., 1999; Sestini et al., 1984), it cannot be assumed that resident
pleural M(j) will have the same role in the initiation of inflammation. Previous work
demonstrated that the pleural eosinophil influx induced by the administration of LPS
was reduced in mice previously treated with diphosphonate-containing liposomes in
order to deplete resident pleural M(|) (Bozza et al., 1994) thereby suggesting an
important role for the resident pleural Mcj>. However, no studies have directly
examined their contribution in the initiation of pleural PMN infiltration. Pleural
MeC are also important in pleural inflammation and may generate important
chemokines such as IL-8 and MCP-1. TNF-a and IL-113 are key cytokines involved
in pleural MeC stimulation to initiate this chemokine production (Antony et al.,
1995; Frode et al., 2001; Goodman et al., 1992; Mohammed et al., 1998a; Park et al.,
2003). Studies using function-blocking antibodies suggest that activated resident
pleural M(() may be responsible for this TNF-a and IL-1(3 secretion (Frode et al.,
2001; Park et al., 2003). Therefore, it is likely that pleural resident M(|) do have an
important role in promoting PMN influx and the CDllb-DTR conditional M())
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ablation model provided an excellent biological tool to dissect the role of the resident
pleural M(j) in initiation of inflammation.
4.2 Results
4.2.1 DT administration ablates pleural M<j>.
In order to investigate the efficacy of M(|) ablation in the pleural cavity,
CDllb-DTR mice were treated with either DT (25ng/g body weight) or PBS IP.
Pleural lavage was performed 24h after treatment with DT for cell count analysis by
flow cytometry. CD1 lb-DTR transgenic mice exhibited almost complete ablation of
F4/80 positive pleural Mcj) (96.1% ± 0.8 M([) ablation, p<0.0001) after a single dose
of DT with M(j> numbers being compared to those evident in the pleural cavity of
non-manipulated control CD 1 lb-DTR mice (Figure 4.1). Representative dot plots of
pleural lavages performed 24h after DT administration in FvB/N and CD1 lb-DTR
mice illustrate the potency of the F4/80 positive resident Mcj) ablation and the
resistance of non-transgenic FvB/N resident Mcj) to DT treatment (Figure 4.2). 50%
of the recoverable cells from a pleural lavage are resident Mcj) and this proportion
was unchanged in FvB/N mice following DT administration. The majority of pleural
cells retrievable by pleural lavage are F4/80 positive and studies of pleural cells
following the intrapleural injection of dyes taken up by phagocytic cells indicate that
the Mcj) marker F4/80 labels almost 100% of resident pleural Mcj) (Kris Houlberg,
personal communication).
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Pre DT Post DT
Figure 4.1- The administration of DT ablates resident pleural Mc|>.
DTR mice underwent pleural lavage in order to establish the number of M<j) present
under normal non-manipulated conditions. Histogram of pleural M(j) number in
CD1 lb-DTR 24h after DT administration (25ng/g body weight) compared to the Mc))
number in the normal non-manipulated pleural cavity (*=p<0.00001 vs pre-DT; n=3-
4 mice per group).
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Figure 4.2 - DT administration to CD11b-DTR mice ablates F4/80
positive pleural M<j>.
DT was injected IP to CD1 lb-DTR and FvB/N control mice (25 ng/g body weight)
and pleural lavage performed 24h later. Cells were stained for F4/80 and analysed by
flow cytometry. (A) Representative flow cytometry dot plot indicating that over 50%
of pleural cells retrievable by pleural lavage from DT-treated FvB/N mice are F4/80
positive. (B) Administration of DT results in marked ablation of resident F4/80
positive pleural M(|) in CD 1 lb-DTR mice.
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4.2.2 Specificity of M<|> elimination in vivo.
To further address the specificity of the conditional ablation model in the
pleural cavity, the numbers of other pleural cells was determined following DT
administration. In these experiments I compared DT treated CDllb-DTR mice to
CD1 lb-DTR mice treated with PBS and FvB/N mice treated with DT (Figure 4.3).
There were no differences evident in the numbers of pleural M(j), B cells, T cells or
MC between CD1 lb-DTR and FvB/N control mice. Although, the administration of
DT to CDllb-DTR mice resulted in a profound reduction in pleural Mcj), it also
induced a reduction in the numbers of B cells and MC compared to both CDllb-
DTR mice treated with PBS and FvB/N mice treated with DT (Figure 4.3). In
addition, a mild influx of PMN was evident but there was no difference in T cell
numbers (Figure 4.3). Potential reasons for such effects were discussed in chapter 3.
4.2.3 Repopulation of pleural M<|> following DT administration.
Pleural M(j) numbers remained markedly reduced for 48 hr following the
administration of DT compared to administration of PBS with almost complete
recovery of pleural Mc() numbers evident at 72 hrs (Figure 4.4). This contrasts
somewhat with the kinetics of repopulation of peritoneal M<j), which persisted at the
72h time point. As indicated previously, this difference in repopulation kinetics may
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Figure 4.3 - Specificity of DT induced cell death: DT induces M(|> ablation
but also reduces also B and mast cell numbers in the pleural space.
DT or PBS was administered IP to CDllb-DTR mice and pleural lavage was
performed 24h later. The numbers of M<j), PMN, B, T and mast cell was determined
by flow cytometry (*=p<0.05 vs CD1 lb-DTR+DT; n=5-7 mice per group). B) DT
was administered IP to CDllb-DTR or FvB/N mice and pleural lavage was
performed 24h later (*=p<0.05 vs CD1 lb-DTR; n=5-7 mice per group).
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Pleural Mc|) Number (105)
Figure 4.4 - Repopulation of monocytes/ M<|> following DT administration
CDllb-DTR mice received either DT or PBS. Pleural lavage was performed at
various time points to determine the repopulation kinetics of pleural M<|>. Cell
numbers were determined by flow cytometry (*=p<0.05; n=3-5 mice per group per
time point).
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4.2.4 Resident pleural M<|> ablation reduces PMN influx in
carrageenan induced pleurisy.
The conditional M(f> ablation strategy was also used to investigate the role of
resident pleural M(j) in initiating PMN recruitment following the administration of
carrageenan. PMN infiltration following the administration of 1% carrageenan was
markedly attenuated at all experimental time points following resident McJ) ablation
(Figure 4.5). It is particularly noteworthy that the early time points of 6 and 24 hours
demonstrated a dramatic difference between groups. Although PMN infiltration in
DT treated CD1 lb-DTR mice did reach approximately 50% of control levels at the
later time point of 72 hours, this was still significantly less than DT-treated non-
transgenic FvB/N control mice.
4.2.5 The adoptive transfer of non-transgenic purified M(|) or M<j>-rich
pleural cell populations partially restores PMN influx in M<|>-
ablated CD11b-DTR mice following carrageenan
administration.
In order to further analyse the role of resident pleural M(j) in the initiation of
acute pleural inflammation, we also performed M(j> repletion studies. These
experiments were also required as DT administration affected the numbers of B cells
and MC within the pleural cavity. I adoptively transferred either M(j)-rich or Mcj)-
depleted pleural cell populations derived from DT insensitive non-transgenic FvB/N
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Figure 4.5 - Resident M<|) ablation 24 hours prior to administration of
carrageenan blunts PMN recruitment.
0.1ml of 1% carrageenan was administered to CD1 lb-DTR and FvB/N control mice
24h after DT treatment. Pleural lavage was performed at 0, 6, 24 and 72h following
carrageenan. Lavaged cells were stained for GR1 and counted by flow cytometry (*
= p<0.05 vs CD1 lb-DTR group, n=4-5 mice per group per time point).
91
control mice. In these experiments, two to three FvB/N mice were used to provide
the pleural cells to adoptively transfer to one CDllb-DTR recipient mouse. The
adoptive transfer of M(j)-rich pleural cell populations resulted in the transfer of
1.5x105±0.3x105 M<|> and this restored Mcj) number to approximately 50% of the Mcj)
number normally present in pleural lavage fluid. A full Mc(> transfer could not be
accomplished as the numbers of FvB/N mice required were prohibitive. In addition,
significant M(J) loss occurred during the immunomagnetic depletion procedure. In
view of the difficulty in performing multiple pleural injections, the M(j) were injected
at the same time as the carrageenan.
Despite the fact that Mcj> reconstitution of DT-treated CDllb-DTR mice was
incomplete, the administration of M(|)-rich pleural cells concurrently with
carrageenan significantly increased the level ofPMN infiltration at 6 hours compared
to that evident in control Mcj)-ablated CDllb-DTR mice treated with carrageenan
(Figure 4.6). The partial restoration of peak PMN infiltration was approximately
35% of levels present in control DT-treated FvB/N control mice at the same time
point. In contrast, administration of Mcj)-depleted pleural cells concurrently with
carrageenan made no significant impact upon PMN infiltration compared to Mcj)-
depleted CDllb-DTR mice (Figure 4.6). Interestingly, the Mcj) number present
(resident M(|) plus any transferred M(j) if performed) in the pleural space at the
initiation of inflammation correlated with the PMN influx present at 6h (R2 =
0.9979). This highlights the simple importance of the number of Mcj) present in the
adoptive transfer. DT treated CD1 lb-DTR mice were also reconstituted with Mcj>
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Figure 4.6 - Adoptive transfer of M<|)-rich pleural cells and purified
pleural macrophages partially restores PMN infiltration in carrageenan-
induced pleurisy.
FvB/N control and 4 groups of CDllb-DTR mice were injected with DT (25 ng/g
body weight) 24 hours prior to carrageenan injection. 3 groups of M(j)-depleted
CD1 lb-DTR mice were reconstituted with either (i) M(J)-rich pleural cells (Mc[)R), (ii)
M(|)-depleted pleural cells (M(J)D) or (iii) 90% pure M(j) isolated by negative selection
at the same time as the administration of carrageenan (CAR). Mice underwent
pleural lavage 6 hours after the induction of inflammation (n=8-10 mice per group
*p<0.05 vs CD1 lb-DTR+DT+CAR group). DT-treated CD1 lb-DTR mice exhibited
a marked reduction in PMN infiltration whilst reconstitution of Mcj)-ablated mice
with either purified M(J> or a M(|)-rich pleural cell population partially restored PMN
infiltration. The adoptive transfer of either purified M(j) or a M(|)-rich pleural cell
population without inflammatory agents did not induce significant PMN infiltration
compared to DT-treated CD1 lb-DTR mice.
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purified by negative selection (90% pure) concurrently with the administration of
carrageenan and this resulted in a comparable PMN influx to that evident following
reconstitution with M(j)-rich pleural cells. It should be noted that, although DT-
induced M()> ablation is associated with a reduction of B cell and MC number, the
administration of M()>-depleted pleural cells comprising B cells, MC and T cells had
no significant impact upon PMN infiltration. Lastly, the adoptive transfer of a
control population of M(j)-rich pleural cells or purified M(j) was non-inflammatory
(Figure 4.6).
4.2.6 M(j> ablation modulates chemokine responses during
carrageenan-induced pleurisy.
In this model, peak levels of the C-X-C chemokines MIP-2 and KC were
found at the lh and 3h time points respectively. Ablation of resident pleural M<|>
prior to administration of carrageenan markedly reduced MIP-2 levels at both 1 h and
3h (Figure 4.7A) suggesting that the early production of MIP-2 in vivo is
predominantly M(j) dependent. In addition, M(j)-ablated mice exhibited a delayed and
significantly blunted peak in the level ofMIP-2. There are very few M([) (<30,000)
present within the pleural cavity of DT-treated CDllb-DTR mice at the 6 hr time
point and this suggests that the delayed MIP-2 response may result from MIP-2
production by local cells such as mesothelial cells etc. MIP-2 levels are very low at
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Figure 4.7 - Resident M<{) ablation attenuates chemokine production in
carrageenan-induced pleurisy.
CD1 lb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to administration of carrageenan. Pleural lavage was performed 1, 3,
6, 24 and 72 hr after the induction of pleurisy. The levels ofMIP-2 (A) and KC (B)
were determined in the pleural lavage supernatant by specific ELISA. (*= p<0.05 vs
CD 1 lb-DTR group, n= 5 mice per group per time point).
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In contrast to the MIP-2 data, there was only a very modest, albeit statistically
significant, reduction in KC levels evident in M(j)-depleted mice at the 1,3 and 6h
time points (Figure 4.7B). No differences were evident at 24 or 72h. These data
indicate that cells other than Mc|) are likely to be responsible for the production of
KC. The kinetics of chemokine production in Mcji-depleted and control mice needs
to be reconciled with the data for PMN infiltration. The dramatic blunting of early
PMN infiltration that follows resident pleural M(() ablation prior to the administration
of carrageenan suggests that this early PMN influx is very much dependent upon
resident M(j> production ofMIP-2.
The levels of MCP-1 were also examined. The ablation of resident pleural
M(j> did not exert marked affects upon the production of MCP-1 with the MCP-1
levels being reduced by approximately 36% at the 3h time point only (Figure 4.8).
This is similar to the results for KC and suggests that MCP-1 is primarily generated
by cells other than M(j).
4.2.7 M<|) ablation modulates cytokine responses during
carrageenan-induced pleurisy.
Analysis of the levels of cytokines in pleural lavage samples indicated a key
role for resident M(|) in the early production of the cytokines TNF-a, IL-6 and IL-10
(Figures 4.9 and 4.10). M(j) ablation resulted in greater than 90% reduction in TNF-a
and IL-6 levels with low cytokine levels evident in M(j) ablated mice (Figure 4.9A
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Figure 4.8 - Resident M<j> ablation attenuates MCP-1 production in
carrageenan-induced pleurisy.
CD1 lb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to administration of carrageenan. Pleural lavage was performed 1, 3,
6, 24 and 72 hr after the induction of pleurisy. The level of MCP-1 in the pleural
lavage supernatant was determined by CBA analysis (*= p<0.05 vs CD1 lb-DTR



















Figure 4.9 - Resident M<j> ablation attenuates TNF-a and IL-6 production
in carrageenan-induced pleurisy.
CDllb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to carrageenan injection. Pleural lavage was performed 1, 3, 6, 24 and
72 hr after the induction of pleurisy. The level of TNF-a (A) in the pleural lavage
supernatant was determined by specific ELISA whilst the level of IL-6 (B) was
determined by CBA analysis (*= p<0.05 vs CD1 lb-DTR group, n= 5 mice per group
per time point).
Oh lh 3h 6h 24h 72h
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and 4.9B). The effect of Mcj) ablation upon IL-10 levels was less dramatic but a
significant inhibitory effect upon IL-10 levels at the time points of 1, 3 and 6h was
seen (Figure 4.10A). IL-12 levels were also reduced with M(j) ablation at 24h (Figure
4.1 OB). In contrast, IFN-y levels were low and comparable between DT treated
CDllb-DTR mice and FvB/N control mice at each time point suggesting that
resident M(j) are not a significant source of IFN-y in this model.
4.2.8 Chemokine and cytokine responses of pleural cell populations
in vitro are M<j> dependent.
Since pleural mesothelial cells may be an important source of chemokines, I
performed additional in vitro studies to determine the production of chemokines and
cytokines by carrageenan stimulated pleural cell populations that had been depleted
of M(j). Immunomagnetic Mc|) depletion using antibodies for the M(j) specific marker
F4/80 resulted in 98% depletion of Mc|) from pleural cell populations whilst B cell
and MC numbers were comparable between groups. Stimulation of control Mc()-rich
pleural cell populations for 6 hours with 0.25% carrageenan resulted in significant
production of MIP-2 and KC (Figure 4.11). In contrast, no significant chemokine
production was evident following stimulation of pleural cell populations depleted of
resident M(j) but containing B cells, T cells and MC thereby indicating that
production of these C-X-C chemokines in vitro was completely M(() dependent.
Indeed, since an equivalent number of cells were stimulated with carrageenan the
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Figure 4.10 - Resident M<|> ablation attenuates IL-10 and IL-12 production
in carrageenan-induced pleurisy.
CD1 lb-DTR and FvB/N control mice were injected with DT (25 ng/g body weight)
24 hours prior to carrageenan injection. Pleural lavage was performed 1, 3, 6, 24 and
72 hr after the induction of pleurisy. The levels of IL-10 (A) and IL-12 (B) were
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Figure 4.11 - In vitro production of MIP-2 and KC following carrageenan
stimulation is M<j> dependent.
Resident pleural cells were harvested and immunodepleted of resident pleural Mcj) by
incubation with PE-conjugated anti-F4/80 followed by incubation with anti-PE
conjugated magnetic beads and passage over a magnetic column. Equivalent
numbers of cells were plated (60,000 cells per well) and stimulated with 0.25%
carrageenan or normal medium for 6h. Supernatants were harvested and analyzed by
specific ELISA for MIP-2 and KC (*=p<0.05 vs all cells with medium, n=4 wells
per condition).
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B cells and MC compared to the control non-depleted pleural cell population. Thus,
the absence of significant chemokine production strongly suggests that B cells or MC
per se are not key players in chemokine generation in response to carrageenan.
Limited production of MCP-1 was evident in vitro but this was also significantly
reduced by depletion of resident M(j> (25.3±5.3 vs 7.1±4.7 pg/ml; Mcj)-rich pleural
cells vs M(()-depleted pleural cells; p<0.05). Analysis of in vitro cytokine production
demonstrated that resident Mcj) were key cytokine producers as Mcj) depletion prior to
carrageenan stimulation resulted in a reduction of 63%, 67% and 92% in the
production ofTNF-a, 1L-10 and IL-6 respectively (Figure 4.12).
4.2.9 Pleural resident M<|> ablation reduces PMN influx in response to
Staphylococcus aureus.
Although the carrageenan model of pleurisy is a useful model of
inflammation and has been used by many investigators to dissect inflammatory
pathways, it was important to assess if resident Mc() were involved in models of
inflammation that were more closely related to clinical disease. Formalin fixed,
fluorescently labelled Staphylococcus aureus were therefore instilled into the pleural
cavity and this induced a marked PMN infiltrate at the 4 hr time point (> 1.5xl06
PMN). The ablation of resident Mcj) significantly reduced PMN infiltration following
the administration of Staphylococcus aureus (Figure 4.13). Comparable PMN
infiltration was also found in DT treated FvB/N control mice and PBS treated
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Figure 4.12 - In vitro production of the cytokines TNF-a, IL-10 and IL-6
following carrageenan stimulation is M<|) dependent.
Resident pleural cells were harvested and immunodepleted of resident pleural M(|) by
incubation with PE-conjugated anti-F4/80 followed by incubation with anti-PE
conjugated magnetic beads and passage over a magnetic column. Equivalent
numbers of cells were plated (60,000 cells per well) and stimulated with 0.25%
carrageenan or normal medium for 6h. Supematants were harvested and analyzed by
specific ELISA for TNF-a and by CBA for IL-10 and IL-6 (*=p<0.05 vs the













Figure 4.13 - Resident M<|) ablation 24 hours prior to the administration
of formalin fixed Staphylococcus aureus significantly blunts PMN
recruitment.
3xl06 formalin fixed fluorescently labelled Staphylococcus aureus bacteria were
instilled into the pleural cavity ofCD1 lb-DTR and FvB/N control mice 24h after DT
treatment with PBS-treated CDllb-DTR serving as an additional control. Pleural
lavage was performed at 4h following the administration of Staphylococcus aureus.
Lavaged cells were stained for GR1 and counted by flow cytometry (* = p<0.05 vs
DT-treated CD 1 lb-DTR group, n=4 mice per group).
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significant effect upon the generation of acute inflammatory responses (Figure 4.13)
with comparable findings evident following the administration of carrageenan. An
extended time course study was not undertaken in this Staphylococcus aureus
mediated model but the significant reduction in PMN influx that followed prior
ablation of resident pleural M(J> provided 'proof of concept' that resident pleural McJ)
are likely to represent key orchestrators of PMN influx in pathogen induced
inflammation.
Cytospin preparations of pleural lavage cells from the 4h time point indicated
prominent ingestion of Staphylococcus aureus particles by M(j) in DT treated FvB/N
control mice (Figure 4.14A and B) with very limited uptake by PMN. In contrast, in
the absence of M(|), DT treated CDllb-DTR mice exhibited marked ingestion of
Staphylococcus aureus particles by PMN (Figure 4.14C and D).
4.3 Summary
The CDllb-DTR mice are a potent experimental conditional M(j) ablation
system. DT administration depletes >96% of pleural resident M()> at 24h. In these
transgenic mice, pleural M(j) ablation was shown to blunt PMN recruitment following
the intrapleural administration of carrageenan and formalin fixed Staphylococcus
aureus bacteria. M(j) repletion studies demonstrated that the adoptive transfer ofM(j)-
rich pleural cells or purified pleural M(j) alone at the same time as carrageenan





Figure 4.14 - Resident M<(> exhibit prominent phagocytosis of formalin
fixed Staphylococcus aureus.
Photomicrographs of Diffquick stained (A and C) or Hoechst stained (B and D)
cytospin preparations of pleural lavage cells from either DT-treated FvB/N mice (A
and B) or DT-treated CD1 lb-DTR mice (C and D) 4 hr after the administration of
3xl06 formalin fixed fluorescently labelled Staphylococcus aureus bacteria.
Prominent ingestion of Staphylococcus aureus particles by M(j) is evident in DT
treated FvB/N control mice (examples arrowed in A and B) with very limited uptake
by PMN. In contrast, DT-treated CD1 lb-DTR mice exhibit marked PMN ingestion
of Staphylococcus aureus particles (examples arrowed in C and D)(100X
magnification).
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Mc() ablated CD1 lb-DTR control mice after carrageenan administration. In contrast,
the adoptive transfer of Mcj)-depleted pleural cells at the same time as carrageenan
did not restore PMN infiltration. In these experiments, it was not possible to
completely restore the numbers of resident pleural M(j) at the initiation of
inflammation and this may well account for the difference in PMN recruitment seen
between FvB/N control mice and CD1 lb-DTR mice that had received either M(j)-rich
cells or Mcj) alone. Again, similar to the peritoneum, B and MC were present in the
M(|)-depleted transferred cell population but this cell transfer did not significantly
recruit PMN thereby suggesting that B cells and MC did not make a major
contribution to PMN recruitment despite the reduction in their numbers that follows
DT administration. Chemokine analysis revealed that M(j)-dependent in vivo
production of MIP-2 plays a crucial role in PMN recruitment, whereas KC
production was less affected by Mcj) depletion suggesting a non-Mcj) origin of KC. A
similar conclusion could be reached for MCP-1 production. In vivo cytokine
analysis revealed that TNF-a production was Mcj) dependent confirming the
important role of Mcj) in the secretion of this initiator cytokine. IL-6 production was
also reduced by Mcj) ablation and the major difference between the two groups was
seen at the 3h time point, suggesting that TNF-a production probably precedes IL-6
production. The important cytokines, IL-10 and IL-12, were also reduced following
Mcj) ablation, suggesting that Mcj) play a role in their production in vivo. In vitro
studies demonstrated Mcj)-dependent production of both C-X-C chemokines and three
cytokines (TNF-a, IL-6 and IL-10).
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Mcf) ablation also reduced PMN recruitment after the instillation of formalin
fixed Staphylococcus aureus bacteria into the pleural cavity. These experiments also
highlighted the importance of the resident M(|> as a phagocyte. M((> phagocytosis of
bacteria was prominent in FvB/N control mice with scanty bacteria evident in PMN.
In contrast, the bacteria were ingested by PMN in M(j) ablated CDllb-DTR mice in
the absence of the 'professional phagocyte' i.e. the M(|). In conclusion, the
experiments highlighted in this chapter indicate that the pleural resident M(j) plays a
crucial role in the initiation of inflammation and PMN recruitment in pleural
inflammation.
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Chapter 5: The role of lymphocytes in experimental peritoneal
inflammation
5.1. Introduction
The experiments outlined in chapter 3 examined the role of resident
peritoneal M(j) and MC in experimental peritonitis induced by administration of
BTG. Resident peritoneal M(|) were found to be critically important in the
orchestration of PMN recruitment with adoptive cell transfer experiments and in
vitro assays of chemokine production suggesting that PMN recruitment was MC
independent. In addition to resident peritoneal M(j> and MC the peritoneal space
contains many lymphocytes which constitute nearly 50% of resident peritoneal
leukocytes in humans (Broche and Tellado, 2001; Kubicka et al., 1996; Lewis and
Holmes, 1991) and almost 14% of resident peritoneal leukocytes in mice although
there are variations between strains (Gjomarkaj et al., 1999). The function of
lymphocytes during peritoneal inflammation has not been explored in detail (Faull,
2000). Although the work outlined in chapter 3 indirectly examined the role of
lymphocytes in experiments involving the adoptive transfer of M(j) depleted
peritoneal cells to Mc|)-depleted CDllb-DTR mice, I became interested in whether
the presence of various lymphocyte populations may modulate the function of
resident M(() including their subsequent chemokine and cytokine responses and
resultant PMN recruitment. In addition, the previous studies involving conditional
Mcj) ablation in experimental peritonitis did not explore the recruitment ofmonocytes
and Mcj) to the inflamed peritoneum as the administration of DT resulted in a
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dramatic reduction in the number of circulating monocytes. I was therefore interested
in addressing the hypothesis that peritoneal lymphocytes may modulate the
recruitment ofmonocytes/M(j) to the inflamed peritoneum.
B cells represent an important component of the resident peritoneal
lymphocyte population in mice (Hayakawa et al., 1985). The peritoneum contains B
cells which are different from circulating B cells (Herzenberg, 2000). B-l cells are
involved in the synthesis of immunoglobulins (Ig) and natural antibodies (IgM)
(Herzenberg, 2000) and have been shown to play an important role in different
models of inflammation such as fdarial (Paciorkowski et al., 2000) and bacterial
infection (Boes et ah, 2000) and delayed-type hypersensitivity (Szczepanik et ah,
2003).
The T cell populations within the peritoneum are also quite different from
circulating T cells with around 17% of peritoneal T cells expressing the yb TcR
(Hartman et ah, 1995). The majority ofperitoneal T cells exhibit markers of thymus-
dependent origin and surface antigens compatible with an activation and memory
phenotype. However there are peritoneal T cells with a phenotype indicating that the
peritoneum is capable of thymus-independent differentiation of T cells (Hartman et
ah, 1995). The yb T cells could have an important role in the regulation of the early
inflammatory response and it is therefore of interest that yb T cell KO mice exhibit
increased pulmonary inflammation with increased numbers of recruited PMN and
M(J) (Zachariadis et ah, 2006). It was suggested that yb Tcells are important in
regulating the extent of the inflammatory response in order to prevent excessive
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tissue damage. However, to my knowledge there are no studies that have directly
examined the role of T cells in experimental peritonitis.
There are a number ofmice available that are deficient in various lymphocyte
populations and such mice may be used to determine whether lymphocytes may
modulate leukocyte recruitment. I therefore examined the inflammatory phenotype
RAG-1 KO mice (mature B and T cell deficient), NUDE mice (T cell deficient),
(J.MT mice (B cell deficient) and their respective controls in the experimental model
of BTG peritonitis. I also wished to compare the experimental data between the
three different lymphocyte deficient mice as previous studies have noted different
effects on leukocyte recruitment depending on the inflammatory model used
(Appelberg, 1992; Burne et al., 2001; Burne-Taney et al., 2003; Chen et al., 2002;
Hancock et al., 2002; Morrison et al., 2006; Zwacka et al., 1997).
5.2. Results
5.2.1. RAG-1 knock-out mice exhibit increased early PMN
infiltration and reduced monocyte recruitment at later time
points.
The RAG-1 KO mice are on the C57BL/10 background and these mice were
used as controls. C57BL/10 mice exhibited a peak in PMN numbers at 24h and a
peak in monocyte/M(|) numbers at 72h following the administration of BTG (Figure
5.1). In contrast, RAG-1 KO mice exhibited markedly increased PMN numbers at 8h
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Figure 5.1 - RAG-1 KO mice exhibit increased PMN influx and reduced
monocyte/M(|> recruitment at later time points in BTG peritonitis.
lml of 3% BTG was administered to RAG-1 KO and C57BL/10 WT mice and
peritoneal lavage was performed at 0, 8, 24, 72 and 120h. Lavaged cells were stained
for GR1 and F4/80 and counted by flow cytometry. The numbers of PMN (A) and
monocyte/M(|) (B) are depicted (* = p<0.05, RAG-1 KO mice vs C57BL/10 mice,
n=6 mice per group per time point).
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compared to C57BL/10 control mice with a significant difference still apparent at
24h (Figure 5.1A). The PMN infiltration had resolved by 72 h in both experimental
groups. Examination of the numbers of monocyte/M(|) indicated that RAG-1 KO
mice exhibited an initial increase in monocyte/M(|> number at 8h compared to
C57BL/10 mice. Despite this initial increase, however, RAG-1 KO exhibited a
profoundly reduced monocyte/M(|) influx at all other time points examined with a
particularly striking difference evident at 72 h (Figure 5.IB).
I also performed a preliminary experiment using the model of zymosan
peritonitis in order to establish if this recruitment pattern could be reproduced using a
different pro-inflammatory agent. PMN and monocyte/M(|) numbers were
determined 24h after the administration of zymosan. Although this preliminary
experiment only comprised of 3 mice per group, there was a slight trend towards
increased PMN numbers and reduced monocyte/M()) numbers in RAG-1 KO mice
(Figure 5.2).
In view of the differences evident between RAG-1 KO mice and C57BL/10
mice in BTG peritonitis, I analysed the numbers of peritoneal Mc(), PMN, MC, B
cells and T cells in non-manipulated mice. This revealed that RAG-1 KO mice
predictably had reduced peritoneal lymphocytes but also had significantly less MC









Figure 5.2 - RAG-1 KO mice exhibit a trend to an increased PMN influx
and reduced M<}> recruitment at the 24 hr time point in zymosan
peritonitis.
0.2mg of zymosan was administered IP to RAG-1 KO and C57BL/10 WT mice.
Peritoneal lavage was performed 24h following zymosan administration. Lavaged
cells were stained for GR1 and F4/80 and counted by flow cytometry (n=3 mice per
group).
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Figure 5.3 - RAG-1 KO mice exhibit an increased number of resident M<j>
compared to C57BL/10 mice but significantly less mast cells, B ceils
and T cells in the peritoneum.
Peritoneal lavage was performed in non-manipulated RAG-1 KO and C57BL/10
mice. The number of M(j), PMN, mast, B and T cells was determined by flow
cytometry following staining for F4/80, GR1, c-kit, B220 and CD3 (*=p<0.005,
RAG-1 KO mice vs C57BL/10 mice; n=6-12 mice per group).
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I also examined the numbers of circulating leukocytes in non-manipulated
RAG-1 KO and C57BL/10 mice. RAG-1 KO mice exhibited a profound B cell and
T cell deficiency (Figure 5.4) but had comparable number of circulating PMN to
C57BL/10 mice (Figure 5.4). Significant differences were found, however, in the
numbers of circulating monocytes with RAG-1 KO mice exhibiting reduced
monocyte numbers compared to C57BL/10 mice (Figure 5.4). These differences in
the circulating and peritoneal leukocyte numbers may explain, at least in part, the
phenotype of the RAG-1 KO mice during BTG peritonitis. Since the work outlined
in chapter 3 indicated a key role for the resident peritoneal M(|) in PMN recruitment,
it is possible that the increased number of resident M(() present in RAG-1 KO mice
underlies the significant increase in PMN recruitment seen at the 8h and 24h time
point in RAG-1 KO mice. The differing numbers of circulating monocytes between
RAG-1 KO and C57BL/10 mice also represents a confounding variable and may
explain the reduced M(f) numbers evident at late time points between RAG-1 KO and
C57BL/10 mice. The increased monocyte/M<j) numbers evident at 8h is not
explained by the circulating monocyte counts but may reflect the differing numbers
of resident peritoneal M(j) evident in the non-manipulated peritonea of RAG-1 KO
and C57BL/10 mice. I therefore went on to examine the levels of chemokines
present during peritoneal inflammation in RAG-1 KO and C57BL/10 mice.
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M<j> PMN B Cells T Cells
Figure 5.4 - RAG-1 KO have comparable circulating PMN numbers to
C57BL/10 mice but significantly less circulating monocytes and
lymphocytes.
Circulating blood leukocyte numbers were compared in non-manipulated RAG-1 KO
and C57BL/10 mice. The number of M((>, PMN, B and T cells was determined by
flow cytometry following staining for F4/80, GR1, B220 and CD3 (*=p<0.01 and
#=p<0.0001, RAG-1 KO mice vs C57BL/10 mice; n=6 mice per group).
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5.2.2. RAG-1 KO exhibit reduced MCP-1 levels at 24h.
RAG-1 KO exhibited a 50% reduction in MCP-1 levels 24h following BTG
administration (20.4±2.3 pg/ml vs 42.8±7.2; RAG-1 KO vs C57BL/10; p<0.01; n=4
mice per group) and this may partly underlie the impaired monocyte/M<|) recruitment
evident at later time points. However, no statistically significant differences between
experimental groups were found for any of the other cytokines and chemokines
analysed. These included the cytokines TNF-a, IFN-y, IL-10, IL-6 and IL-12 and
the C-X-C chemokines MIP-2 and KG. Unfortunately, I was unable to perform
complete cytokine analysis at the very early time points, however no differences
were found in the levels of the C-X-C chemokines MIP-2 and KC at lh and 3h after
BTG administration. Since RAG-1 KO mice have an increased numbers of resident
peritoneal M(j), I would have expected an increased MIP-2 and KC production based
on the work outlined in chapter 3. Thus, other C-X-C chemokines might be
involved.
5.2.3. NUDE mice recruited more PMN at 8h and 24h and more
monocytes at 24h.
The NUDE mice are on the CD 1 background and these mice were therefore
used as controls. CD1 mice exhibited a peak in PMN numbers at 8h and 24h but
monocyte/M(() numbers were not striking elevated with similar numbers evident at
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Figure 5.5 - NUDE mice have an increased PMN influx at 8 and 24h and
increased monocyte/M(|> recruitment at 24h following BTG peritonitis.
lml of 3% BTG was administered to NUDE and CD1 mice. Peritoneal lavage was
performed at 0, 8, 24 and 72 h following BTG. Lavaged cells were stained for GR1
and F4/80 and counted by flow cytometry. PMN (A) and monocyte/M({> (B) number
progression are depicted (* = p<0.05, NUDE mice vs CD1 mice; n=6 mice per group
per time point). There was one outlier at 8h and one at 24h in the CD1 group.
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NUDE mice exhibited markedly increased PMN numbers at both 8h and 24h
compared to CD1 mice (Figure 5.5A). The PMN infiltration had resolved by 72 h in
both experimental groups. Examination of the numbers of monocyte/M(J) indicated
that NUDE mice exhibited increased numbers ofmonocyte/M(j) at 24h compared to
CD1 mice (Figure 5.5B).
Analysis of the numbers of peritoneal and circulating leukocytes in NUDE
and CD1 mice was informative as they may be similar to RAG-1 KO mice and differ
in the numbers of resident peritoneal M(j) and circulating monocytes. Interestingly,
however, NUDE mice have comparable numbers of resident peritoneal M(|) to CD 1
mice (Figure 5.6) but do exhibit significantly reduced numbers of peritoneal MC and
B cells at baseline (figure 5.6). Thus the increased PMN recruitment in NUDE mice
cannot be explained by a difference in resident peritoneal M(j) number. Analysis of
circulating leukocyte numbers indicated that NUDE and CD1 mice had comparable
numbers of circulating blood monocytes but NUDE mice did exhibit a trend to
increased circulating PMN numbers (p=0.09 between NUDE and CD1 mice (Figure
5.7). It may therefore be the case that the increased peritoneal PMN numbers at 8h
and 24h may be explained by this trend towards more circulating PMN in the NUDE
compared to CD1 mice. However, the increased numbers of peritoneal
monocyte/M(j) numbers in NUDE mice at the 24h time point during peritoneal
inflammation is not secondary to differing numbers of circulating monocytes.
It is interesting that the pattern of increased PMN recruitment in NUDE mice
is comparable to that observed in RAG-1 KO mice suggesting that T cells may be
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M(|) PMN Mast Cells B Cells T Cells
Figure 5.6 - NUDE mice have less peritoneal mast cells and B cells at
baseline compared to C57BL/10 mice.
Peritoneal lavage was performed in non-manipulated NUDE and CD1 mice. The
number of M<j), PMN, mast, B and T cells was determined by flow cytometry
following staining for F4/80, GR1, c-kit, B220 and CD3 (*=p<0.05, NUDE mice vs
CD1 mice; n=4-6 mice per group).
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Figure 5.7 - NUDE mice have a trend towards increased circulating
PMN numbers compared to control CD1 mice and comparable numbers
of circulating monocytes.
Circulating blood leukocyte numbers are compared between non-manipulated NUDE
and CD1 mice. The number of M(|), PMN, B and T cells was determined by flow
cytometry following staining for F4/80, B220, CD3 and GR1 (*=p>0.09, NS; NUDE
mice vs CD1 mice; n=4 mice per group).
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capable ofmodulating PMN recruitment. In contrast, the monocyte/Mc)) recruitment
profile in NUDE mice differs from that observed in RAG-1 KO mice and this
suggests that T cells are not critical regulators of M<f> influx.
5.2.4. The adoptive transfer of T cells to NUDE mice did not
normalise PMN influx.
In order to evaluate if leukocyte recruitment in NUDE mice could be
normalised, I used the adoptive cell transfer strategy. Approximately 50,000
peritoneal T cells purified by negatively immunoselection from CD1 mice were
transferred into NUDE mice (Rescued NUDE). This resulted in reconstituting
peritoneal T cell numbers to about 50% of that found in the non-manipulated CD1
peritoneum. In this experiment, approximately 150,000 M(j) were also transferred
with the T cells and this represents a confounding variable as my previous work
indicated a prominent role for M(j) in the recruitment of PMN. Elowever, 150,000
Mcj) represents less than 10% of the number of M(|) present normally in NUDE or
CD1 mice. Peritoneal lavage was performed 8h after the adoptive cell transfer and
BTG administration. The numbers of recruited PMN evident in the rescued NUDE
mice was comparable to the control group ofNUDE mice (Figure 5.8). It should be





Figure 5.8 - The adoptive transfer of T cells to NUDE mice does not
normalise peritoneal PMN influx.
Peritoneal lavages from CD1 were pooled and T cells were negatively selected by
immunodepletion. Approximately 50,000 T cells were transferred into NUDE mice
at the same time as 3% BTG and peritoneal lavage was perfomed 8h later. Lavaged
cells were stained for GR1 and PMN were then counted by flow cytometry (* =
p<0.05, vs NUDE: n=3 mice per group).
124
5.2.5. In vivo chemokine/cytokine analysis reveals increased levels
of KC, MCP-1 and IL-6 at various time points in NUDE mice
compared to CD1 mice.
The levels of the chemokines MIP-2, KC and MCP-1 and the cytokines IFN-
y, TNF-a, IL-6 and IL-10 in peritoneal lavage fluid were determined by ELISA at
the lh, 3h, 8h, 24h and 72h time points.
Interestingly, despite the increased PMN recruitment evident in NUDE mice,
there were no significant differences in the levels ofMIP-2 between NUDE and CD1
mice at any time points (Figure 5.9A). Analysis of the C-X-C chemokine KC levels
indicated a significantly higher KC level in NUDE mice at 8h compared to CD1
controls (Figure 5.9B). However, KC levels peaked at the earlier time points of lh
and 3h and the levels present at 8h were very much lower than these peak early
values (Figure 5.9). Analysis of the levels of the C-C chemokine MCP-1 revealed
similar profiles in both experimental groups with NUDE mice exhibiting
significantly higher levels at the 3h time point (Figure 5.10A).
There were no differences in the levels of IFN-y, TNF-a or IL-10 between
experimental groups (data not shown). The only significant difference between
groups was that NUDE mice had a higher level of IL-6 at the 8h time point (Figure






Figure 5.9 - Chemokine levels in NUDE and CD1 mice in BTG
peritonitis: no difference in MIP-2 levels with increased KC at the 8h
time-point.
NUDE and CD1 mice were injected with 1ml of 3% BTG. Peritoneal lavage was
performed 1, 3, 8, 24 and 72 hr after the induction of peritonitis. The level ofMIP-2
(A) and KC (B) in the peritoneal lavage supernatant was determined by specific





Figure 5.10 - MCP-1 and IL-6 time course in NUDE and CD1 mice in BTG
peritonitis: higher levels of MCP-1 and IL-6 at 3h and 8h respectively.
NUDE and CD1 mice were injected with 1ml of 3% BTG. Peritoneal lavage was
performed 1, 3, 8, 24 and 72 hr after the induction of peritonitis. The level ofMCP-1
(A) and IL-6 (B) in the peritoneal lavage supernatant was determined by specific
ELISA (*=p<0.01 vs CD1 group, n= 6 mice per group per time point).
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It is unclear whether the difference in KC level at 8h is sufficient to explain the
increased PMN number found in NUDE mice at 8 and 24h after BTG and the
tendency ofNUDE mice to have more circulating PMN may also be involved. The
increased MCP-1 level found in NUDE mice at the 3h time point is somewhat early
to explain the difference in monocyte/M(j) numbers at 24h but it does indicate that
NUDE mice are able to produce more MCP-1. The higher IL-6 levels at 8h are
consistent with a more prolonged inflammatory state.
5.2.6. Supernatant transfer from NUDE mice did not increase
peritoneal PMN recruitment in CD1 mice, but did augment
blood-circulating PMN mobilisation.
In the absence of clear cut chemokine differences to explain the different
leukocyte kinetics seen in NUDE and CD 1 mice, I went on to perform experiments
involving the transfer of pro-inflammatory peritoneal supernatant between NUDE
and CD 1 mice in order to investigate whether there were other PMN chemotactic
factors present or other factors that inhibited PMN recruitment. Peritoneal
supernatant (SN) was obtained by performing peritoneal lavage on NUDE and CD1
mice 3h after the administration of BTG. This time point was chosen in view of the
early increase in MIP-2 and KC levels found at lh and 3h and the fact that PMN
influx was markedly increased at the 8h time point. Pro-inflammatory peritoneal SN
transfer was performed in a cross-over fashion with SN from NUDE mice being
transferred to both naive CD 1 mice and NUDE mice and vice versa.
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The IP injection of SN derived from either NUDE or CD1 mice did induce a
mild PMN infiltrate (Figure 5.11A) though this was significantly less than that
provoked by BTG at the same time point despite the presence of significant levels of
C-X-C chemokines in the transferred supernatants (around 1200 pg/ml of KC and
MIP-2 for both groups). This is likely to be secondary to the inevitable dilution of
chemokines and cytokines etc. There were no differences in the numbers of
peritoneal PMN recruited between NUDE and CD1 mice irrespective of whether
they received SN from a NUDE or CD1 mouse (Figure 5.11A). The circulating
PMN numbers in blood were also determined 8h after SN transfer. Despite the
absence of differences in peritoneal PMN numbers, the transfer of NUDE SN
significantly augmented circulating blood PMN numbers in CD1 mice compared to
CD1 mice that had received SN derived from CD1 mice. Indeed, circulating PMN
numbers were elevated to levels similar to those observed in NUDE mice that had
received SN derived from NUDE mice (Figure 5.1 IB). There was also trend toward
a reduction of circulating PMN in NUDE mice receiving CD1 SN compared to
NUDE mice administered NUDE SN (Figure 5.1 IB). Thus, in these experiments it
appeared that the number of circulating PMN was determined by the nature and
source of the supernatant and not the recipient mouse into which it was administered.
Since the number of circulating PMN in NUDE or CD1 mice receiving SN from
NUDE mice were greater, this suggested NUDE SN was either 'more chemotactic'
or contained a more robust signal for mobilising PMN from the bone marrow.
However, the absence of any differences in the actual number of recruited peritoneal





















Figure 5.11 - The transfer of peritoneal supernatant from NUDE mice
does not influence peritoneal PMN numbers but does increase
circulating blood PMN mobilisation in CD1 mice.
NUDE and CD1 mice were injected with BTG and peritoneal lavages were
performed after 3h. Peritoneal supernatants from NUDE and CD1 mice were injected
back into naive NUDE and CD1 in a cross-over fashion (see text). After 8h
peritoneal cells were obtained by lavage (A) and circulating cells obtained from tail
vein blood. Cells were stained for GR1 and counted by flow cytometry (n=4-5 per
group; #=p=0.0549, not significant, NUDE SN vs other NUDE group and *=p<0.05
vs other CD1 group).
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5.2.7. |jMT KO mice exhibit reduced PMN recruitment at 24h and
reduced monocyte/M<|> recruitment at 72h and 120h but no
differences in MIP-2, KC or MCP-1 levels compared to C57BL/6
mice.
I next examined the peritoneal response of pMT KO mice following the
administration of BTG. pMT KO mice are on the C57BL/6 background and
C57BL/6 mice were used as controls. pMT KO mice exhibited a blunted peak in
PMN influx and recruited less PMN at the 24h time point (Figure 5.12A). In
addition, M(() influx was also reduced at 72h and 120h (Figure 5.12B). Importantly,
pMT mice had comparable numbers of circulating blood monocytes to C57BL/6, but
had significantly less circulating PMN (Figure 5.13). Apart from the profound
reduction in peritoneal B cells numbers, the numbers of resident peritoneal M(|), MC
and T cells were similar in pMT KO and C57BL/6 control mice (data not shown). I
was unable to perform experiments involving the short time points of lh and 3h
because of lack of mice but analysis ofMIP-2 and KC levels on the peritoneal lavage
fluid from available time points did not demonstrate any differences between the
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Figure 5.12 - pMT mice exhibit a reduced PMN influx at 24h and a
decreased M<|) influx at 72 and 120h following BTG peritonitis.
lml of 3% BTG was administered to pMT and C57BL/6 mice. Peritoneal lavage
was performed at 0, 8, 24, 72 and 120h following BTG. Lavaged cells were stained
for GR1 and F4/80 and counted by flow cytometry. PMN (A) and M(j) (B) number
progression are depicted (* = p<0.001 and #=p<0.05, pMT mice vs C57BL/6 mice,
n=5 mice per group per time point).
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Figure 5.13 - pMT mice have comparable numbers of circulating
monocytes but less circulating PMN numbers compared to control
C57BL/6 mice.
Circulating blood leukocyte numbers are compared in non-manipulated pMT KO
and C57BL/6 mice. The number of M(|), PMN, B and T cells was determined
following staining for F4/80, GR1, B220 and CD3 by flow cytometry (*=p<0.01,
#=p<0.0001; pMT KO mice and C57BL/6 mice; n=4-5 mice per group).
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5.2.8. In vitro assessment of C-X-C chemokine production by
peritoneal cell populations following immunodepletion of B
and T cells: modulation is stimulus specific.
The data generated by the in vivo experiments outlined did not provide any
unequivocally clear insights into the role of lymphocytes in peritoneal inflammation
as interpretation of the data was confounded by differences in the peritoneal cell
populations or circulating leukocyte numbers. I therefore undertook a series of in
vitro experiments involving the stimulation of peritoneal cells that had been
immunodepleted of either B or T cells. Cell populations were then exposed to either
normal medium, 1% BTG or LPS (lOng/ml) for 3h and chemokine production
determined by ELISA. My previous work outlined in chapter 3 had demonstrated
that the production of chemokines in such in vitro experiments is entirely dependent
upon M(|). Therefore the data were normalised for the numbers of Mcj) present in the
'All Cells' group.
The levels of the C-X-C chemokines MIP-2 and KC were compared (Figure
5.14A and 5.14B). The basal production of both MIP-2 and KC was significantly
reduced with B cell or T cell depletion. Stimulation with 1% BTG increased the
production of MIP-2 and KC with no significant effect of B cell or T cell depletion
being evident (Figure 5.14A and 5.14B).
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Figure 5.14 - In vitro peritoneal cell stimulation resulted in stimulus-
dependent MIP-2 and KC production that is modulated by lymphocyte
immunodepletion.
Peritoneal lavages were pooled and immunodepleted of either B cell ('All Cells
minus B cells') or T cells ('All Cells minus T Cells'). Stimulated total peritoneal
cells served as control ('All Cells'). Chemokine levels were normalised according to
M((> number present in the 'All Cells' population. Cells were incubated in either
medium alone, 1% BTG or LPS (lOng/ml) for 6h. Supernatants were harvested and
analysed by ELISA for A) MIP-2 (*=p<0.05 vs All cells; n=6) and B) KC (*=p<0.05
vs All cells; n=6).
■Medium CI ±o/o BTG HLPS
i
All Cells A" Cells minus All Cells minus
B Cells T Cells
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Stimulation with LPS induced a mild increase in MIP-2 and KC levels. B
cell depletion significantly reduced the levels of both MIP-2 and KC after LPS
stimulation (Figure 5.14A and 5.14B). Although T cell depletion also exhibited a
trend toward reduced chemokine production with LPS stimulation, this was not
statistically significant.
5.2.9. In vitro cell stimulation demonstrated a reduced production
of MCP-1 with B cell depletion and variable effects with T cell
depletion.
I then examined the production of MCP-1 by peritoneal cells in vitro.
Initially, 1% BTG was used to stimulate cells with an incubation period of 6h but this
protocol resulted in MCP-1 levels (adjusted for the M(|) number) that were much
lower than those evident in vivo (Figure 5.15A). However, preliminary data could
demonstrate increased induction of MCP-1 production in the absence of T cells but
no difference in the absence of B cells (Figure 5.15A).
LPS (lOng/ml) stimulation of peritoneal cells for 6h did result in significant
production of MCP-1. Using LPS as a stimulus, B cell depletion significantly
reduced MCP-1 production whereas T cell depletion had no significant effect (Figure
5.15A). I then performed studies with various concentrations ofBTG and found that
stimulation of peritoneal cells with 0.25% BTG with 10% serum for 6h resulted in
significant MCP-1 production. Both B and T cell immunodepletion resulted in a
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Figure 5.15 - In vitro peritoneal cells stimulation resulted in stimuli-
dependent MCP-1 production by lymphocyte immunodepletion.
Peritoneal lavages were pooled and immunodepleted of either B cell ('All Cells
minus B cells') or T cells ('All Cells minus T Cells'). Stimulated total peritoneal
cells served as control ('All Cells'). MCP-1 levels were normalised according to M(j)
number present in the 'All Cells' population. A) Cells were incubated in medium
alone, 1% BTG or LPS (lOng/ml) for 6h. Supernatant were harvested and analysed
by ELISA for MCP-1 (*=p<0.05 vs All cells; n=6). B) Cells were incubated in











significant reduction in MCP-1 production (Figure 5.15B). In contrast, the basal
secretion of MCP-1 from unstimulated peritoneal cells incubated in medium alone
was reduced following B cell depletion and increased following T cell depletion
(Figure 5.15B). Again these in vitro studies are not conclusive but suggest the
following:
(i) The absence of B cells reduces basal MIP-2/KC production, has no effect
upon MIP-2/KC levels following 1% BTG stimulation but does decrease
MIP-2/KC levels following LPS stimulation.
(ii) The absence of B cells reduces the basal production of MCP-1 and
reduces the MCP-1 production induced by LPS and 0.25% BTG.
(iii) The absence of T cells reduces basal MIP-2/KC production but has no
significant effect upon MIP-2/KC levels following stimulation with 1%
BTG or LPS.
(iv) The absence of T cells increases the basal production of MCP-1, reduces
the MCP-1 production induced by 0.25% BTG but has no effect upon
LPS induced MCP-1 production.
5.3. Summary
Table 5.1 highlights the major findings outlined in this chapter and table 5.2
compares the populations of peritoneal resident leukocytes in the different strains of
mice used in this chapter. RAG-1 KO mice exhibited increased PMN infiltration and
blunted monocyte/M(j) infiltration with a trend for a similar recruitment pattern in
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Table 5.1-Summary of experimental findings with the various
lymphocyte KO















PMN Recruitment Increased at 8h
and 24h
Increased at 8h and
24h
Reduced at 24h
M(|) Recruitment Increased at 8h
and reduced
thereafter
Increased at 24h Reduced at 72h
and 120h
C-X-C Chemokines No difference Increased KC at 8h No difference






Table 5.2-Comparison of the populations of resident peritoneal
leukocytes for each of the mouse strains used.
M(j> PMN B Cells T Cells Mast Cells
RAG-1
KO
2.5xl06 1.2xl04 0.8xl05 0.5x10s 1.7xl04
±0.3x106 ±0.8xl04 ±0.08xl05 ±0.07xl04 ±0.2xl04
NUDE
1.6xl06 3.6xl04 0.7xl06 O.lxlO5 0.5xl05
±0.1xl06 ±1.9xl04 ±0.1xl05 ±0.04x105 ±0.04xl04
|JMT
1.8xl06 8.0xl03 0.9x105 5.7xl04 6.1xl04
±0.3xl06 ±l.lxl03 ±0.1xl05 ±0.9x104 ±0.5xl04
C57BL/10
1.6xl06 1.2xl04 7.2x105 2.6xl05 3.2xl04
±0.3xl06 ±0.8xl04 ±1.3xl05 ±0.4xl05 ±0.3xl04
CD1
2.5xl06 3.1xl04 1.6xl06 l.OxlO5 1.0x10s
±0.1xl06 ±0.9xl04 ±0.2x106 ±0.3x105 ±0.03xl05
C57BL/6
2.2xl06 8.6xl03 7.4xl05 7.5xl04 7.1xl04
±0.4xl06 ±4.6xl03 ±1.8xl05 ±1.9xl04 ±0.4xl04
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zymosan-induced peritonitis. Interpretation of this data is confounded by the fact
that RAG-1 KO mice have an increased number of resident peritoneal M(|) (key
players in PMN recruitment) and reduced circulating monocyte numbers. There was
no difference evident in MIP-2 or KC levels. In addition to reduced circulating
monocyte numbers, RAG-1 KO mice exhibited reduced levels of MCP-1 at the 24h
time point and this may also be involved in the impaired peritoneal recruitment of
monocyte/M(|) seen in RAG-1 KO mice.
In BTG-peritonitis, NUDE mice exhibited increased PMN infiltration at 8h and
24h and increased monocyte/M(|) infiltration at 24 hr. NUDE mice exhibited
increased levels of KC at 8h and increased levels of MCP-1 at 3h together with
elevated levels of IL-6 at the 8h time point. Despite the absence of clear
chemokine/cytokine differences to explain the observed findings, the SN transfer
experiments between NUDE and CD1 mice may shed some light on a possible
explanation.
Although SN transfer between NUDE and CD 1 mice did not affect peritoneal
PMN numbers, analysis of circulating blood PMN numbers revealed that the transfer
of NUDE SN increased the number of circulating PMN of CD1 mice compared to
CD1 mice that had received SN derived from CD1 mice. Furthermore, the transfer
of SN from CD1 mice into NUDE mice resulted in a reduction in the number of
circulating blood PMN in NUDE mice compared to the circulating PMN numbers of
NUDE mice that had received SN from NUDE mice. The circulating number of
PMN was similar amongst mice that had received NUDE SN suggesting the possible
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presence of a stronger signal for bone marrow mobilisation of PMN in this SN.
There may be increased chemotactic agents or the absence of an inhibitor of PMN
mobilisation (or decoy cytokine receptor) in NUDE mice that would enhance the
systemic inflammatory response and leukocyte mobilisation.
The lack of increased peritoneal PMN recruitment despite the elevation in
circulating PMN numbers highlights the complexity of leukocyte recruitment. One
explanation could be that NUDE mice may have a different peritoneal vasculature
structure that would facilitate leukocyte transmigration or they may have endothelial
cells in an enhanced state of activation (increased selectins or ICAMs at their
surface) that would promote rolling of circulating leukocytes thereby facilitating
transmigration. It is also possible that the PMN from NUDE and CD1 mice may
behave differently to chemotactic stimuli as a result of different leukocyte surface
receptors/molecules that would affect emigration from the blood. A full
understanding of the effect of T cells on the modulation of peritoneal leukocyte
recruitment is still lacking and further work is required.
The pMT KO mice exhibited decreased PMN influx and a reduced M(j)
influx. Unlike RAG-1 KO mice and NUDE mice there were no differences in
chemokine levels evident in pMT KO mice. The in vitro experiments involving
analysis of chemokine production by peritoneal cell populations in the presence or
absence of B cells and T cells suggested that lymphocytes may modulate the
generation of chemokines by Mcj) but that this is complex. For example, the
experimental findings differed according to the stimulus used.
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However, the overall impression derived from this body ofwork suggests that
T cells may have the capacity to downregulate leukocyte recruitment with a lack ofT
cells facilitating increased PMN and monocyte/M(|) recruitment as in the NUDE
mice. B cells may play a role in promoting later Mcj) recruitment as both RAG-1 KO
mice and pMT KO mice exhibited reduced monocyte/M(j) recruitment. However, the




In the experiments described in this thesis, a conditional M<|) ablation strategy
was used to dissect the role of the resident peritoneal and pleural M(j) in the initiation
of serosal inflammation and the orchestration of PMN recruitment in two well
established inflammatory models i.e. BTG induced peritonitis and carrageenan
induced pleurisy.
Previous work indicated that leukotrienes derived from resident peritoneal
M(j> are involved in the development of early vascular permeability in sterile
peritonitis (Kolaczkowska et al., 2002). Although early work in rat models of
peritonitis implicated the resident peritoneal M(j) in the orchestration of PMN
recruitment (de Souza and Ferreira, 1985) (Souza et ah, 1988) (Barja-Fidalgo et ah,
1992), more recent studies have produced conflicting results (Ajuebor et ah, 1999;
Knudsen et ah, 2002). Indeed, studies by Ajuebor et al demonstrated that resident
M(j) depletion inhibits PMN influx in LPS induced inflammation, has no effect in
BTG peritonitis and augments PMN influx in zymosan peritonitis (Ajuebor et ah,
1999). In the latter model, it was proposed that M(j)-derived IL-10 inhibits PMN
recruitment. Conversely, work by Knudsen et al using clodronate-induced depletion
of peritoneal Mc() in a rat model of sterile peritonitis demonstrated that PMN
infiltration was M(j) dependent (Knudsen et ah, 2002).
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In the pleural space, carrageenan induces prominent inflammatory responses
that are likely to be involved in human disease. In addition, I examined the effect of
M(j) ablation prior to the administration of fixed Staphylococcus aureus bacteria as a
model with more direct clinical relevance. Although the resident pleural Mc() is
eminently capable of secreting chemokines and cytokines, its role in pleurisy is
currently unclear. It has been demonstrated by multiple investigators that pleural
mesothelial cells have the capacity to secrete various chemokines (Antony et al.,
1995; Jonjic et al., 1992; Loghmani et al., 2002; Mohammed et al., 1999; Pace et al.,
1999; Park et al., 2003). In addition, some studies have identified resident pleural
M(|)-derived pro-inflammatory cytokines such as TNF-a that are essential for the
secretion of C-X-C and C-C chemokines from pleural mesothelial cells (Antony et
al., 1995; Cuzzocrea et al., 1999b; Frode et al., 2001; Goodman et al., 1992;
Mohammed et al., 1998b; Pace et al., 1999; Park et al., 2003) thereby suggesting
important cross talk between different cells within the pleural cavity.
In my studies, the administration of 25ng/g body weight of DT to CD1 lb-
DTR transgenic mice resulted in the rapid and effective ablation of resident serosal
Mcj) with 98% M(J) ablation in the peritoneum and greater than 96% ablation in the
pleural space with resident M0 undergoing rapid apoptosis following administration
of DT. This dose was used because of its potency compared to lower doses and it
was well tolerated in the short time scale of these studies. M(j) ablation dramatically
blunted PMN infiltration both in the peritoneal and pleural cavities thereby
indicating a key role for the serosal resident Mcj) in the initiation of acute serosal
inflammation in these experimental models. It is important to note that the reduced
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PMN infiltration in DT treated mice was not attributable to a systemic neutropenia as
circulating PMN were not sensitive to DT such that the number of circulating PMN
in DT treated mice was not reduced compared to PBS treated mice at 24 hours (the
timing of BTG administration). Similarly, recruited peritoneal PMN were resistant to
DT thereby excluding this as a potential cause for diminished PMN infiltration of the
peritoneal cavity. It is unclear why CD1 lb positive PMN are resistant to DT but this
may be a reflection of their lower level of CDllb protein synthesis or the
intracytoplasmic localisation of the DTR receptor when PMN are not activated.
The importance of the resident Mcj) was reinforced by experiments involving
the adoptive transfer of DT insensitive non-transgenic M(j) following DT-mediated
M(J) ablation and prior to the initiation of peritonitis or concurrent with the induction
of pleurisy. The protocol for adoptive transfer evolved over the course ofmy studies
but studies involving the depletion of M({) by adhesion or the purification of M(j) by
immunomagnetic selection yielded similar results. Since the data regarding PMN
recruitment differed somewhat between the peritoneal and the pleural adoptive
transfer experiments they will be discussed separately.
The adoptive transfer of peritoneal M<j) was successful with 7.9xl05±2.7xl05
non-transgenic M(|) being injected into the peritoneal cavities ofM(j) ablated CD1 lb-
DTR mice. This restored the number of peritoneal M(j) to approximately 90% of the
M(j) number normally present in the peritoneal cavities of FvB/N control mice. The
presence of M((> in the transferred peritoneal cell population correlated with the
restoration of the PMN influx. The absence of M(|) in the adoptively transferred cell
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population resulted in no significant PMN recruitment thereby suggesting that the
peritoneal M(j) exerts a critical role in this process. PMN recruitment following the
adoptive transfer of M<j) was not secondary to any intrinsic inflammatory nature of
the cell transfer since mice receiving the M(j)-rich peritoneal cell transfer without any
BTG did not exhibit significant PMN recruitment.
The adoptive transfer of pleural cell populations that had been effectively
depleted of M<j) by magnetic immunodepletion had no significant effect upon PMN
recruitment in the carrageenan induced pleurisy model with PMN numbers being
comparable to those in control M(j)-depleted mice. In contrast, the adoptive transfer
of pleural cell populations containing M(j) or a population of purified M(j)
significantly increased pleural PMN infiltration thereby reinforcing the key role of
the resident pleural Mcj). In these experiments 1.5xl05±0.3xl05 M(j) were transferred
but this adoptive transfer was unable to restore M(|) numbers to the normal values
found in non-manipulated mice; reconstituted mice had about 45% of the total M(|>
number present in FvB/N control mice. This differs significantly from the peritoneal
model and is a likely explanation for the partial restoration of PMN infiltration
compared to DT treated FvB/N control mice in the carrageenan model. However,
the strong correlation between the number of pleural M(j) present at the initiation of
inflammation and the number of infiltrating PMN 6h after the administration of
carrageenan strongly supports a key pro-inflammatory role for the resident pleural
M<|>.
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It is also possible that the model of carrageenan pleurisy may be partially
dependent upon the pro-inflammatory actions of recruited monocytes, unlike
experimental peritonitis where acute PMN infiltration is monocyte independent, as
DT treatment markedly reduces the number of circulating monocytes. It should be
noted, however, that the presented results indicate a profound effect of M(|) depletion
upon PMN recruitment at the early time point of 6hr and since monocyte recruitment
occurs significantly later in the carrageenan model it is likely that monocyte
recruitment will be very limited at this early time point. Thus, a reduction in
monocyte recruitment in DT-treated CD1 lb-DTR mice is unlikely to be involved in
the very early reduction in PMN infiltration evident in these studies although
recruited monocytes may play a role in PMN infiltration at later time points.
Although defective PMN migration consequent upon exposure to DT is an
alternative explanation for these findings, it should be noted that work in
experimental peritonitis indicated that reconstitution of M(j> depleted mice with non-
transgenic M<|) was able to fully restore PMN infiltration in response to BTG.
In these experiments, the administration of DT and the subsequent induction
of widespread M<J) death did affect the numbers of B cells and MC within both the
peritoneal and pleural cavity. However, despite this potentially confounding issue,
there are several factors that support the prominent role of the serosal Mcj) in the BTG
and carrageenan models. First, the adoptive transfer of Mc()-rich peritoneal cells
restored PMN recruitment induced by BTG, whereas M(j)-depleted peritoneal cells
did not. Similar findings were found in the pleurisy model, but PMN influx was only
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partially restored. The M(j)-depleted serosal cell populations used in these studies
comprised B cells, T cells and MC but they did not induce a significant PMN influx
following the administration of BTG or carrageenan. In contrast, the adoptive
transfer ofM(|)-rich serosal cells or purified pleural M(j) isolated by negative selection
significantly increased PMN infiltration in response to inflammatory stimuli.
Second, data from in vitro experiments indicated a dramatic reduction in the
production of chemokines and cytokines following the depletion of M(j) from both
resident peritoneal and pleural cell populations. It should be noted that in these
studies, peritoneal and pleural cells were labelled with a PE conjugated antibody to
the specific Mcj) marker F4/80 prior to immunomagnetic depletion and F4/80 is not
expressed by B cells or MC. Lastly, previous work suggested that MC do not play a
significant role in BTG-induced peritonitis (Ajuebor et al., 1999) or in the
carrageenan model of pleural inflammation (Horakova et al., 1980; Takeshita et al.,
2003).
The magnitude of the M(j) depletion may explain the apparent discrepancy
between these results and the study by Ajuebor et al (Ajuebor et al., 1999).
Administration of a single dose of DT induced 98% M(j) ablation of peritoneal M())
whilst 3 doses of liposomal clodronate resulted in '>85%' M(|) depletion in their
study. M(|) are a very potent source of chemokines and cytokines and it may be the
case that in certain circumstances a relatively small population of residual M(|> may
exert significant biological effects. Although the administration of liposomal
clodronate may have marked biological effects despite depletion of only around 80%
of M(j) (Jose et al., 2003), it may be necessary to deplete almost all peritoneal M(|) in
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order to delineate their roles as sentinel cells. PMN recruitment after M(j) depletion
in the pleural space has been less studied.
Although peritoneal M(J) may produce myriad mediators capable of recruiting
PMN (Desouza et al., 2002; Souza et al., 1997), the effect of M(j> ablation upon the
level of C-X-C chemokines was examined in this model. The data suggest that the
initiation of PMN infiltration is mediated by resident peritoneal M(j) dependent
production of chemokines such as MIP-2 and KC previously documented to play a
role in orchestrating PMN recruitment in BTG peritonitis (Call et al., 2001; Remick
et al., 2001) and in other inflammatory situations (Goncalves and Appelberg, 2002;
McColl and Clark-Lewis, 1999; Walley et al., 1997). Although MC are also a rich
source of pro-inflammatory and vasoactive mediators and have been documented to
play an important role in PMN recruitment during inflammation of the peritoneum
(Ajuebor et al., 1999) as well as other sites such as the skin (Chen et al., 2002) my
studies do not suggest a prominent role for MC.
It was found that ablation of resident peritoneal M((> markedly reduced the
peak level ofMIP-2 and significantly blunted the level ofKC at 1 hr. However, the
partial inhibition (around 50%) of KC production at 1 hour and the persistent
elevation of KC at 3 hours in M(f> depleted mice suggested that KC may be produced
by other cells within the peritoneum. The persistent elevation of KC also suggests
that Mc() may play a role in the negative regulation ofKC production by non-M(j) cells
within the peritoneum although this may also result from the dysregulated PMN
recruitment consequent to M(j) ablation. In this context it is pertinent that the in vitro
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data indicate that both KC and MIP-2 production by peritoneal cells obtained by
peritoneal lavage is almost entirely dependent upon M(j) since peritoneal cells
depleted ofM(j) produced minimal levels of chemokines. These findings suggest that
peritoneal cells retrievable by peritoneal lavage are not the source of KC detected in
the in vivo study and that non-lavageable peritoneal cells represent a significant
additional source of KC. This is consistent with recent work in a wound model of
inflammation (Armstrong et ah, 2004). This work demonstrated MIP-2 expression
by inflammatory cells whilst KC was predominantly expressed by resident tissue
cells such as endothelial cells and fibroblasts. Peritoneal mesothelial cells
undoubtedly participate in peritoneal inflammation and can produce chemokines and
cytokines (Robson et ah, 2001; Topley et al., 1993a; Topley et ah, 1993b) and it may
be the case that mesothelial cells contribute to the KC production evident in this
study. Despite this, however, PMN infdtration is still markedly blunted despite the
persistent presence of KC at 3 hours. Peritoneal Mc() depletion also affected
production of C-C chemokines such as MlP-la and MCP-1; MlP-la levels were
reduced by 80% percent whereas MCP-1 levels were only slightly affected with a
55% reduction at 8h. However, MCP-1 levels at 24h were higher in the M<j> ablated
CD1 lb-DTR mice suggesting that peritoneal Mcj) might be involved in the control of
MCP-1 production but that other cells are involved in its secretion. In contrast to
studies of C-X-C chemokine production in vitro, MCP-1 production in vitro resulted
in levels that were much less than those observed in vivo. Again, this suggests an
important role for a cellular MCP-1 source not recoverable by peritoneal lavage such
as the peritoneal MeC.
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Study of cytokine levels indicated that TNF-a levels at lh were reduced by
60% by M<j) depletion. This supports an important role for resident peritoneal M(j) in
the secretion of this key pro-inflammatory cytokine (Topley et al., 1993a; Topley et
al., 1993b). Therefore, peritoneal resident M(j) would be important in the initiation of
secretion of C-X-C chemokines and cytokines by other resident cells such as the
MeC (Topley et ah, 1993a; Topley et ah, 1993b; Topley et ah, 1993c). There were
no observed differences for any of the other cytokines (IL-6, IL-10, IL12p70 and
IFN-y) measured at any of the time points studied. However, the studies were
performed at relatively late time points with 8h being the shortest. In addition, there
is also the dilution issue as peritoneal lavages were realised with 5ml of PBS and
thus low but biologically significant levels of cytokine might have been missed. The
study of earlier time points such as 1 and 3h would be informative.
M<)> depletion also resulted in a profound reduction in TGF-(3 levels in the
peritoneal lavages at 24h. Intracellular staining revealed that mature M(j) produced
TGF-(3 whereas newly recruited monocytes did not. It has been shown that M<J>-
driven phagocytosis of apoptotic cells is an important source of TGF-(3 (Fadok et ah,
1998; McDonald et ah, 1999) and therefore the observed reduced levels could be
explained by the marked reduction in PMN infiltration at earlier time points in the
M<|> ablated CDllb-DTR mice combined with the relative absence of M(|> to
phagocytose apoptotic PMN. However, the importance of these TGF-fl differences
in the resolution phase of inflammation and repair are unknown since no peritoneal
biopsies were undertaken to assess whether there was evidence of peritoneal fibrosis
or injury.
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The effect of resident pleural Mcj) ablation upon the level of C-X-C
chemokines was also examined in the carrageenan induced pleurisy. Resident
pleural M(|) ablation resulted in a marked reduction in MIP-2 levels in the pleural
exudates but had a lesser, albeit significant, inhibitory effect upon KC levels. The in
vitro study of M(|)-rich or M(j)-depleted pleural cell populations indicated that M(j) are
a key source of chemokines since pleural cell populations depleted of Mc|) produced
minimal amounts of the chemokines MIP-2 and KC. It is of interest, however, that
these in vitro studies demonstrated comparable production ofMIP-2 and KC whereas
the analysis of pleural lavage fluid indicated that the levels of KC were
approximately 2-3 fold higher than MIP-2 in vivo. These data are similar to what
was found in the peritonitis model suggesting that other cells within the pleural
cavity such as pleural mesothelial cells may be an important source of KC
production in vivo. It should be stressed, however, that marked inhibition of PMN
recruitment was evident at early time points in the presence of relatively preserved
KC levels suggesting that MIP-2 is more important in vivo in this model.
It was found that pleural cell populations stimulated with carrageenan in vitro
produced relatively low levels of the C-C chemokine MCP-1 compared to the levels
found in vivo. Again this suggests a prominent role for pleural mesothelial cells in
the production of MCP-1 in vivo and the subsequent recruitment of mononuclear
cells. These data are in accordance with previous reports highlighting the importance
of the pleural mesothelial cells in the secretion of these chemokines (Antony et al.,
1995; Hill et ah, 2003; Mohammed et ah, 1999).
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M(|> ablation in other experimental models has suggested a key role for M([> in
inflammation. For example, M<j) ablation reduces pancreatic inflammation and is
associated with reduced levels of IL-6, IL-10 and IL-12 (Shifrin et al., 2005). Also,
clodronate pre-treatment reduced the levels of IL-1 (3, TNF-a, IL-6, IL-10 and IL-12
produced in the liver after LPS administration, suggesting that M([> are an important
source of these chemokines in vivo (Salkowski et ah, 1995). The presented data in
this thesis also indicate that resident pleural Mc(> are critically involved in the
generation of cytokines at inflamed sites as the levels of TNF-a, IL-10 and IL-6 in
the pleural exudates were significantly reduced in CDllb-DTR mice treated with
DT. Also, in vitro studies of carrageenan stimulated pleural cell populations
demonstrated a significant reduction in cytokine levels following magnetic
immunodepletion of pleural Mcj).
These studies do raise the question as to why there was no significant PMN
infiltration in response to the significant KC production evident in vivo. In this
regard, it is pertinent to note the results of previous work studying the effect of
function blocking antibodies to either MIP-2 or KC in BTG peritonitis. These studies
indicate that inhibition of either chemokine individually results in marked (>70%)
inhibition of PMN infiltration with inhibition of both chemokines giving little
additional effect (Call et al., 2001). The chemotactic activity of pleural lavage fluid
from M(|)-depleted and control mice with pleurisy was not assessed using in vitro
PMN chemotaxis assays as the preparation of a pure population of non-activated
murine neutrophils is problematic. In addition, previous studies and my studies (see
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later) indicate that experiments involving the adoptive transfer of lavage fluid are
confounded by the resultant dilution of chemokines, cytokines etc. However, it may
also be the case that the dramatic reduction in the levels of intrapleural cytokines in
M(j) depleted mice may contribute to the defective PMN infiltration evident in these
mice via modulation of local endothelial cell expression of adhesion molecules
involved in PMN diapedesis. Although many mediators including cytokines, nitric
oxide, complement proteins and prostaglandins are involved in acute inflammatory
processes and leukocyte recruitment, the presented findings indicate that both
peritoneal and pleural resident M(j> play a critically important role in orchestrating
PMN influx in the BTG model ofperitonitis and in the carrageenan model of pleural
inflammation.
However, biological generalisation of the findings was sought by the study of
2 clinically relevant models involving different recognition pathways: zymosan
peritonitis and the intrapleural administration of killed Staphylococcus aureus
bacteria. Depletion of resident peritoneal M(() significantly reduced PMN infiltration
in zymosan peritonitis, thereby suggesting that the 'sensing' function of the
peritoneal resident M(j) may be stimulus independent. In addition, limited
experiments performed in mice administered killed Staphylococcus aureus indicated
that Mcj) depletion markedly reduces staphylococcal induced PMN infiltration. Also,
prominent M(j) ingestion of Staphylococcus aureus was evident in control DT treated
FvB/N mice and this finding reinforces the key role for resident M(j) as sentinel cells
that act to recognize and clear pro-inflammatory pathogens and particulate material.
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Since MC have been involved in the initiation of inflammation (Ajuebor et
al., 1999; Chen et ah, 2002), potential interactions between peritoneal Mcj) and MC
were examined by performing in vitro studies of peritoneal cells that had been
depleted ofM(j) or MC prior to stimulation with BTG. Interestingly, depletion ofMC
had no significant effect upon the production of KC and MIP-2 following BTG
stimulation suggesting that chemokine production in this model was M<j) dependent
and MC independent. Since previous work suggests that MC do not play a
significant role in the carrageenan model of pleural inflammation (Horakova et ah,
1980; Takeshita et ah, 2003), no in vitro experiments with MC depletion were done
with pleural resident cells.
These studies have used a transgenic model of conditional M(() ablation to
dissect the role of the resident peritoneal and pleural M<j) in the initiation of acute
serosal inflammation. The data indicate a key role for the resident M(j) in sensing
peritoneal and pleural irritation and orchestrating PMN infiltration in BTG and
zymosan peritonitis as well as in carrageenan- and killed Staphylococcus aureus
induced pleural inflammation. This pro-inflammatory function is predominantly
mediated by production of the potent PMN C-X-C chemokine MIP-2 and, to a lesser
extent, KC by peritoneal resident M(j) as well as M([) dependent TNF-a production
that can initiate production of such chemokines as well as promoting conditions that
favour PMN infiltration. In addition, resident pleural M(J> are involved in the
production of the potent PMN C-X-C chemokine MIP-2 and pro-inflammatory
cytokines such as TNF-a and IL-6 that can promote the production of the PMN C-X-
C chemokine KC by mesothelial cells. Although previous work has implicated the
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involvement of other cells such as peritoneal MC, this study suggests that peritoneal
resident Mcj) are critically important producers of C-X-C PMN chemokines and act to
orchestrate PMN recruitment in murine BTG peritonitis. The data also suggest that
M()>-derived products such as TNF-a might be important in the initiation of pleurisy
and stimulation of additional MeC-dependent chemokine production. This work
therefore suggests that resident M(|) are critically important producers of PMN
chemokines and pro-inflammatory cytokines and act to orchestrate PMN recruitment
in murine BTG-induced peritonitis and carrageenan-induced pleurisy.
Consequently, it is important to understand the crucial role of serosal resident
Mcj) in the initiation of inflammation. Previous studies of pleural and peritoneal
inflammation have suggested that the main role of the M(j) is to stimulate other
resident cells such as MeC or fibroblasts by producing cytokine such as TNF-a
(Antony et al., 1995; Cuzzocrea et al., 1999b; Frode et al., 2001; Goodman et al.,
1992; Liberek et al., 1996; Mohammed et al., 1998b; Pace et al., 1999; Park et al.,
2003; Topley et al., 1994; Witowski et al., 2001). The work presented in this thesis,
however, suggests that the M(j) plays a significantly more important role since
resident Mcj) respond to inflammatory stimuli by generating cytokines such as TNF-a
that can activate other resident Mcj) (Danis et al., 1991; Kos, 1989; Kumaratilake et
al., 1990; Leibovich et al., 1987) thereby inducing the production of significant
amounts of chemokines such as MIP-2 that contribute to leukocyte recruitment. The
Mcj) also responds very rapidly as MIP-2 production was already present at lh. In
contrast the production of the chemokine KC by other resident cells was significantly
slower in the absence of Mcj) dependent activation. Therefore, it is very important
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that future work in this area should examine more than just MeC or other single cells
in isolation, but try to reproduce a more complex microenvironment with resident
Mcj) and/or other resident leukocytes in order to include all the secreted pro¬
inflammatory products and not just only a few 'chosen' cytokines.
Resident M<j) are therefore crucial for the initiation of inflammation. However, they
can be also essential to promote the resolution of inflammation and promote repair
since, depending upon the timing of M<f> depletion, the initiation, progression or
resolution of inflammation can be affected (Cailhier et al., 2005; Cailhier et al.,
2006; Duffield et al., 2005a; Kotter et ah, 2001; Kotter et ah, 2005). Thus M([)
ablation needs to be targeted to the appropriate stage of inflammation to be beneficial
as current data would suggest that M(|) ablation during the resolution of inflammatory
processes may be detrimental.
Chapters 3 and 4 of this thesis focused on the role of the resident serosal Mcj)
in the initiation of inflammation. In chapter 5, the involvement of lymphocytes was
assessed. The literature regarding the importance of lymphocytes in leukocyte
recruitment using mice exhibiting various deficiencies in lymphocyte populations is
varied and controversial. Some studies have shown a reduction in leukocyte
recruitment (either PMN or Mcj)) (Appelberg, 1992; Hall et ah, 1999; Hancock et ah,
2002; Zwacka et ah, 1997) whereas others did not observe any significant difference
(Burne et ah, 2001; Burne-Taney et ah, 2003; Chen et ah, 2002; Kopf et ah, 2002;
Morrison et ah, 2006) between various lymphocyte deficient animals and control
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animals. T cells have been shown to be essential for accelerated allograft rejection
and leukocyte recruitment whereas B cells were not key (Hancock et al., 2002).
Obviously, the immunologic nature of the stimuli might be important and affect the
data generated but prior to undertaking my studies there was no clear evidence as to
whether lack of B or T lymphocytes will increase or decrease leukocyte recruitment.
The data presented in chapter 5 suggested that lymphocytes may be involved
in the regulation of PMN recruitment and monocyte/M(j) recruitment although a
variety of confounding factors were encountered. RAG-1 KO mice, which have no
mature lymphocytes, developed increased early PMN recruitment and (apart from a
slight increase in M(J) number at 8h) a failure of monocyte/M<|) recruitment at late
time points. This was found in the model of BTG peritonitis but there was also a
similar trend with the zymosan peritonitis model; only a small number of mice were
available for the latter experiment. Chemokine analysis could not delineate any
differences in the levels of the C-X-C chemokines M1P-2 and KC between RAG-1
KO mice and control mice. However, MCP-1 levels were higher in the C57BL/10
control mice at 24h, an observation, which may partly account for the observed
differences in peritoneal monocyte/M(j) number at later time points. There were no
differences in the levels of the other C-C chemokine MlP-la.
Increased PMN recruitment coupled with reduced M(j) recruitment could be
explained by reduced FFN-y secretion. IFN-y has been shown to reduce MeC
production of pro-inflammatory C-X-C chemokines such as KC, both in vitro and in
vivo, but increases MCP-1 secretion thereby favouring M<|) influx and resolution of
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inflammation (McLoughlin et al., 2003; Mohammed et al., 1999; Robson et al.,
2001; Schnyder-Candrian et al., 1995). Experiments with IFN-y KO mice in a lung
Mycobacterium avium model highlighted the increased influx of PMN, compatible
with a down-regulatory function of IFN-y. Similar findings were made in a model of
constrictive pericarditis (Afanasyeva et al., 2004). In the lung Mycobacterium avium
model, IFN-y mRNA levels were reduced in RAG-1 KO mice (Ehlers et al., 2001).
Studies in IFN-y KO mice demonstrated that this inhibitory effect was only possible
when IL-6 signalling is normal (McLoughlin et al., 2003). Therefore, the lack of
IFN-y secretion secondary to an absence of lymphocytes would result in the loss of
the inhibitory signal for PMN recruitment and would also impede M(|) recruitment by
loss of the stimulatory signal for MCP-1 production. However, NK cell activity,
presumably via IFN-y production, has been shown to be enhanced in RAG-1 KO
(Shultz et al., 2000). Moreover, I did not find any significant levels of IFN-y in
RAG-1 KO or in their controls. There is also evidence that IL-6 signalling with the
formation of sIL-6R/IL-6 complex can downregulate production of C-X-C
chemokines and stimulate C-C chemokines production (Hurst et al., 2001).
Disturbance of this pathway would result in leukocyte recruitment and MCP-1
production similar to that found in RAG-1 KO mice. However, it is not clear how
IL-6 signalling would be affected in RAG-1 KO mice.
A study in the CCR2 (receptor for MCP-1) KO mice revealed that after IP
BTG administration, these mice did not recruit M(j) above the baseline level whereas
PMN recruitment was increased at early time points (Kuziel et al., 1997). This
recruitment pattern is similar to that seen in RAG-1 KO mice. IFN-y, TNF-a, IL-1
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and LPS can decrease CCR2 gene transcription and IL-2 treatment of T cells and
monocytes can augment CCR2 expression (Kuziel et al., 1997). CCR2 expression at
the cell surface of leukocytes was not evaluated in RAG-1 KO mice and there is no
evidence that absence of lymphocytes would modulate such protein expression, but
the similarities between the 2 models with BTG peritonitis are intriguing.
These observed differences in the peritoneal leukocyte recruitment between
RAG-1 KO mice and their controls cannot be explained by a higher number of PMN
in the blood since analysis of circulating PMN numbers revealed that there were no
differences between the two groups. However, circulating monocyte numbers were
reduced in the RAG-1 KO mice and this could partly explain why there was a lower
number of recruited M(j) at later time points. Nevertheless, the absence of M(j)
recruitment (no elevation of the M(j) number in the peritoneal cavity after 8h)
highlighted a difference in the pattern of leukocyte recruitment in the RAG-1 KO
mice.
The specific involvement of either B or T cells cannot be discerned using
RAG-1 KO mice as these mice lack both cell types and therefore studies were
undertaken in NUDE mice. Studies with NUDE mice, lacking T cells, revealed a
marked increase in PMN recruitment at the 8 and 24h time points and increased M(|)
numbers at 24h in BTG peritonitis. Here, however, a trend toward an increased level
of circulating PMN numbers in the NUDE mice could partly explain the observed
difference in recruited PMN numbers. However, the increased peritoneal Mcj)
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numbers at 24h could not be explained by any difference in the circulating monocyte
number.
Dysregulation in leukocyte apoptosis has been described in IFN-y KO mice
(McLoughlin et al., 2003). The levels of apoptosis were not determined in NUDE
mice so it is impossible to tell if the increased PMN and M(j) numbers were due to
reduced levels of apoptosis. However, NK cells and M(j) from NUDE mice have
been shown to exhibit increased cytotoxic activity (Budzynski and Radzikowski,
1994) and IFN-y production by NK cells in NUDE mice has been demonstrated in a
model of sepsis (Seki et al., 1998). Therefore, the lack of IFN-y production in
NUDE mice and loss of its modulating role on C-X-C and C-C chemokines cannot
be supported.
In order to assess if the observed phenotype in the NUDE mice could be
corrected, I performed adoptive transfer studies of peritoneal T cells from CD1
control mice. The restoration of the initial T cell number was partial since just a
little more than 50% of the T cell number present in the WT could be transferred in
NUDE mice. Furthermore, a significant number of resident peritoneal Mc)) were also
transferred and they may have had a confounding effect as they are involved in PMN
recruitment as described previously. Chemokine and cytokine analysis revealed no
significant differences in MIP-2 production though there was a small albeit
statistically significant increased KC production at the 8h time point. These
differences may be involved in the increased PMN recruitment found in NUDE mice
but the magnitude of the differences suggests that they are unlikely to be the entire
162
explanation. IL-6 levels analysis revealed a 2.5-fold persistent increase present at 8h
after BTG stimulation in NUDE compared to WT mice and may reflect a sustained
pro-inflammatory reaction resulting from the increased leukocyte recruitment.
In order to further investigate the elevated PMN recruitment seen in NUDE
mice, I undertook experiments involving the transfer of peritoneal SN between
NUDE and control mice. Transfer of SN from NUDE into CD1 control mice failed
to increase peritoneal PMN recruitment at the studied time point of 8h. Also, SN
derived from CD1 mice and transferred into NUDE mice failed to normalise PMN
recruitment such that no significant difference in peritoneal PMN numbers were
evident between groups. Interestingly, however, analysis of circulating PMN
numbers revealed that the transfer of SN derived from NUDE mice increased the
number of circulating blood PMN in CD 1 mice compared to control CD 1 mice that
had received SN derived from CD1 mice. Furthermore, CD1 SN transfer into NUDE
mice reduced the number of circulating PMN in NUDE mice compared to NUDE
mice that had received SN derived from NUDE i.e. circulating PMN number
appeared to be determined by the source of the SN and not the recipient mouse into
which it was injected. Circulating PMN numbers in NUDE or CD1 mice that had
received SN from NUDE mice were similar and greater than those of mice that had
received CD1 SN. This suggested that the SN from NUDE mice contained a more
robust 'signal' for PMN mobilisation from the bone marrow compared to that in SN
from CD1 mice. There may be a factor in NUDE SN that enhances the
chemoattractant response of leukocytes. In the absence of any striking differences in
peritoneal C-X-C chemokine levels between NUDE and CD 1 it may be that the SN
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from NUDE mice might contain a factor that results in increased recruitment of
PMN e.g. either an unknown cytokine/chemokine or a decoy cytokine receptor. IL-
6/sIL-6R can upregulate production of other C-X-C chemokines such as CXCL5 and
CXCL6. Although the exact function of these chemokines in PMN recruitment is
unclear, they could be present at higher concentrations in the SN from NUDE mice
since NUDE mice had higher levels of IL-6 at 8h (McLoughlin et al., 2004).
Decoy cytokine receptors exhibit a high affinity and specificity for their
ligand, but are unable to mediate signalling. They constitute molecular traps for
cytokines or chemokines, thereby controlling the intensity of the inflammation
(Mantovani et al., 2001). IL-1RII is an important decoy receptor that acts as a
negative regulator of IL-1 (3 and is not involved in signal transduction (Matsuki et al.,
2005). IL-1RII is expressed on monocytes, T cells and PMN but it can also be
cleaved and act as a soluble receptor (Mantovani et al., 2001). Chemokine decoy
receptors such as the Duffy antigen receptor for chemokines (DARC) and D6 silence
C-X-C and C-C chemokine actions respectively (Locati et al., 2005). There are also
other ways to impede the action of a cytokine/chemokine such as functional decoy
receptors. For example, IL-l-Ra is a regulating antagonistic protein for IL-1(3, and
binds to the active IL-1RI thereby preventing its activation (Matsuki et al., 2005). It
synergises with IL-1RII to inhibit IL-1 (3 signalling (Mantovani et al., 2001). Any of
these antagonistic molecules could be present at reduced levels in the SN ofNUDE
mice thereby resulting in a more pro-inflammatory milieu.
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A pro-inflammatory environment could also be generated in NUDE mice by
anomalous expression of the suppressors of cytokine signalling (SOCS). SOCS are
intracellular proteins that act as key regulators of cytokine responses (Alexander and
Hilton, 2004). Anomalies in SOCS result in uncontrolled inflammation (Chong et
al., 2005). However, to my knowledge, there is no evidence to support abnormal
SOCS expression in NUDE or RAG-1 KO mice.
The lack of increased peritoneal PMN recruitment in CD1 mice that have
received SN from NUDE mice despite higher circulating PMN numbers highlights
the complexity of leukocyte recruitment. A potential explanation is that NUDE mice
have a different peritoneal vasculature that would more easily facilitate leukocyte
transmigration or the presence of endothelial cells in an enhanced state of activation
(increased selectins or ICAMs at their surface) that would promote rolling of
circulating leukocytes thereby facilitating transmigration. Alternatively, the
leukocytes of NUDE mice may have subtle differences in surface receptors or
integrins that would enhance emigration from the blood into tissues. This would
explain why peritoneal PMN recruitment could not be enhanced in CD1 mice
administered SN from NUDE mice as the circulating leukocytes would differ
between the mice.
Despite this work, a full understanding of the effect of T cells on the
modulation of peritoneal leukocyte recruitment is still lacking. An additional
confounding factor is that NUDE mice had significantly less resting peritoneal B cell
numbers number compared to CD1 control mice. So, all of the above discussion
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regarding the role of T cells needs to take account of the fact that B cells could also
be implicated in the altered leukocyte recruitment found in NUDE mice.
Experiments in RAG-1 KO mice and NUDE mice suggest that T cells might
be involved in a form of negative feedback loop controlling PMN influx such that an
absence of T cells would result in loss of an inhibitory influence. According to
previous studies in 76 T cell KO mice, the phenotype of a heightened inflammatory
reaction in NUDE mice could be compatible specifically with the absence of 76 T
cells (Skeen et al., 2001; Zachariadis et ah, 2006). However, the markedly impaired
monocyte/M(j) recruitment seen in RAG-l KO would not be compatible with a lack
of 76 T cells (Zachariadis et ah, 2006).
An alternative explanation is that the leukocytes of NUDE mice are more
responsive to chemotactic signals such that they would exhibit increased leukocyte
extravasation than control mice when confronted with an identical chemotactic
gradient. Such a phenotype has been reported in leukocyte-specific protein (LSP)-1
KO mice. LSP-1 is an F-actin binding protein expressed in lymphocytes, M(j) and
PMN in mice and humans and is involved in leukocyte migration. BTG peritonitis in
LSP-1 KO mice results in an increased recruitment of PMN and M(j). LSP-1 KO
PMN have an increased chemotactic response to fMLP and a trend toward a similar
response for KC (Jongstra-Bilen et ah, 2000). In the absence of clear cut differences
in chemokine levels in the NUDE and RAG-1 KO mice, modulation of LSP-1
expression at the leukocyte cell surface may explain the recruitment kinetics.
However, there is no data regarding LSP-1 expression in NUDE or RAG-1 KO mice
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and the fact that PMN mobilisation was increased with SN transfer suggests a pro-
chemotactic signal.
It was obviously important to examine the role of B cells since NUDE mice
exhibited a reduced number of resting peritoneal B cells. PMN recruitment was
significantly reduced in pMT KO mice compared to C57BL/6 control mice at the
24h time point. However, pMT KO have a reduced number of circulating PMN at
baseline. Impaired monocyte/McJ) recruitment was found in pMT KO mice at the
later time points of 72 and 120h despite similar circulating monocyte numbers in
pMT KO mice and C57BL/6 control mice. The pattern of M(|) recruitment is similar
to that found in the RAG-1 KO mice. However, despite this similarity in phenotype
of leukocyte kinetics, there were no differences observed in MCP-1 levels between
pMT KO mice and C57BL/6 control mice; unlike that found in the RAG-1 KO mice
experiment. C-X-C chemokine levels were also similar in both groups. As stated in
Chapter 5,1 was unable to perform additional experiments at shorter time points (lh
and 3h) because of the limited number of mice available. A difference at these early
time points could explain the differences in monocyte/M(j) recruitment. It is of
interest that the 'combination' of leukocyte recruitment kinetic curves from both
NUDE and pMT KO mice produce a kinetic profile that is very similar to that
observed in the RAG-1 KO mice i.e. increased early PMN influx and diminished
monocyte/M(|) recruitment at later time points.
These data suggest that B cells may play a role in promoting monocyte/M(|)
recruitment. The B cell compartment of the peritoneal space is characterized by the
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important presence of B1 cells (Hayakawa et al., 1985), which differ from the B cells
found in the blood. B1 cells can produce natural antibodies and these antibodies or
IgM may be involved in monocyte/M(|) recruitment since immune complexes derived
from interactions between Clq and IgM have been shown to promote MCP-1
production by endothelial cells (van den Berg et al., 1998). Therefore, the lack of
IgM due to the absence of B cells could reduce the formation of theses immune
complexes and prevent MCP-1 production by resident peritoneal cells such as MeC.
MCP-1 production can also be modified by other factors. For example, IL-10
was shown to play an important role in inducing MCP-1 production in Mc|) and
monocytes (Seitz et al., 1995; Yano et al., 1996). Therefore, any modifications of
IL-10 production, either by (i) a reduction of phagocytosis of apoptotic cells (Voll et
al., 1997) due to the absence of IgM (a known promoter of engulfment of apoptotic
cells (Boes et al., 2000)), or (ii) the absence of B cells which can also produce IL-10
(Popi et al., 2004), would result in a reduced MCP-1 production and thus less
monocyte/M(|) recruitment. However, despite the difference in MCP-1 levels seen in
RAG-1 KO there were no significant differences in the chemokine/cytokine profile
of (iMT KO mice and thus no mechanistic insights could be drawn from the in vivo
studies involving pMT KO mice.
The 3% BTG that I have used has been widely used by other investigators
(Ajuebor et al., 1999; Baron and Proctor, 1982; Call et al., 2001; Hanayama et al.,
2002; Henderson et al., 2003). I did not undertake additional experiments to define
dose response curves for reasons of time, cost and the numbers of mice that would be
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required for such studies. However, there is evidence that the induced inflammation
might be dose dependent since the administration of 0.3% BTG results in a 10-fold
reduction in PMN recruitment and IL-6 production (Call et al., 2001). Therefore, the
intensity of the inflammation elicited by 3% BTG might have precluded the
demonstration of subtle differences beside leukocyte numbers in the experiments
performed.
I then attempted to use an in vitro approach with the selective depletion of
either B or T lymphocytes to dissect the interaction between lymphocytes and Mcj) in
order to find a modulating role for the peritoneal lymphocytes in chemokine
production. Important elements that are overlooked by such an approach is the
potential involvement of recruited lymphocytes in chemokine/cytokine production
within the peritoneum and of course the exclusion of the MeC - the most abundant
cell within the peritoneum. As indicated previously, MeC are important producers of
chemokines and cytokines with the M(j) depletion studies suggesting a prominent role
for MeC in the production ofKC and MCP-1.
C-X-C chemokine analysis after 1% BTG stimulation failed to show any
impact of B lymphocyte depletion. The intensity of the stimulation might have been
maximal thereby precluding any modulation. In contrast, B cell depletion prior to
LPS stimulation resulted in a reduced production of both MIP-2 and KC.
Extrapolation of this finding to inflammation in vivo would result in a reduction in
PMN recruitment as evident in the BTG model in pMT KO mice. T cell depletion
had no effect upon the production ofMIP-2 and KC after BTG or LPS stimulation.
169
The initial in vitro experiments were performed with 1% BTG and a 6h
incubation period but this protocol resulted in very low MCP-1 levels compared to
the levels found in vivo. However, T cell depletion did augment MCP-1 production
following BTG stimulation whilst B cell depletion had no effect. LPS stimulation
was also used and B cell depletion reduced MCP-1 production; T cell depletion had
no significant effect. The use of 0.25% BTG in these assays resulted in increased
MCP-1 production - although still much lower levels than the levels observed in
vivo. In response to 0.25% BTG, both B and T cell immunodepletion reduced MCP-
1 production. Although these in vitro data are of interest, these experiments only
provide partial answers to the as yet unanswered questions regarding the role of
lymphocytes in the regulation of peritoneal leukocyte recruitment.
6.2. Future Work:
The CDllb-DTR mice provided a useful resource to ask key questions
regarding the interactions between leukocytes in situ and the M(j) ablation strategy
was complemented by the experimental approach involving the adoptive transfer of
peritoneal cells. Using these tools, I have demonstrated that resident M((> are
important in the initiation of serosal inflammation and that lymphocytes play a role
in the regulation of leukocyte influx. However, the exact mechanisms whereby
lymphocytes modulate these processes remain elusive. There are several issues that
would be interesting to address in future studies.
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1) Can the M<j> gate-keeping role be modulated?
I have demonstrated that resident M(j) can sense perturbation of their local
milieu generated by different stimuli. These stimuli are sensed by the different M(j)
receptors such as TLRs and RAGE. Is it possible that the ability of Mc() to sense
these 'irritants' can be modulated. Phagocytosis of apoptotic cells is thought to be an
important part of resolution of inflammation and it has been demonstrated that
instillation of apoptotic cells into an inflamed peritoneum can induce TGF-|3
production and reduce pro-inflammatory cytokines (Fadok et al., 1998). However, it
is not known if Mcj) that have ingested apoptotic cells will be less responsive to pro¬
inflammatory agents in vivo. Resident peritoneal M(J) from FvB/N mice could be co-
incubated with apoptotic cells to allow phagocytosis and the phagocytic Mc|) would
be resuspended into BTG or zymosan and administered into M(j)-ablated CD 11b-
DTR mice. Peritoneal lavage at 8h would provide good evidence of any change in
the 'sensitivity' to pro-inflammatory signals in vivo following apoptotic cell
ingestion. Furthermore, siRNA for different surface receptors or other proteins such
as cytokines or chemokines could be used in order to investigate which receptors are
involved in sensing different inflammatory stimuli and which cytokines/chemokines
are important.
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2) Experiments in NUDE mice in order to establish the role of
T cells in regulating leukocyte influx.
It would be prudent to repeat certain experiments such as the T cell repletion
using sufficient 'donor' CD1 control mice to fully restore the resident T cell
population in NUDE mice. The measurement of PMN number after the induction of
peritonitis would indicate whether T cells regulated PMN influx. If so, the
supernatants from peritoneal lavages of inflamed NUDE mice and CD1 control mice
could be screened for other cytokines, chemokines, eicosanoids or complement
proteins. In an attempt to dissect the factors responsible for modulating PMN
recruitment, other mediators must be looked at; potential molecules of interest
include C-X-C chemokines such as CXCL5 since it was modulated by IL-6 in vivo
(McLoughlin et al., 2004) as well as decoy cytokine receptors and antagonistic
molecules. The use of technology such as proteomic analysis and mass spectrometry
could be used in order to compare the NUDE and CD1 derived supernatants to
identify differences.
Since peritoneal recruitment was not enhanced despite higher blood PMN
mobilisation, there might be structural and/or functional differences in the
peritoneum/vasculature in the NUDE. Histology evaluation of the vasculature and
lymphoid structure could be performed in fixed tissue after induction of experimental
peritonitis. Functional assessment could be done by evaluation of the expression of
172
adhesion molecules on the vasculature or omental lymphoid organ, either by
fluorescent microscopy or molecular biological techniques.
3) How can B cells modulate M<|) recruitment?
Studies from the RAG-1 KO mice and in vitro experiments involving B cell
depletion suggest that B cells might be involved in modulating M(|) recruitment but
the exact mechanism remains ill defined. MCP-1 production in vivo was reduced in
the RAG-1 KO mice and was also diminished in vitro after B and T cell depletion.
However, it is not clear how B cells could modulate this. In vivo experiments with
adoptive transfer of B cells into the peritonea of pMT mice would be of interest to
see if this normalises Mcj) recruitment. SN transfer experiments could also be
undertaken in order to examine the effect upon both peritoneal leukocyte recruitment
and circulating blood PMN numbers. A more extensive cytokine and chemokine
analysis could also be performed and analysis of earlier time points in the peritonitis
model could be done with CBA analysis of the SN as this would provide useful
information regarding the early secretion of cytokines such as IL-10 which can
promote MCP-1 production. Also, the levels of additional C-X-C and C-C
chemokines such as CXCL5 and MIP-lcx could be determined.
Since IgM and Clq might be important in regulating MCP-1 production, in vitro
stimulation of resident leukocytes could be done with serum from different KO
animals (Clq KO, IgM KO and pMT KO mice) in order to assess the respective role
ofClq, IgM and B cells in the modulation ofMCP-1 production.
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6.3. Conclusion
To conclude, I have drafted two figures to illustrate the complex interactions
between the different cytokines and chemokines as suggested by the results
presented in this thesis(Figure 6.1 and6.2).
In this thesis, it was demonstrated that:
1) Peritoneal and pleural resident Mc() play a crucial role in the initiation of
inflammation and promoting PMN recruitment.
2) Serosal resident M(|) are key producers of TNF-a, IL-6 and IL-10 in vivo.
This cytokine production promotes M(J>-dependent MIP-2 production,
which is a key C-X-C chemokine in both BTG peritonitis and
carrageenan induced pleurisy.
3) In vitro stimulation of serosal cells can generate C-X-C chemokines but
these studies highlighted the M(j)-independent KC production by other
resident cells such as the MeC that occurs in vivo.
4) Using mice exhibiting deficiencies in various lymphocyte populations, it
was demonstrated that T cells negatively regulate PMN influx and that B
cells are probably involved in enhancing monocyte/Mcj) recruitment.
5) MCP-1 levels were reduced by 50% at 24h in the RAG-1 KO mice and
this correlated with impaired monocyte/M((> recruitment.
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6) The in vitro experiments involving immunodepletion of B and T cells
suggested the possible modulation of C-X-C chemokine and MCP-1
production by lymphocytes.
My work has demonstrated that resident Mtj) are essential for the initiation of
inflammation and has highlighted their role as gate-keeping or sentinel cells. I would
like to end this thesis by a quote from a microbiologist:
"But it is not microorganisms only which set up the inflammatory reaction
accompanied by the emigration and accumulation of leukocytes. The
introduction of inert bodies and of aseptic fluid brings about the same results.
The macrophages are, as a matter of fact, endowed with a special
susceptibility which enable them to perceive exceedingly small changes in
the chemical or physical composition in the medium that surrounds them."
(Metchnikoff, 1968).












Figure 6.1- PMN recruitment interactions:
Ai) Upon an inflammatory insult, TNF-a would be secreted by resident M(j) and A2)
resident T cells would modulate this inflammatory response by an ill defined
mechanism and B) this would induce C-X-C chemokine production by M(j>, MeC and
fibroblasts C) This chemokine secretion would promote PMN recruitment.
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Insult
Figure 6.2- M(|) recruitment interactions:
Ai) Upon an inflammatory insult, TNF-a would be secreted by resident M(f) and A2)
resident B cells would modulate this inflammatory response by an ill defined
mechanism and B) this would induce C-C chemokine production by MeC and
fibroblasts C) This chemokine secretion would promote M(|) recruitment
177
References
Ackerman, N., Tomolonis, A., Miram, L., Kheifets, J., Martinez, S., and Carter, A.
(1980). Three day pleural inflammation: a new model to detect drug effects on
macrophage accumulation. J Pharmacol Exp Ther 275, 588-595.
Afanasyeva, M., Georgakopoulos, D., Fairweather, D., Caturegli, P., Kass, D. A.,
and Rose, N. R. (2004). Novel model of constrictive pericarditis associated with
autoimmune heart disease in interferon-gamma-knockout mice. Circulation 110,
2910-2917.
Ajuebor, M. N., Das, A. M., Virag, L., Flower, R. J., Szabo, C., and Perretti, M.
(1999). Role of resident peritoneal macrophages and mast cells in chemokine
production and neutrophil migration in acute inflammation: evidence for an
inhibitory loop involving endogenous IF-10. J Immunol 162, 1685-1691.
Albertine, K. H., Wiener-Kronish, J. P., and Staub, N. C. (1984). The structure of the
parietal pleura and its relationship to pleural liquid dynamics in sheep. Anat Rec 208,
401-409.
Alexander, W. S., and Hilton, D. J. (2004). The role of suppressors of cytokine
signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol
22, 503-529.
Ames, R. S., Li, Y., Sarau, H. M., Nuthulaganti, P., Foley, J. J., Ellis, C., Zeng, Z.,
Su, K., Jurewicz, A. J., Hertzberg, R. P., et al. (1996). Molecular cloning and
characterization of the human anaphylatoxin C3a receptor. J Biol Chem 271, 20231-
20234.
Ansel, K. M., Harris, R. B., and Cyster, J. G. (2002). CXCL13 is required for B1 cell
homing, natural antibody production, and body cavity immunity. Immunity 16, 67-
76.
Antony, V. B., Hott, J. W., Kunkel, S. L., Godbey, S. W., Burdick, M. D., and
Strieter, R. M. (1995). Pleural mesothelial cell expression of C-C (monocyte
chemotactic peptide) and C-X-C (interleukin 8) chemokines. Am J Respir Cell Mol
Biol 72, 581-588.
Appelberg, R. (1992). T cell regulation of the chronic peritoneal neutrophilia during
mycobacterial infections. Clin Exp Immunol 89, 120-125.
Arbibe, L., Mira, J. P., Teusch, N., Kline, L., Guha, M., Mackman, N., Godowski, P.
J., Ulevitch, R. J., and Knaus, U. G. (2000). Toll-like receptor 2-mediated NF-kappa
B activation requires a Racl-dependent pathway. Nat Immunol 7, 533-540.
Armstrong, D. A., Major, J. A., Chudyk, A., and Hamilton, T. A. (2004). Neutrophil
chemoattractant genes KC and MIP-2 are expressed in different cell populations at
sites of surgical injury. J Leukoc Biol.
178
Baatz, H., Puchta, J., Reszka, R., and Pleyer, U. (2001). Macrophage depletion
prevents leukocyte adhesion and disease induction in experimental melanin-protein
induced uveitis. Exp Eye Res 73, 101-109.
Backteman, K., Ledent, E., Berlin, G., and Ernerudh, J. (2002). A rapid and reliable
flow cytometric routine method for counting leucocytes in leucocyte-depleted
platelet concentrates. Vox Sang 83, 29-34.
Balabanian, K., Foussat, A., Bouchet-Delbos, L., Couderc, J., Krzysiek, R., Amara,
A., Baleux, F., Portier, A., Galanaud, P., and Emilie, D. (2002). Interleukin-10
modulates the sensitivity of peritoneal B lymphocytes to chemokines with opposite
effects on stromal cell-derived factor-1 and B-lymphocyte chemoattractant. Blood
99, 427-436.
Banchereau, J., and Steinman, R. M. (1998). Dendritic cells and the control of
immunity. Nature 392, 245-252.
Barja-Fidalgo, C., Carlini, C. R., Guimaraes, J. A., Flores, C. A., Cunha, F. Q., and
Ferreira, S. H. (1992). Role of resident macrophages in canatoxin-induced in vivo
neutrophil migration. Inflammation 16, 1-12.
Barnet, V., and Lewis, T. (1998). Outliers in statistical data, 3rd edn (Chichester,
Wiley).
Baron, E. J., and Proctor, R. A. (1982). Elicitation of peritoneal polymorphonuclear
neutrophils from mice. J Immunol Methods 49, 305-313.
Barrington, R., Zhang, M., Fischer, M., and Carroll, M. C. (2001). The role of
complement in inflammation and adaptive immunity. Immunol Rev 180, 5-15.
Bauermeister, K., Burger, M., Almanasreh, N., Knopf, H. P., Schumann, R. R.,
Schollmeyer, P., and Dobos, G. J. (1998). Distinct regulation of IL-8 and MCP-1 by
LPS and interferon-gamma-treated human peritoneal macrophages. Nephrol Dial
Transplant 13, 1412-1419.
Bellingan, G. J., Xu, P., Cooksley, H., Cauldwell, H., Shock, A., Bottoms, S.,
Haslett, C., Mutsaers, S. E., and Laurent, G. J. (2002). Adhesion molecule-dependent
mechanisms regulate the rate of macrophage clearance during the resolution of
peritoneal inflammation. J Exp Med 196, 1515-1521.
Besredka, A. (1921). Flistoire d'une idee; l'oeuvre de E. Metchnikoff. Embryogenie,
inflammation, immunite, senescence, pathologie, philosophic. (Paris, Masson).
Biedermann, T., Kneilling, M., Mailhammer, R., Maier, K., Sander, C. A., Kollias,
G., Kunkel, S. L., Hultner, L., and Rocken, M. (2000). Mast cells control neutrophil
recruitment during T cell-mediated delayed-type hypersensitivity reactions through
tumor necrosis factor and macrophage inflammatory protein 2. J Exp Med 192,
1441-1452.
179
Birkhofer, A., Rehbock, J., and Fricke, H. (1996). T lymphocytes from the normal
human peritoneum contain high frequencies of Th2-type CD8+ T cells. Eur J
Immunol 26, 957-960.
Boes, M., Schmidt, T., Linkemann, K., Beaudette, B. C., Marshak-Rothstein, A., and
Chen, J. (2000). Accelerated development of IgG autoantibodies and autoimmune
disease in the absence of secreted IgM. Proc Natl Acad Sci U S A 97, 1184-1189.
Bogsan, C. S., Novaes e Brito, R. R., Palos Mda, C., Mortara, R. A., Almeida, S. R.,
Lopes, J. D., and Mariano, M. (2005). B-l cells are pivotal for in vivo inflammatory
giant cell formation. Int J Exp Pathol 86, 257-265.
Bokisch, V. A., Muller-Eberhard, H. J., and Cochrane, C. G. (1969). Isolation of a
fragment (C3a) of the third component of human complement containing
anaphylatoxin and chemotactic activity and description of an anaphylatoxin
inactivator of human serum. J Exp Med 129, 1109-1130.
Bono, M. R., Reyes, L. I., and Rosemblatt, M. (1999). A flow cytometric procedure
for the quantification of cell adhesion in complex mixtures of cells. J Immunol
Methods 223, 27-36.
Boutin, C., Dumortier, P., Rey, F., Viallat, J. R., and De Vuyst, P. (1996). Black
spots concentrate oncogenic asbestos fibers in the parietal pleura. Thoracoscopic and
mineralogic study. Am J Respir Crit Care Med 153, 444-449.
Bozza, P. T., Castro-Faria-Neto, H. C., Penido, C., Larangeira, A. P., das Gracas, M.,
Henriques, M. O., Silva, P. M., Martins, M. A., dos Santos, R. R., and Cordeiro, R.
S. (1994). Requirement for lymphocytes and resident macrophages in LPS-induced
pleural eosinophil accumulation. J Leukoc Biol 56, 151-158.
Breitman, M. L., Clapoff, S., Rossant, J., Tsui, L. C., Glode, L. M., Maxwell, I. H.,
and Bernstein, A. (1987). Genetic ablation: targeted expression of a toxin gene
causes microphthalmia in transgenic mice. Science 238, 1563-1565.
Broche, F., and Tellado, J. M. (2001). Defense mechanisms of the peritoneal cavity.
Curr Opin Crit Care 7, 105-116.
Brown, E. J., Hosea, S. W., and Frank, M. M. (1983). The role of antibody and
complement in the reticuloendothelial clearance of pneumococci from the
bloodstream. Rev Infect Dis 5 Suppl 4, S797-805.
Brown, E. J., Hosea, S. W., Hammer, C. H., Burch, C. G., and Frank, M. M. (1982).
A quantitative analysis of the interactions of antipneumococcal antibody and
complement in experimental pneumococcal bacteremia. J Clin Invest 69, 85-98.
Bruno, L., Seidl, T., and Lanzavecchia, A. (2001). Mouse pre-immunocytes as non-
proliferating multipotent precursors of macrophages, interferon-producing cells,
CD8alpha(+) and CD8alpha(-) dendritic cells. Eur J Immunol 31, 3403-3412.
180
Budzynski, W., and Radzikowski, C. (1994). Cytotoxic cells in immunodeficient
athymic mice. Immunopharmacol Immunotoxicol 16, 319-346.
Burgess, S. C., and Davison, T. F. (1999). Counting absolute numbers of specific
leukocyte subpopulations in avian whole blood using a single-step flow cytometric
technique: comparison of two inbred lines of chickens. J Immunol Methods 227,
169-176.
Burne, M. J., Daniels, F., El Ghandour, A., Mauiyyedi, S., Colvin, R. B., O'Donnell,
M. P., and Rabb, H. (2001). Identification of the CD4(+) T cell as a major
pathogenic factor in ischemic acute renal failure. J Clin Invest 108, 1283-1290.
Burne-Taney, M. J., Ascon, D. B., Daniels, F., Racusen, L., Baldwin, W., and Rabb,
H. (2003). B cell deficiency confers protection from renal ischemia reperfusion
injury. J Immunol 171, 3210-3215.
Burnett, S. H., Kershen, E. J., Zhang, J., Zeng, L., Straley, S. C., Kaplan, A. M., and
Cohen, D. A. (2004). Conditional macrophage ablation in transgenic mice expressing
a Fas-based suicide gene. J Leukoc Biol 75, 612-623.
Cailhier, J. F., Partolina, M., Vuthoori, S., Wu, S., Ko, K., Watson, S., Savill, J.,
Hughes, J., and Lang, R. A. (2005). Conditional macrophage ablation demonstrates
that resident macrophages initiate acute peritoneal inflammation. J Immunol 174,
2336-2342.
Cailhier, J. F., Sawatzky, D. A., Kipari, T., Houlberg, K., Walbaum, D., Watson, S.,
Lang, R. A., Clay, S., Kluth, D., Savill, J., and Hughes, J. (2006). Resident pleural
macrophages are key orchestrators of neutrophil recruitment in pleural inflammation.
Am J Respir Crit Care Med 173, 540-547.
Caksen, H., Ozturk, M. K., Uzum, K., Yuksel, S., and Ustunbas, H. B. (2000).
Pulmonary complications in patients with staphylococcal sepsis. Pediatr Int 42, 268-
271.
Call, D. R., Nemzek, J. A., Ebong, S. J., Bolgos, G. L., Newcomb, D. E., and
Remick, D. G. (2001). Ratio of local to systemic chemokine concentrations regulates
neutrophil recruitment. Am J Pathol 158, 715-721.
Cameron, S., Davison, A., Grunfeld, J., Kerr, D., and Ritz, E. (1992). Oxford
Textbook of Clinical Nephrology, First edn (Oxford, Oxford University Press).
Carlos, T. M., and Harlan, J. M. (1994). Leukocyte-endothelial adhesion molecules.
Blood 84, 2068-2101.
Carroll, M. C. (2004). The complement system in regulation of adaptive immunity.
Nat Immunol 5, 981-986.
181
Cecchini, M. G., Dominguez, M. G., Mocci, S., Wetterwald, A., Felix, R., Fleisch,
H., Chisholm, O., Hofstetter, W., Pollard, J. W., and Stanley, E. R. (1994). Role of
colony stimulating factor-1 in the establishment and regulation of tissue
macrophages during postnatal development of the mouse. Development 120, 1357-
1372.
Chavakis, T., Bierhaus, A., Al-Fakhri, N., Schneider, D., Witte, S., Linn, T.,
Nagashima, M., Morser, J., Arnold, B., Preissner, K. T., and Nawroth, P. P. (2003).
The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte
integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 198, 1507-
1515.
Chen, R., Fairley, J. A., Zhao, M. L., Giudice, G. J., Zillikens, D., Diaz, L. A., and
Liu, Z. (2002). Macrophages, but not T and B lymphocytes, are critical for
subepidermal blister formation in experimental bullous pemphigoid: macrophage-
mediated neutrophil infiltration depends on mast cell activation. J Immunol 169,
3987-3992.
Chen, Y., Lui, V. C., Rooijen, N. V., and Tarn, P. K. (2004). Depletion of intestinal
resident macrophages prevents ischaemia reperfusion injury in gut. Gut 53, 1772-
1780.
Chenoweth, D. E., Goodman, M. G., and Weigle, W. O. (1982). Demonstration of a
specific receptor for human C5a anaphylatoxin on murine macrophages. J Exp Med
156, 68-78.
Cheung, D. O., Halsey, K., and Speert, D. P. (2000). Role of pulmonary alveolar
macrophages in defense of the lung against Pseudomonas aeruginosa. Infect Immun
68, 4585-4592.
Chevallier, N., Berthelemy, M., Laine, V., Le Rhun, D., Femenia, F., Polack, B.,
Naessens, J., Levy, D., and Schwartz-Cornil, I. (1998). B-l-like cells exist in sheep.
Characterization of their phenotype and behaviour. Immunology 95, 178-184.
Chong, M. M., Metcalf, D., Jamieson, E., Alexander, W. S., and Kay, T. W. (2005).
Suppressor of cytokine signaling-1 in T cells and macrophages is critical for
preventing lethal inflammation. Blood 106, 1668-1675.
Cochrane, C. G. (1968). Immunologic tissue injury mediated by neutrophilic
leukocytes. Adv Immunol 9, 97-162.
Cuzzocrea, S., Costantino, G., Mazzon, E., and Caputi, A. P. (1999a). Beneficial
effects of raxofelast (IRFI 016), a new hydrophilic vitamin E-like antioxidant, in
carrageenan-induced pleurisy. Br J Pharmacol 126, 407-414.
Cuzzocrea, S., Mazzon, E., Calabro, G., Dugo, L., De Sarro, A., van De, L. F., and
Caputi, A. P. (2000a). Inducible nitric oxide synthase-knockout mice exhibit
resistance to pleurisy and lung injury caused by carrageenan. Am J Respir Crit Care
Med 162, 1859-1866.
182
Cuzzocrea, S., McDonald, M. C., Filipe, H. M., Costantino, G., Mazzon, E.,
Santagati, S., Caputi, A. P., and Thiemermann, C. (2000b). Effects of tempol, a
membrane-permeable radical scavenger, in a rodent model of carrageenan-induced
pleurisy. Eur J Pharmacol 390, 209-222.
Cuzzocrea, S., Pisano, B., Dugo, L., Ianaro, A., Maffia, P., Patel, N. S., Di Paola, R.,
Ialenti, A., Genovese, T., Chatterjee, P. K., et al. (2004). Rosiglitazone, a ligand of
the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation.
Eur J Pharmacol 483, 79-93.
Cuzzocrea, S., Sautebin, L., De Sarro, G., Costantino, G., Rombola, L., Mazzon, E.,
Ialenti, A., De Sarro, A., Ciliberto, G., Di Rosa, M., et al. (1999b). Role of IL-6 in
the pleurisy and lung injury caused by carrageenan. J Immunol 163, 5094-5104.
D'Souza, M. J., Oettinger, C. W., Shah, A., Tipping, P. G., Huang, X. R., and Milton,
G. V. (1999). Macrophage depletion by albumin microencapsulated clodronate:
attenuation of cytokine release in macrophage-dependent glomerulonephritis. Drug
Dev Ind Pharm 25, 591-596.
Daems, W. T., and de Bakker, J. M. (1982). Do resident macrophages proliferate?
Immunobiology 161, 204-211.
Dalmarco, E. M., Frode, T. S., and Medeiros, Y. S. (2002). Effects of methotrexate
upon inflammatory parameters induced by carrageenan in the mouse model of
pleurisy. Mediators Inflamm 11, 299-306.
Danenberg, H. D., Fishbein, I., Epstein, H., Waltenberger, J., Moerman, E.,
Monkkonen, J., Gao, J., Gathi, I., Reichi, R., and Golomb, G. (2003). Systemic
depletion of macrophages by liposomal bisphosphonates reduces neointimal
formation following balloon-injury in the rat carotid artery. J Cardiovasc Pharmacol
42,671-679.
Danis, V. A., Franic, G. M., Rathjen, D. A., and Brooks, P. M. (1991). Effects of
granulocyte-macrophage colony-stimulating factor (GM-CSF), IL-2, interferon-
gamma (IFN-gamma), tumour necrosis factor-alpha (TNF-alpha) and IL-6 on the
production of immunoreactive IL-1 and TNF-alpha by human monocytes. Clin Exp
Immunol 85, 143-150.
Das, S., and Khar, A. (2002). Regulation ofNK cell function in vivo by the dose of
tumour transplanted in the peritoneum. Immunol Lett 83, 133-142.
de Haas, C. J., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J.,
Heezius, E. C., Poppelier, M. J., Van Kessel, K. P., and van Strijp, J. A. (2004).
Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial
antiinflammatory agent. J Exp Med 199, 687-695.
de Souza, G. E., and Ferreira, S. H. (1985). Blockade by antimacrophage serum of
the migration of PMN neutrophils into the inflamed peritoneal cavity. Agents
Actions 77, 97-103.
183
Deneys, V., Mazzon, A. M., Robert, A., Duvillier, H., and De Bruyere, M. (1994).
Reliable and very sensitive flow-cytometric method for counting low leucocyte
numbers in platelet concentrates. Vox Sang 67, 172-177.
Derer, M., Walker, C., Kristensen, F., and Reinhardt, M. C. (1983). A simple and
rapid flow cytometric method for routine assessment of baker's yeast uptake by
human polymorphonuclear leukocytes. J Immunol Methods 61, 359-365.
Desouza, I. A., Hyslop, S., Franco-Penteado, C. F., and Ribeiro-DaSilva, G. (2002).
Evidence for the involvement of a macrophage-derived chemotactic mediator in the
neutrophil recruitment induced by staphylococcal enterotoxin B in mice. Toxicon 40,
1709-1717.
Diez-Roux, G., Argilla, M., Makarenkova, H., Ko, K., and Lang, R. A. (1999).
Macrophages kill capillary cells in G1 phase of the cell cycle during programmed
vascular regression. Development 126, 2141-2147.
Dorger, M., Munzing, S., Allmeling, A. M., Messmer, K., and Krombach, F. (2001).
Phenotypic and functional differences between rat alveolar, pleural, and peritoneal
macrophages. Exp Lung Res 27, 65-76.
Dubois, B., Fayette, J., Vanbervliet, B., Banchereau, J., Briere, F., and Caux, C.
(1995). Human dendritic cells enhance growth and differentiation of CD40 activated
B cells. Adv Exp Med Biol 378, 397-399.
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori,
S., Wu, S., Lang, R., and Iredale, J. P. (2005a). Selective depletion of macrophages
reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115, 56-
65.
Duffield, J. S., Tipping, P. G., Kipari, T., Cailhier, J. F., Clay, S., Lang, R.,
Bonventre, J. V., and Hughes, J. (2005b). Conditional ablation of macrophages halts
progression of crescentic glomerulonephritis. Am J Pathol 167, 1207-1219.
Ehlers, S., Benini, J., Held, H. D., Roeck, C., Alber, G., and Uhlig, S. (2001).
Alphabeta T cell receptor-positive cells and interferon-gamma, but not inducible
nitric oxide synthase, are critical for granuloma necrosis in a mouse model of
mycobacteria-induced pulmonary immunopathology. J Exp Med 194, 1847-1859.
Eichner, R. D., and Smeaton, T. C. (1983). Agar accumulates in rat peritoneal
macrophages elicited with thioglycollate broth. Scand J Immunol 18, 259-263.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., and
Henson, P. M. (1998). Macrophages that have ingested apoptotic cells in vitro inhibit
proinflammatory cytokine production through autocrine/paracrine mechanisms
involving TGF-beta, PGE2, and PAF. J Clin Invest 101, 890-898.
Faull, R. J. (2000). Peritoneal defenses against infection: winning the battle but
losing the war? Semin Dial 13, 47-53.
184
Faull, R. J., Wang, J., and Stavros, W. (1996). Changes in the expression of adhesion
molecules as peripheral blood monocytes differentiate into peritoneal macrophages.
Nephrol Dial Transplant 11, 2037-2044.
Faust, D., and Loos, M. (2002). In vitro modulation ofClq mRNA expression and
secretion by interleukin-1, interleukin-6, and interferon-gamma in resident and
stimulated murine peritoneal macrophages. Immunobiology 206, 368-376.
Feldmann, M., Brennan, F. M., and Maini, R. N. (1996). Role of cytokines in
rheumatoid arthritis. Annu Rev Immunol 14, 397-440.
Ferraris, V. A., and DeRubertis, F. R. (1974). Release of prostaglandin by mitogen-
and antigen-stimulated leukocytes in culture. J Clin Invest 54, 378-386.
Festing, M. F., Legg, R., Eydmann, T., and Brammall, A. (1990). Mouse strain
differences in resident peritoneal cells: a flow cytometric analysis. Lab Anim 24, 53-
62.
Fogg, D. K., Sibon, C., Miled, C., Jung, S., Aucouturier, P., Littman, D. R., Cumano,
A., and Geissmann, F. (2006). A clonogenic bone marrow progenitor specific for
macrophages and dendritic cells. Science 311, 83-87.
Foti, M., Granucci, F., and Ricciardi-Castagnoli, P. (2004). A central role for tissue-
resident dendritic cells in innate responses. Trends Immunol 25, 650-654.
Foussat, A., Balabanian, K., Amara, A., Bouchet-Delbos, L., Durand-Gasselin, I.,
Baleux, F., Couderc, J., Galanaud, P., and Emilie, D. (2001). Production of stromal
cell-derived factor 1 by mesothelial cells and effects of this chemokine on peritoneal
B lymphocytes. Eur J Immunol 31, 350-359.
Frode, T. S., Souza, G. E., and Calixto, J. B. (2001). The modulatory role played by
TNF-alpha and IL-1 beta in the inflammatory responses induced by carrageenan in
the mouse model of pleurisy. Cytokine 13, 162-168.
Frode-Saleh, T. S., and Calixto, J. B. (2000). Synergistic antiinflammatory effect of
NF-kappaB inhibitors and steroidal or non steroidal antiinflammatory drugs in the
pleural inflammation induced by carrageenan in mice. Inflamm Res 49, 330-337.
Funk, C. D. (2001). Prostaglandins and leukotrienes: advances in eicosanoid biology.
Science 294, 1871-1875.
Gallily, R., and Feldman, M. (1967). The role of macrophages in the induction of
antibody in x-irradiated animals. Immunology 12, 197-206.
Gallily, R., Warwick, A., and Bang, F. B. (1964). Effect of Cortisone of Genetic
Resistance to Mouse Hepatitis Virus in Vivo and in Vitro. Proc Natl Acad Sci U S A
51, 1158-1164.
185
Gantner, B. N., Simmons, R. M., Canavera, S. J., Akira, S., and Underhill, D. M.
(2003). Collaborative induction of inflammatory responses by dectin-1 and Toll-like
receptor 2. J Exp Med 197, 1107-1117.
Garcia-Ramallo, E., Marques, T., Prats, N., Beleta, J., Kunkel, S. L., and Godessart,
N. (2002). Resident cell chemokine expression serves as the major mechanism for
leukocyte recruitment during local inflammation. J Immunol 169, 6467-6473.
Geissmann, F., Jung, S., and Littman, D. R. (2003). Blood monocytes consist of two
principal subsets with distinct migratory properties. Immunity 19, 71-82.
Gerard, N. P., and Gerard, C. (1991). The chemotactic receptor for human C5a
anaphylatoxin. Nature 349, 614-617.
Gilroy, D. W., Colville-Nash, P. R., Willis, D., Chivers, J., Paul-Clark, M. J., and
Willoughby, D. A. (1999). Inducible cyclooxygenase may have anti-inflammatory
properties. Nat Med 5, 698-701.
Gilroy, D. W., Newson, J., Sawmynaden, P., Willoughby, D. A., and Croxtall, J. D.
(2004). A novel role for phospholipase A2 isoforms in the checkpoint control of
acute inflammation. Faseb J 18, 489-498.
Gjomarkaj, M., Pace, E., Melis, M., Spatafora, M., Profita, M., Vignola, A. M.,
Bonsignore, G., and Toews, G. B. (1999). Phenotypic and functional characterization
of normal rat pleural macrophages in comparison with autologous peritoneal and
alveolar macrophages. Am J Respir Cell Mol Biol 20, 135-142.
Godfrey, D. I., and Kronenberg, M. (2004). Going both ways: immune regulation via
CDld-dependent NKT cells. J Clin Invest 114, 1379-1388.
Godshall, C. J., Scott, M. J., Burch, P. T., Peyton, J. C., and Cheadle, W. G. (2003).
Natural killer cells participate in bacterial clearance during septic peritonitis through
interactions with macrophages. Shock 19, 144-149.
Goldmann, O., Rohde, M., Chhatwal, G. S., and Medina, E. (2004). Role of
macrophages in host resistance to group A streptococci. Infect Immun 72, 2956-
2963.
Goncalves, A. S., and Appelberg, R. (2002). The involvement of the chemokine
receptor CXCR2 in neutrophil recruitment in LPS-induced inflammation and in
Mycobacterium avium infection. Scand J Immunol 55, 585-591.
Goodman, M. G. (1984). Monokine generation as a consequence of binding of
human C5a anaphylatoxin to specific cell-surface receptors. Lymphokine Res 3, 7-
10.
Goodman, R. B., Wood, R. G., Martin, T. R., Hanson-Painton, O., and Kinasewitz,
G. T. (1992). Cytokine-stimulated human mesothelial cells produce chemotactic
activity for neutrophils including NAP-l/IL-8. J Immunol 148, 457-465.
186
Gordon, S. (2002). Pattern recognition receptors: doubling up for the innate immune
response. Cell 111, 927-930.
Gordon, S. (2003). Alternative activation of macrophages. Nat Rev Immunol 3, 23-
35.
Gouon-Evans, V., Rothenberg, M. E., and Pollard, J. W. (2000). Postnatal mammary
gland development requires macrophages and eosinophils. Development 727, 2269-
2282.
Gouwy, M., Struyf, S., Proost, P., and Van Damme, J. (2005). Synergy in cytokine
and chemokine networks amplifies the inflammatory response. Cytokine Growth
Factor Rev 16, 561-580.
Granucci, F., Vizzardelli, C., Pavelka, N., Feau, S., Persico, M., Virzi, E., Rescigno,
M., Moro, G., and Ricciardi-Castagnoli, P. (2001). Inducible IL-2 production by
dendritic cells revealed by global gene expression analysis. Nat Immunol 2, 882-888.
Green, J. R. (2003). Antitumor effects of bisphosphonates. Cancer 97, 840-847.
Guo, R. F., and Ward, P. A. (2005). Role of C5a in inflammatory responses. Annu
Rev Immunol 23, 821-852.
Hall, L. R., Lass, J. H., Diaconu, E., Strine, E. R., and Pearlman, E. (1999). An
essential role for antibody in neutrophil and eosinophil recruitment to the cornea: B
cell-deficient (microMT) mice fail to develop Th2-dependent, helminth-mediated
keratitis. J Immunol 163, 4970-4975.
Hanayama, R., Tanaka, M., Miwa, K., Shinohara, A., Iwamatsu, A., and Nagata, S.
(2002). Identification of a factor that links apoptotic cells to phagocytes. Nature 417,
182-187.
Hancock, W. W., Gao, W., Shemmeri, N., Shen, X. D., Gao, F., Busuttil, R. W.,
Zhai, Y., and Kupiec-Weglinski, J. W. (2002). Immunopathogenesis of accelerated
allograft rejection in sensitized recipients: humoral and nonhumoral mechanisms.
Transplantation 73, 1392-1397.
Harada, Y., Hatanaka, K., Kawamura, M., Saito, M., Ogino, M., Majima, M., Ohno,
T., Ogino, K., Yamamoto, K., Taketani, Y., et al. (1996). Role of prostaglandin H
synthase-2 in prostaglandin E2 formation in rat carrageenin-induced pleurisy.
Prostaglandins 51, 19-33.
Harizi, H., and Gualde, N. (2005). The impact of eicosanoids on the crosstalk
between innate and adaptive immunity: the key roles of dendritic cells. Tissue
Antigens 65, 507-514.
Hartman, J., Maassen, V., Rieber, P., and Fricke, H. (1995). T lymphocytes from
normal human peritoneum are phenotypically different from their counterparts in
peripheral blood and CD3- lymphocyte subsets contain mRNA for the recombination
activating gene RAG-1. Eur J Immunol 25, 2626-2631.
187
Hashimoto, S., Pittet, J. F., Hong, K., Folkesson, H., Bagby, G., Kobzik, L., Frevert,
C., Watanabe, K., Tsurufuji, S., and Wiener-Kronish, J. (1996). Depletion of alveolar
macrophages decreases neutrophil chemotaxis to Pseudomonas airspace infections.
Am J Physiol 270, L819-828.
Hastings, W. D., Gurdak, S. M., Tumang, J. R., and Rothstein, T. L. (2006).
CD5(+)/Mac-l(-) peritoneal B cells: A novel B cell subset that exhibits
characteristics of B-l cells. Immunol Lett.
Hayakawa, K., Hardy, R. R., and Herzenberg, L. A. (1985). Progenitors for Ly-1 B
cells are distinct from progenitors for other B cells. J Exp Med 161, 1554-1568.
He, S., and Walls, A. F. (1998). Human mast cell chymase induces the accumulation
of neutrophils, eosinophils and other inflammatory cells in vivo. Br J Pharmacol 125,
1491-1500.
Henderson, R. B., Hobbs, J. A., Mathies, M., and Hogg, N. (2003). Rapid
recruitment of inflammatory monocytes is independent of neutrophil migration.
Blood 102, 328-335.
Henson, P. M. (2005). Dampening inflammation. Nat Immunol 6, 1179-1181.
Herzenberg, L. A. (2000). B-l cells: the lineage question revisited. Immunol Rev
175,9-22.
Heyman, R. A., Borrelli, E., Lesley, J., Anderson, D., Richman, D. D., Baird, S. M.,
Hyman, R., and Evans, R. M. (1989). Thymidine kinase obliteration: creation of
transgenic mice with controlled immune deficiency. Proc Natl Acad Sci USA 86,
2698-2702.
Hill, G. D., Mangum, J. B., Moss, O. R., and Everitt, J. I. (2003). Soluble ICAM-1,
MCP-1, and MIP-2 protein secretion by rat pleural mesothelial cells following
exposure to amosite asbestos. Exp Lung Res 29, 277-290.
Hodge-Dufour, J., Noble, P. W., Horton, M. R., Bao, C., Wysoka, M., Burdick, M.
D., Strieter, R. M., Trinchieri, G., and Pure, E. (1997). Induction of IL-12 and
chemokines by hyaluronan requires adhesion- dependent priming of resident but not
elicited macrophages. J Immunol 159, 2492-2500.
Horakova, Z., Bayer, B. M., Almeida, A. P., and Beaven, M. A. (1980). Evidence
that histamine does not participate in carrageenan-induced pleurisy in rat. Eur J
Pharmacol 62, 17-25.
Howell, K., Campo, M., Chiasson, R., Duffy, K., and Riggs, J. (2002). B-l B cell
subset composition of DBA/2J mice. Immunobiology 205, 303-313.
Hu, B., Jennings, J. H., Sonstein, J., Floros, J., Todt, J. C., Polak, T., and Curtis, J. L.
(2004). Resident murine alveolar and peritoneal macrophages differ in adhesion of
apoptotic thymocytes. Am J Respir Cell Mol Biol 30, 687-693.
188
Hu, B., Sonstein, J., Christensen, P. J., Punturieri, A., and Curtis, J. L. (2000).
Deficient in vitro and in vivo phagocytosis of apoptotic T cells by resident murine
alveolar macrophages. J Immunol 165, 2124-2133.
Huber-Lang, M., Younkin, E. M., Sarma, J. V., Riedemann, N., McGuire, S. R., Lu,
K. T., Kunkel, R., Younger, J. G., Zetoune, F. S., and Ward, P. A. (2002).
Generation of C5a by phagocytic cells. Am J Pathol 161, 1849-1859.
Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., and Dijkstra, C. D.
(1990). Suppression of experimental allergic encephalomyelitis in Lewis rats after
elimination of macrophages. J Exp Med 172, 1025-1033.
Hurst, S. M., Wilkinson, T. S., McLoughlin, R. M., Jones, S., Horiuchi, S.,
Yamamoto, N., Rose-John, S., Fuller, G. M., Topley, N., and Jones, S. A. (2001). II-
6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte
recruitment seen during acute inflammation. Immunity 14, 705-714.
Ishizaka, S., Kuriyama, S., and Tsujii, T. (1989). In vivo depletion of macrophages
by desulfated iota-carrageenan in mice. J Immunol Methods 124, 17-24.
Janeway, C., Travers, P., Walport, M., and Shlomchik, M. (2001). Immunobiology:
The immune system in health and disease, 5th edn (New York, Garland Publish).
Jayne, D. G., Perry, S. L., Morrison, E., Farmery, S. M., and Guillou, P. J. (2000).
Activated mesothelial cells produce heparin-binding growth factors: implications for
tumour metastases. Br J Cancer 82, 1233-1238.
Jongstra-Bilen, J., Misener, V. L., Wang, C., Ginzberg, H., Auerbach, A., Joyner, A.
L., Downey, G. P., and Jongstra, J. (2000). LSP1 modulates leukocyte populations in
resting and inflamed peritoneum. Blood 96, 1827-1835.
Jonjic, N., Peri, G., Bernasconi, S., Sciacca, F. L., Colotta, F., Pelicci, P.,
Lanfrancone, L., and Mantovani, A. (1992). Expression of adhesion molecules and
chemotactic cytokines in cultured human mesothelial cells. J Exp Med 176, 1165-
1174.
Jose, M. D., Ikezumi, Y., van Rooijen, N., Atkins, R. C., and Chadban, S. J. (2003).
Macrophages act as effectors of tissue damage in acute renal allograft rejection.
Transplantation 76, 1015-1022.
Jun, H. S., Yoon, C. S., Zbytnuik, L., van Rooijen, N., and Yoon, J. W. (1999). The
role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic
mice. J Exp Med 189, 347-358.
Jung, S., Unutmaz, D., Wong, P., Sano, G., De los Santos, K., Sparwasser, T., Wu,
S., Vuthoori, S., Ko, K., Zavala, F., et al. (2002). In vivo depletion of CD1 lc(+)
dendritic cells abrogates priming of CD8(+) T cells by exogenous cell-associated
antigens. Immunity 17, 211-220.
189
Kawamura, T., Seki, S., Takeda, K., Narita, J., Ebe, Y., Naito, M., Hiraide, H., and
Abo, T. (1999). Protective effect of NK1.1(+) T cells as well as NK cells against
intraperitoneal tumors in mice. Cell Immunol 193, 219-225.
Kay, A. B., Shin, H. S., and Austen, K. F. (1973). Selective attraction of eosinophils
and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a
fragment cleaved from the fifth component of complement (C5a). Immunology 24,
969-976.
Kildsgaard, J., Hollmann, T. J., Matthews, K. W., Bian, K., Murad, F., and Wetsel,
R. A. (2000). Cutting edge: targeted disruption of the C3a receptor gene
demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock. J
Immunol 165, 5406-5409.
Kishore, U., Gaboriaud, C., Waters, P., Shrive, A. K., Greenhough, T. J., Reid, K. B.,
Sim, R. B., and Arlaud, G. J. (2004). Clq and tumor necrosis factor superfamily:
modularity and versatility. Trends Immunol 25, 551-561.
Kishore, U., and Reid, K. B. (2000). Clq: structure, function, and receptors.
Immunopharmacology 49, 159-170.
Kiss, A. L., Turi, A., Muller, N., Kantor, O., and Botos, E. (2002). Caveolae and
caveolin isoforms in rat peritoneal macrophages. Micron 33, 75-93.
Kitamura, D., Roes, J., Kuhn, R., and Rajewsky, K. (1991). A B cell-deficient mouse
by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.
Nature 350, 423-426.
Knudsen, E., Benestad, H. B., Seierstad, T., and Iversen, P. O. (2004). Macrophages
in spleen and liver direct the migration pattern of rat neutrophils during
inflammation. Eur J Haematol 73, 109-122.
Knudsen, E., Iversen, P. O., Van Rooijen, N., and Benestad, H. B. (2002).
Macrophage-dependent regulation of neutrophil mobilization and chemotaxis during
development of sterile peritonitis in the rat. Eur J Haematol 69, 284-296.
Kobayashi, H., Dubois, S., Sato, N., Sabzevari, H., Sakai, Y., Waldmann, T. A., and
Tagaya, Y. (2005). Role of trans-cellular IL-15 presentation in the activation ofNK
cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood
705,721-727.
Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon,
R., Sherman, F., Perussia, B., and Trinchieri, G. (1989). Identification and
purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple
biologic effects on human lymphocytes. J Exp Med 170, 827-845.
Kolaczkowska, E. (2002). Shedding light on vascular permeability during peritonitis:
role of mast cell histamine versus macrophage cysteinyl leukotrienes. Inflamm Res
57,519-521.
190
Kolaczkowska, E., Shahzidi, S., Seljelid, R., van Rooijen, N., and Plytycz, B. (2002).
Early vascular permeability in murine experimental peritonitis is co-mediated by
resident peritoneal macrophages and mast cells: crucial involvement of macrophage-
derived cysteinyl-leukotrienes. Inflammation 26, 61-71.
Kopf, M., Brombacher, F., and Bachmann, M. F. (2002). Role of IgM antibodies
versus B cells in influenza virus-specific immunity. Eur J Immunol 32, 2229-2236.
Kos, F. J. (1989). Augmentation of recombinant interleukin-2-dependent murine
macrophage-mediated tumour cytotoxicity by recombinant tumour necrosis factor-
alpha. Immunol Cell Biol 67 ( Pt 6), 433-436.
Kotter, M. R., Setzu, A., Sim, F. J., Van Rooijen, N., and Franklin, R. J. (2001).
Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-
induced demyelination. Glia 35, 204-212.
Kotter, M. R., Zhao, C., van Rooijen, N., and Franklin, R. J. (2005). Macrophage -
depletion induced impairment of experimental CNS remyelination is associated with
a reduced oligodendrocyte progenitor cell response and altered growth factor
expression. Neurobiol Dis 18, 166-175.
Kubicka, U., Olszewski, W. L., Tarnowski, W., Bielecki, K., Ziolkowska, A., and
Wierzbicki, Z. (1996). Normal human immune peritoneal cells: subpopulations and
functional characteristics. Scand J Immunol 44, 157-163.
Kumaratilake, F. M., Ferrante, A., Bates, E. J., and Kowanko, I. C. (1990).
Augmentation of the human monocyte/macrophage chemiluminescence response
during short-term exposure to interferon-gamma and tumour necrosis factor-alpha.
Clin Exp Immunol 80, 257-262.
Kunkel, S. L. (1996). Thl- and Th2-type cytokines regulate chemokine expression.
Biol Signals 5, 197-202.
Kurosaka, K., Watanabe, N., and Kobayashi, Y. (2001). Production of
proinflammatory cytokines by resident tissue macrophages after phagocytosis of
apoptotic cells. Cell Immunol 211, 1-7.
Kuziel, W. A., Morgan, S. J., Dawson, T. C., Griffin, S., Smithies, O., Fey, K., and
Maeda, N. (1997). Severe reduction in leukocyte adhesion and monocyte
extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S
A 94, 12053-12058.
Fandel, C. P., Zhao, J., Bok, D., and Evans, G. A. (1988). Fens-specific expression
of recombinant ricin induces developmental defects in the eyes of transgenic mice.
Genes Dev 2, 1168-1178.
191
Lanfrancone, L., Boraschi, D., Ghiara, P., Falini, B., Grignani, F., Peri, G.,
Mantovani, A., and Pelicci, P. G. (1992). Human peritoneal mesothelial cells
produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-
monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated
and stimulated to grow by IL-1. Blood 80, 2835-2842.
Lang, R. A., and Bishop, J. M. (1993). Macrophages are required for cell death and
tissue remodeling in the developing mouse eye. Cell 74, 453-462.
Lawlor, K. E., Wong, P. K., Campbell, I. K., van Rooijen, N., and Wicks, I. P.
(2005). Acute CD4+ T lymphocyte-dependent interleukin-1-driven arthritis
selectively requires interleukin-2 and interleukin-4, joint macrophages, granulocyte-
macrophage colony-stimulating factor, interleukin-6, and leukemia inhibitory factor.
Arthritis Rheum 52, 3749-3754.
Lawson, L. J., Perry, V. H., and Gordon, S. (1992). Turnover of resident microglia in
the normal adult mouse brain. Neuroscience 48, 405-415.
Leenen, P. J., Radosevic, K., Voerman, J. S., Salomon, B., van Rooijen, N.,
Klatzmann, D., and van Ewijk, W. (1998). Heterogeneity of mouse spleen dendritic
cells: in vivo phagocytic activity, expression of macrophage markers, and
subpopulation turnover. J Immunol 160, 2166-2173.
Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., and
Nuseir, N. (1987). Macrophage-induced angiogenesis is mediated by tumour necrosis
factor-alpha. Nature 329, 630-632.
Leijh, P. C., van Zwet, T. L., ter Kuile, M. N., and van Furth, R. (1984). Effect of
thioglycolate on phagocytic and microbicidal activities of peritoneal macrophages.
Infect Immun 46, 448-452.
Lenda, D. M., Kikawada, E., Stanley, E. R., and Kelley, V. R. (2003). Reduced
macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-
deficient mice results in decreased tubular apoptosis during renal inflammation. J
Immunol 170, 3254-3262.
Lewis, S., and Holmes, C. (1991). Host defense mechanisms in the peritoneal cavity
of continuous ambulatory peritoneal dialysis patients. 1. Perit Dial Int 11, 14-21.
Lewis, S. L., Kutvirt, S. G., Cooper, C. L., Bonner, P. N., and Holmes, C. J. (1993).
Characteristics of peripheral and peritoneal lymphocytes from continuous
ambulatory peritoneal dialysis patients. Perit Dial Int 13 Suppl 2, S273-277.
Li, F. K., Davenport, A., Robson, R. L., Loetscher, P., Rothlein, R., Williams, J. D.,
and Topley, N. (1998). Leukocyte migration across human peritoneal mesothelial
cells is dependent on directed chemokine secretion and ICAM-1 expression. Kidney
Int 54, 2170-2183.
192
Li, Y. M., Baviello, G., Vlassara, H., and Mitsuhashi, T. (1997). Glycation products
in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J
Immunol Methods 201, 183-188.
Liberek, T., Topley, N., Luttmann, W., and Williams, J. D. (1996). Adherence of
neutrophils to human peritoneal mesothelial cells: role of intercellular adhesion
molecule-1. J Am Soc Nephrol 7, 208-217.
Locati, M., Torre, Y. M., Galliera, E., Bonecchi, R., Bodduluri, H., Vago, G.,
Vecchi, A., and Mantovani, A. (2005). Silent chemoattractant receptors: D6 as a
decoy and scavenger receptor for inflammatory CC chemokines. Cytokine Growth
Factor Rev 16, 679-686.
Loghmani, F., Mohammed, K. A., Nasreen, N., Van Horn, R. D., Hardwick, J. A.,
Sanders, K. L., and Antony, V. B. (2002). Inflammatory cytokines mediate C-C
(monocyte chemotactic protein 1) and C-X-C (interleukin 8) chemokine expression
in human pleural fibroblasts. Inflammation 26, 73-82.
Loos, M., Muller, W., Boltz-Nitulescu, G., and Forster, O. (1980). Evidence that
Clq, a subcomponent of the first component of complement, is an Fc receptor of
peritoneal and alveolar macrophages. Immunobiology 157, 54-61.
Luster, A. D. (1998). Chemokines—chemotactic cytokines that mediate
inflammation. N Engl J Med 338, 436-445.
Mackay, C. R. (2001). Chemokines: immunology's high impact factors. Nat
Immunol 2, 95-101.
Mackenzie, R. K., Coles, G. A., and Williams, J. D. (1990). Eicosanoid synthesis in
human peritoneal macrophages stimulated with S. epidermidis. Kidney Int 37, 1316-
1324.
Mackenzie, R. K., Coles, G. A., and Williams, J. D. (1991). The response of human
peritoneal macrophages to stimulation with bacteria isolated from episodes of
continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis 163, 837-
842.
Malaviya, R., and Abraham, S. N. (2000). Role of mast cell leukotrienes in
neutrophil recruitment and bacterial clearance in infectious peritonitis. J Leukoc Biol
67, 841-846.
Malaviya, R., Navara, C., and Uckun, F. M. (2001). Role of Janus kinase 3 in mast
cell-mediated innate immunity against gram-negative bacteria. Immunity 15, 313-
321.
Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., and Allavena, P. (2001). Decoy
receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends
Immunol 22, 328-336.
193
Matsuki, T., Isoda, K., Horai, R., Nakajima, A., Aizawa, Y., Suzuki, K., Ohsuzu, F.,
and Iwakura, Y. (2005). Involvement of tumor necrosis factor-alpha in the
development of T cell-dependent aortitis in interleukin-1 receptor antagonist-
deficient mice. Circulation 112, 1323-1331.
McColl, S. R., and Clark-Lewis, I. (1999). Inhibition of murine neutrophil
recruitment in vivo by CXC chemokine receptor antagonists. J Immunol 163, 2829-
2835.
McDonald, P. P., Fadok, V. A., Bratton, D., and Henson, P. M. (1999).
Transcriptional and translational regulation of inflammatory mediator production by
endogenous TGF-beta in macrophages that have ingested apoptotic cells. J Immunol
163, 6164-6172.
Mclntyre, T. M., Prescott, S. M., Weyrich, A. S., and Zimmerman, G. A. (2003).
Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol 10,
150-158.
McKercher, S. R., Torbett, B. E., Anderson, K. L., Henkel, G. W., Vestal, D. J.,
Baribault, H., Klemsz, M., Feeney, A. J., Wu, G. E., Paige, C. J., and Maki, R. A.
(1996). Targeted disruption of the PU.l gene results in multiple hematopoietic
abnormalities. Embo J 15, 5647-5658.
McLoughlin, R. M., Hurst, S. M., Nowell, M. A., Harris, D. A., Horiuchi, S.,
Morgan, L. W., Wilkinson, T. S., Yamamoto, N., Topley, N., and Jones, S. A.
(2004). Differential regulation of neutrophil-activating chemokines by IL-6 and its
soluble receptor isoforms. J Immunol 172, 5676-5683.
McLoughlin, R. M., Witowski, J., Robson, R. L., Wilkinson, T. S., Hurst, S. M.,
Williams, A. S., Williams, J. D., Rose-John, S., Jones, S. A., and Topley, N. (2003).
Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and
apoptosis during acute inflammation. J Clin Invest 112, 598-607.
Melnicoff, M. J., Horan, P. K., and Morahan, P. S. (1989). Kinetics of changes in
peritoneal cell populations following acute inflammation. Cell Immunol 118, 178-
191.
Metcalfe, D. D., Baram, D., and Mekori, Y. A. (1997). Mast cells. Physiol Rev 77,
1033-1079.
Metchnikoff, E. (1968). Immunity in infective diseases / by Elie Metchnikoff ; with a
new introduction by Gert H. Brieger (New York, Johnson Reprint Corp).
Mevorach, D., Mascarenhas, J. O., Gershov, D., and Elkon, K. B. (1998).
Complement-dependent clearance of apoptotic cells by human macrophages. J Exp
Med 188, 2313-2320.
194
Minasi, L. E., Kamogawa, Y., Carding, S., Bottomly, K., and Flavell, R. A. (1993).
The selective ablation of interleukin 2-producing cells isolated from transgenic mice.
J Exp Med 777, 1451-1459.
Misawa, R., Kawagishi, C., Watanabe, N., and Kobayashi, Y. (2001). Infiltration of
neutrophils following injection of apoptotic cells into the peritoneal cavity.
Apoptosis 6, 411-417.
Miserocchi, G. (1997). Physiology and pathophysiology of pleural fluid turnover.
Eur Respir J 10, 219-225.
Mohammed, K. A., Nasreen, N., Ward, M. J., and Antony, V. B. (1998a).
Macrophage inflammatory protein-1 alpha C-C chemokine in parapneumonic pleural
effusions. J Lab Clin Med 132, 202-209.
Mohammed, K. A., Nasreen, N., Ward, M. J., and Antony, V. B. (1999). Helper T
cell type 1 and 2 cytokines regulate C-C chemokine expression in mouse pleural
mesothelial cells. Am J Respir Crit Care Med 159, 1653-1659.
Mohammed, K. A., Nasreen, N., Ward, M. J., Mubarak, K. K., Rodriguez-Panadero,
F., and Antony, V. B. (1998b). Mycobacterium-mediated chemokine expression in
pleural mesothelial cells: role of C-C chemokines in tuberculous pleurisy. J Infect
Dis 178, 1450-1456.
Mombaerts, P., Iacomini, J., Johnson, R. S., Herrup, K., Tonegawa, S., and
Papaioannou, V. E. (1992). RAG-1-deficient mice have no mature B and T
lymphocytes. Cell 68, 869-877.
Morley, J. (1974). Prostaglandins and lymphokines in arthritis. Prostaglandins 8,
315-326.
Morrison, T. E., Whitmore, A. C., Shabman, R. S., Lidbury, B. A., Mahalingam, S.,
and Heise, M. T. (2006). Characterization of Ross River virus tropism and virus-
induced inflammation in a mouse model of viral arthritis and myositis. J Virol 80,
737-749.
Murai, N., Nagai, K., Fujisawa, H., Hatanaka, K., Kawamura, M., and Harada, Y.
(2003). Concurrent evolution and resolution in an acute inflammatory model of rat
carrageenin-induced pleurisy. J Leukoc Biol 73, 456-463.
Mutsaers, S. E. (2004). The mesothelial cell. Int J Biochem Cell Biol 36, 9-16.
Mutsaers, S. E., McAnulty, R. J., Laurent, G. J., Versnel, M. A., Whitaker, D., and
Papadimitriou, J. M. (1997). Cytokine regulation of mesothelial cell proliferation in
vitro and in vivo. Eur J Cell Biol 72, 24-29.
Naglich, J. G., Metherall, J. E., Russell, D. W., and Eidels, L. (1992). Expression
cloning of a diphtheria toxin receptor: identity with a heparin-binding EGF-like
growth factor precursor. Cell 69, 1051-1061.
195
Naito, M., Umeda, S., Yamamoto, T., Moriyama, H., Umezu, H., Hasegawa, G.,
Usuda, H., Shultz, L. D., and Takahashi, K. (1996). Development, differentiation,
and phenotypic heterogeneity of murine tissue macrophages. J Leukoc Biol 59, 133-
138.
Nourshargh, S., and Marelli-Berg, F. M. (2005). Transmigration through venular
walls: a key regulator of leukocyte phenotype and function. Trends Immunol 26,
157-165.
O'Shea, J. J., Ma, A., and Lipsky, P. (2002). Cytokines and autoimmunity. Nat Rev
Immunol 2, 37-45.
Pace, E., Gjomarkaj, M., Melis, M., Profita, M., Spatafora, M., Vignola, A. M.,
Bonsignore, G., and Mody, C. H. (1999). Interleukin-8 induces lymphocyte
chemotaxis into the pleural space. Role of pleural macrophages. Am J Respir Crit
Care Med 159, 1592-1599.
Pace, E., Profita, M., Melis, M., Bonanno, A., Paterno, A., Mody, C. H., Spatafora,
M., Ferraro, M., Siena, L., Vignola, A. M., et al. (2004). LTB4 is present in
exudative pleural effusions and contributes actively to neutrophil recruitment in the
inflamed pleural space. Clin Exp Immunol 135, 519-527.
Paciorkowski, N., Porte, P., Shultz, L. D., and Rajan, T. V. (2000). BIB
lymphocytes play a critical role in host protection against lymphatic filarial parasites.
J Exp Med 797, 731-736.
Pantelouris, E. M. (1968). Absence of thymus in a mouse mutant. Nature 277, 370-
371.
Pappenheimer, A. M., Jr. (1977). Diphtheria toxin. Annu Rev Biochem 46, 69-94.
Park, J. S„ Kim, Y. S„ Jee, Y. K„ Myong, N. H„ and Lee, K. Y. (2003). Interleukin-
8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine
network involving tumour necrosis factor-alpha and interleukin-1 beta. Scand J
Immunol 57, 463-469.
Peao, M. N., Aguas, A. P., and Grande, N. R. (1992). Cellular kinetics of
inflammation in the pleural space of mice in response to the injection of exogenous
particles. Exp Lung Res 18, 863-876.
Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y., and Fisher, P. B. (2004).
Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22, 929-979.
Popi, A. F., Lopes, J. D., and Mariano, M. (2004). Interleukin-10 secreted by B-l
cells modulates the phagocytic activity of murine macrophages in vitro. Immunology
775,348-354.
196
Pouvreau, I., Zech, J. C., Thillaye-Goldenberg, B., Naud, M. C., Van Rooijen, N.,
and de Kozak, Y. (1998). Effect of macrophage depletion by liposomes containing
dichloromethylene-diphosphonate on endotoxin-induced uveitis. J Neuroimmunol
86, 171-181.
Qureshi, R., and Jakschik, B. A. (1988). The role of mast cells in thioglycollate-
induced inflammation. J Immunol 141, 2090-2096.
Rabs, U., Martin, H., Hitschold, T., Golan, M. D., Heinz, H. P., and Loos, M. (1986).
Isolation and characterization of macrophage-derived Clq and its similarities to
serum CIq. Eur J Immunol 16, 1183-1186.
Ramalingam, T., Rajan, B., Lee, J., and Rajan, T. V. (2003). Kinetics of cellular
responses to intraperitoneal Brugia pahangi infections in normal and
immunodeficient mice. Infect Immun 71, 4361-4367.
Ramos, C. D., Heluy-Neto, N. E., Ribeiro, R. A., Ferreira, S. H., and Cunha, F. Q.
(2003). Neutrophil migration induced by IL-8-activated mast cells is mediated by
CINC-1. Cytokine 21, 214-223.
Rapoport, J., Hausmann, M. J., and Chaimovitz, C. (1999). The peritoneal immune
system and continuous ambulatory peritoneal dialysis. Nephron 81, 373-380.
Remick, D. G., Green, L. B., Newcomb, D. E., Garg, S. J., Bolgos, G. L., and Call,
D. R. (2001). CXC chemokine redundancy ensures local neutrophil recruitment
during acute inflammation. Am J Pathol 159, 1149-1157.
Renauld, J. C. (2003). Class II cytokine receptors and their ligands: key antiviral and
inflammatory modulators. Nat Rev Immunol 3, 667-676.
Rennard, S. I., Jaurand, M. C., Bignon, J., Kawanami, O., Ferrans, V. J., Davidson,
J., and Crystal, R. G. (1984). Role of pleural mesothelial cells in the production of
the submesothelial connective tissue matrix of lung. Am Rev Respir Dis 130, 267-
274.
Ribeiro, R. A., Vale, M. L., Thomazzi, S. M., Paschoalato, A. B., Poole, S., Ferreira,
S. H., and Cunha, F. Q. (2000). Involvement of resident macrophages and mast cells
in the writhing nociceptive response induced by zymosan and acetic acid in mice.
Eur J Pharmacol 387, 111-118.
Robson, R. L., McLoughlin, R. M., Witowski, J., Loetscher, P., Wilkinson, T. S.,
Jones, S. A., and Topley, N. (2001). Differential regulation of chemokine production
in human peritoneal mesothelial cells: IFN-gamma controls neutrophil migration
across the mesothelium in vitro and in vivo. J Immunol 167, 1028-1038.
Romano, M., Sironi, M., Toniatti, C., Polentarutti, N., Fruscella, P., Ghezzi, P.,
Faggioni, R., Luini, W., van Hinsbergh, V., Sozzani, S., et al. (1997). Role of IL-6
and its soluble receptor in induction of chemokines and leukocyte recruitment.
Immunity 6, 315-325.
197
Rosenkranz, A. R., Coxon, A., Maurer, M., Gurish, M. F., Austen, K. F., Friend, D.
S., Galli, S. J., and Mayadas, T. N. (1998). Impaired mast cell development and
innate immunity in Mac-1 (CD1 lb/CD18, CR3)-deficient mice. J Immunol 161,
6463-6467.
Rossi, D., and Zlotnik, A. (2000). The biology of chemokines and their receptors.
Annu Rev Immunol 18, 217-242.
Rossi, L., Serafini, S., Antonelli, A., Pierige, F., Carnevali, A., Battistelli, V.,
Malatesta, M., Balestra, E., Calio, R., Perno, C. F., and Magnani, M. (2005).
Macrophage depletion induced by clodronate-loaded erythrocytes. J Drug Target 13,
99-111.
Rugtveit, J., Haraldsen, G., Hogasen, A. K., Bakka, A., Brandtzaeg, P., and Scott, H.
(1995). Respiratory burst of intestinal macrophages in inflammatory bowel disease is
mainly caused by CD14+L1+ monocyte derived cells. Gut 37, 367-373.
Saito, M., Iwawaki, T., Taya, C., Yonekawa, H., Noda, M., Inui, Y., Mekada, E.,
Kimata, Y., Tsuru, A., and Kohno, K. (2001). Diphtheria toxin receptor-mediated
conditional and targeted cell ablation in transgenic mice. Nat Biotechnol 19, 746-
750.
Saito, M., Shima, C., Takagi, M., Ogino, M., Katori, M., and Majima, M. (2002).
Enhanced exudation of fibrinogen into the perivascular space in acute inflammation
triggered by neutrophil migration. Inflamm Res 51, 324-331.
Salkowski, C. A., Neta, R., Wynn, T. A., Strassmann, G., van Rooijen, N., and
Vogel, S. N. (1995). Effect of liposome-mediated macrophage depletion on LPS-
induced cytokine gene expression and radioprotection. J Immunol 155, 3168-3179.
Salvemini, D., Mazzon, E., Dugo, L., Riley, D. P., Serraino, I., Caputi, A. P., and
Cuzzocrea, S. (2001). Pharmacological manipulation of the inflammatory cascade by
the superoxide dismutase mimetic, M40403. Br J Pharmacol 132, 815-827.
Sato, M., Sano, H., Iwaki, D., Kudo, K., Konishi, M., Takahashi, H., Takahashi, T.,
Imaizumi, H., Asai, Y., and Kuroki, Y. (2003). Direct binding of Toll-like receptor 2
to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion
are down-regulated by lung collectin surfactant protein A. J Immunol 171, 417-425.
Savill, J., Dransfield, I., Gregory, C., and Haslett, C. (2002). A blast from the past:
clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2, 965-
975.
Schmidt-Weber, C. B., Rittig, M., Buchner, E., Hauser, I., Schmidt, I., Palombo-
Kinne, E., Emmrich, F., and Kinne, R. W. (1996). Apoptotic cell death in activated
monocytes following incorporation of clodronate-liposomes. J Leukoc Biol 60, 230-
244.
198
Schnyder-Candrian, S., Strieter, R. M., Kunkel, S. L., and Walz, A. (1995).
Interferon-alpha and interferon-gamma down-regulate the production of interleukin-
8 and ENA-78 in human monocytes. J Leukoc Biol 57, 929-935.
Schumann, J., Wolf, D., Pahl, A., Brune, K., Papadopoulos, T., van Rooijen, N., and
Tiegs, G. (2000). Importance of Kupffer cells for T-cell-dependent liver injury in
mice. Am J Pathol 157, 1671-1683.
Schweppe, F., Hausmann, M., Hexel, K., Barths, J., and Cremer, C. (1992). An
adapter for defined sample volumes makes it possible to count absolute particle
numbers in flow cytometry. Anal Cell Pathol 4, 325-334.
Scott, A., Khan, K. M., Cook, J. L., and Duronio, V. (2004). What is
"inflammation"? Are we ready to move beyond Celsus? Br J Sports Med 38, 248-
249.
Scott, E. W., Simon, M. C., Anastasi, J., and Singh, H. (1994). Requirement of
transcription factor PU.l in the development of multiple hematopoietic lineages.
Science 265, 1573-1577.
Scott, M. J., Hoth, J. J., Gardner, S. A., Peyton, J. C., and Cheadle, W. G. (2003).
Natural killer cell activation primes macrophages to clear bacterial infection. Am
Surg 69, 679-686; discussion 686-677.
Sean Eardley, K., and Cockwell, P. (2005). Macrophages and progressive
tubulointerstitial disease. Kidney Int 68, 437-455.
Segal, A. W. (2005). How neutrophils kill microbes. Annu Rev Immunol 23, 197-
223.
Seitz, M., Loetscher, P., Dewald, B., Towbin, H., Gallati, H., and Baggiolini, M.
(1995). Interleukin-10 differentially regulates cytokine inhibitor and chemokine
release from blood mononuclear cells and fibroblasts. Eur J Immunol 25, 1129-1132.
Seki, S., Osada, S., Ono, S., Aosasa, S., Habu, Y., Nishikage, T., Mochizuki, H., and
Hiraide, H. (1998). Role of liver NK cells and peritoneal macrophages in gamma
interferon and interleukin-10 production in experimental bacterial peritonitis in mice.
Infect Immun 66, 5286-5294.
Serhan, C. N., and Savill, J. (2005). Resolution of inflammation: the beginning
programs the end. Nat Immunol 6, 1191-1197.
Sestini, P., Tagliabue, A., and Boraschi, D. (1984). Modulation of macrophage
suppressive activity and prostaglandin release by lymphokines and interferon:
comparison of alveolar, pleural and peritoneal macrophages. Clin Exp Immunol 58,
573-580.
Shaw, P. X., Goodyear, C. S., Chang, M. K., Witztum, J. L., and Silverman, G. J.
(2003). The autoreactivity of anti-phosphorylcholine antibodies for atherosclerosis-
associated neo-antigens and apoptotic cells. J Immunol 170, 6151-6157.
199
Shaw, P. X., Horkko, S., Chang, M. K., Curtiss, L. K., Palinski, W., Silverman, G. J.,
and Witztum, J. L. (2000). Natural antibodies with the T15 idiotype may act in
atherosclerosis, apoptotic clearance, and protective immunity. J Clin Invest 105,
1731-1740.
Shifrin, A. L., Chirmule, N., Zhang, Y., and Raper, S. E. (2005). Macrophage
ablation attenuates adenoviral vector-induced pancreatitis. Surgery 137, 545-551.
Shultz, L. D., Lang, P. A., Christianson, S. W., Gott, B., Lyons, B., Umeda, S.,
Leiter, E., Hesselton, R., Wagar, E. J., Leif, J. H., et al. (2000). NOD/LtSz-Raglnull
mice: an immunodeficient and radioresistant model for engraftment of human
hematolymphoid cells, HIV infection, and adoptive transfer of NOD mouse
diabetogenic T cells. J Immunol 164, 2496-2507.
Sigal, L. H. (2004). Basic science for the clinician 33: Interleukins of current clinical
relevance (part I). J Clin Rheumatol 10, 353-359.
Skeen, M. J., Freeman, M. M., and Ziegler, H. K. (2004). Changes in peritoneal
myeloid populations and their proinflammatory cytokine expression during infection
with Listeria monocytogenes are altered in the absence of gamma/delta T cells. J
Leukoc Biol 76, 104-115.
Skeen, M. J., Rix, E. P., Freeman, M. M., and Ziegler, H. K. (2001). Exaggerated
proinflammatory and Thl responses in the absence of gamma/delta T cells after
infection with Listeria monocytogenes. Infect Immun 69, 7213-7223.
Smyth, M. J., and Godfrey, D. I. (2000). NKT cells and tumor immunity—a double-
edged sword. Nat Immunol 1, 459-460.
Snyderman, R., Phillips, J. K., and Mergenhagen, S. E. (1971). Biological activity of
complement in vivo. Role of C5 in the accumulation of polymorphonuclear
leukocytes in inflammatory exudates. J Exp Med 134, 1131-1143.
Souza, G. E., Cunha, F. Q., Mello, R., and Ferreira, S. H. (1988). Neutrophil
migration induced by inflammatory stimuli is reduced by macrophage depletion.
Agents Actions 24, 377-380.
Souza, M. H., Melo-Filho, A. A., Rocha, M. F., Lyerly, D. M., Cunha, F. Q., Lima,
A. A., and Ribeiro, R. A. (1997). The involvement of macrophage-derived tumour
necrosis factor and lipoxygenase products on the neutrophil recruitment induced by
Clostridium difficile toxin B. Immunology 91, 281-288.
Stenson, W. F., and Parker, C. W. (1980). Prostaglandins, macrophages, and
immunity. J Immunol 125, 1-5.
Stuart, L. M., Deng, J., Silver, J. M., Takahashi, K., Tseng, A. A., Hennessy, E. J.,
Ezekowitz, R. A., and Moore, K. J. (2005). Response to Staphylococcus aureus
requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic
domain. J Cell Biol 170, 477-485.
200
Szczepanik, M., Akahira-Azuma, ML, Bryniarski, K., Tsuji, R. F., Kawikova, I., Ptak,
W., Kiener, C., Campos, R. A., and Askenase, P. W. (2003). B-l B cells mediate
required early T cell recruitment to elicit protein-induced delayed-type
hypersensitivity. J Immunol 171, 6225-6235.
Tagaya, Y., Bamford, R. N., DeFilippis, A. P., and Waldmann, T. A. (1996). IL-15: a
pleiotropic cytokine with diverse receptor/signaling pathways whose expression is
controlled at multiple levels. Immunity 4, 329-336.
Tager, A. M., Dufour, J. H., Goodarzi, K., Bercury, S. D., von Andrian, U. H., and
Luster, A. D. (2000). BLTR mediates leukotriene B(4)-induced chemotaxis and
adhesion and plays a dominant role in eosinophil accumulation in a murine model of
peritonitis. J Exp Med 192, 439-446.
Takahashi, K. (1994). [Development and differentiation of macrophages and their
related cells]. Hum Cell 7, 109-115.
Takahashi, K., Naito, M., and Takeya, M. (1996). Development and heterogeneity of
macrophages and their related cells through their differentiation pathways. Pathol Int
46, 473-485.
Takeshita, K., Sakai, K., Bacon, K. B., and Gantner, F. (2003). Critical role of
histamine H4 receptor in leukotriene B4 production and mast cell-dependent
neutrophil recruitment induced by zymosan in vivo. J Pharmacol Exp Ther 307,
1072-1078.
Takeuchi, O., Hoshino, K., and Akira, S. (2000). Cutting edge: TLR2-deficient and
MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J
Immunol 165, 5392-5396.
Takeuchi, O., Hoshino, K., Kawai, T., Sanjo, H., Takada, H., Ogawa, T., Takeda, K.,
and Akira, S. (1999). Differential roles of TLR2 and TLR4 in recognition of gram-
negative and gram-positive bacterial cell wall components. Immunity 11, 443-451.
Tauber, A. I. (2003). Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell
Biol 4, 897-901.
Taylor, P. R., and Gordon, S. (2003). Monocyte heterogeneity and innate immunity.
Immunity 19, 2-4.
Taylor-Robinson, D., Schorlemmer, H. U., Furr, P. M„ and Allison, A. C. (1978).
Macrophage secretion and the complement cleavage product C3a in the pathogenesis
of infections by mycoplasmas and L-forms of bacteria and in immunity to these
organisms. Clin Exp Immunol 33, 486-494.
Tessier, P. A., Naccache, P. H., Clark-Lewis, I., Gladue, R. P., Neote, K. S., and
McColl, S. R. (1997). Chemokine networks in vivo: involvement of C-X-C and C-C
chemokines in neutrophil extravasation in vivo in response to TNF-alpha. J Immunol
159, 3595-3602.
201
Texereau, J., Chiche, J. D., Taylor, W., Choukroun, G., Comba, B., and Mira, J. P.
(2005). The importance of Toll-like receptor 2 polymorphisms in severe infections.
Clin Infect Dis 41 Suppl 7, S408-415.
Tilg, H., Dinarello, C. A., and Mier, J. W. (1997). IL-6 and APPs: anti-inflammatory
and immunosuppressive mediators. Immunol Today 18, 428-432.
Tilg, H., Trehu, E., Atkins, M. B., Dinarello, C. A., and Mier, J. W. (1994).
Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1
receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83, 113-
118.
Topley, N. (1995a). The cytokine network controlling peritoneal inflammation. Perit
Dial Int 15, S35-39; discussion S39-40.
Topley, N. (1995b). The host's initial response to peritoneal infection: the pivotal
role of the mesothelial cell. Perit Dial Int 15, 116-117.
Topley, N., Brown, Z., Jorres, A., Westwick, J., Davies, M., Coles, G. A., and
Williams, J. D. (1993a). Human peritoneal mesothelial cells synthesize interleukin-8.
Synergistic induction by interleukin-1 beta and tumor necrosis factor-alpha. Am J
Pathol 142, 1876-1886.
Topley, N., Jorres, A., Luttmann, W., Petersen, M. M., Lang, M. J., Thierauch, K.
H., Muller, C., Coles, G. A., Davies, M., and Williams, J. D. (1993b). Human
peritoneal mesothelial cells synthesize interleukin-6: induction by IL-1 beta and TNF
alpha. Kidney Int 43, 226-233.
Topley, N., Mackenzie, R., Jorres, A., Coles, G. A., Davies, M., and Williams, J. D.
(1993c). Cytokine networks in continuous ambulatory peritoneal dialysis:
interactions of resident cells during inflammation in the peritoneal cavity. Perit Dial
Int 13 Suppl 2, S282-285.
Topley, N., Mackenzie, R. K., and Williams, J. D. (1996). Macrophages and
mesothelial cells in bacterial peritonitis. Immunobiology 195, 563-573.
Topley, N., Petersen, M. M., Mackenzie, R., Neubauer, A., Stylianou, E., Kaever, V.,
Davies, M., Coles, G. A., Jorres, A., and Williams, J. D. (1994). Human peritoneal
mesothelial cell prostaglandin synthesis: induction of cyclooxygenase mRNA by
peritoneal macrophage-derived cytokines. Kidney Int 46, 900-909.
Topley, N., and Williams, J. D. (1994). Role of the peritoneal membrane in the
control of inflammation in the peritoneal cavity. Kidney Int Suppl 48, S71-78.
Trinchieri, G., Pflanz, S., and Kastelein, R. A. (2003). The IL-12 family of
heterodimeric cytokines: new players in the regulation of T cell responses. Immunity
19, 641-644.
Utsunomiya, I., Nagai, S., and Oh-ishi, S. (1991). Sequential appearance of IL-1 and
IL-6 activities in rat carrageenin-induced pleurisy. J Immunol 147, 1803-1809.
202
van den Berg, R. H., Faber-Krol, M. C., Sim, R. B., and Daha, M. R. (1998). The
first subcomponent of complement, Clq, triggers the production of IL-8,1L-6, and
monocyte chemoattractant peptide-1 by human umbilical vein endothelial cells. J
Immunol 161, 6924-6930.
van der Meer, P. F., Gratama, J. W., van Delden, C. J., Laport, R. F., Levering, W.
H., Schrijver, J. G., Tiekstra, M. J., Keeney, M., and de Wildt-Eggen, J. (2001).
Comparison of five platforms for enumeration of residual leucocytes in leucoreduced
blood components. Br J Haematol 115, 953-962.
Van Rooijen, N. (1989). The liposome-mediated macrophage 'suicide' technique. J
Immunol Methods 124, 1-6.
Van Rooijen, N., and Sanders, A. (1994). Liposome mediated depletion of
macrophages: mechanism of action, preparation of liposomes and applications. J
Immunol Methods 174, 83-93.
van Vugt, E., Arkema, J. M., Verdaasdonk, M. A., Beelen, R. H., and Kamperdijk, E.
W. (1991). Morphological and functional characteristics of rat steady state peritoneal
dendritic cells. Immunobiology 184, 14-24.
van Zaanen, H. C., Vet, R. J., de Jong, C. M., von dem Borne, A. E., and van Oers,
M. H. (1995). A simple and sensitive method for determining plasma cell isotype and
monoclonality in bone marrow using flowcytometry. Br J Haematol 91, 55-59.
Vijayakumar, R. K., and Muthukkaruppan, V. R. (1990). Immunoregulatory
processes induced by carrageenan in BALB/C mice. Immunol Invest 19, 163-183.
Vijayakumar, R. K., Palanivel, V., and Muthukkaruppan, V. R. (1989). Influence of
carrageenan on peritoneal macrophages. Immunol Lett 23, 55-59.
Virchow, R. L. K. (1971). Cellular pathology, as based upon physiological and
pathological histology, by Rudolf Virchow. (New York, Dover).
Volkman, A., Chang, N. C., Strausbauch, P. H., and Morahan, P. S. (1983).
Differential effects of chronic monocyte depletion on macrophage populations. Lab
Invest 49, 291-298.
Voll, R. E., Herrmann, M., Roth, E. A., Stach, C., Kalden, J. R., and Girkontaite, I.
(1997). Immunosuppressive effects of apoptotic cells [letter]. Nature 390, 350-351.
Volman, T. J., Hendriks, T., and Goris, R. J. (2005). Zymosan-induced generalized
inflammation: experimental studies into mechanisms leading to multiple organ
dysfunction syndrome. Shock 23, 291-297.
Walley, K. R., Lukacs, N. W., Standiford, T. J., Strieter, R. M., and Kunkel, S. L.
(1997). Elevated levels of macrophage inflammatory protein 2 in severe murine
peritonitis increase neutrophil recruitment and mortality. Infect Immun 65, 3847-
3851.
203
Watanabe, N., Ikuta, K., Nisitani, S., Chiba, T., and Honjo, T. (2002). Activation and
differentiation of autoreactive B-l cells by interleukin 10 induce autoimmune
hemolytic anemia in Fas-deficient antierythrocyte immunoglobulin transgenic mice.
J Exp Med 796, 141-146.
Weiss, S. J. (1989). Tissue destruction by neutrophils. N Engl J Med 320, 365-376.
Wershil, B. K., Murakami, T., and Galli, S. J. (1988). Mast cell-dependent
amplification of an immunologically nonspecific inflammatory response. Mast cells
are required for the full expression of cutaneous acute inflammation induced by
phorbol 12-myristate 13-acetate. J Immunol 140, 2356-2360.
White, P., Liebhaber, S. A., and Cooke, N. E. (2002). 129Xl/SvJ mouse strain has a
novel defect in inflammatory cell recruitment. J Immunol 168, 869-874.
Wicha, M. S., and Huard, T. K. (1983). Macrophages express cell surface laminin.
Exp Cell Res 143, 475-479.
Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A. W., Jr., Ahmed-Ansari, A., Sell,
K. W., Pollard, J. W., and Stanley, E. R. (1990). Total absence of colony-stimulating
factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci
U S A 87, 4828-4832.
Wiktor-Jedrzejczak, W., and Gordon, S. (1996). Cytokine regulation of the
macrophage (M phi) system studied using the colony stimulating factor-1-deficient
op/op mouse. Physiol Rev 76, 927-947.
Wilson, S. B., and Delovitch, T. L. (2003). Janus-like role of regulatory iNKT cells
in autoimmune disease and tumour immunity. Nat Rev Immunol 3, 211-222.
Witmer-Pack, M. D., Hughes, D. A., Schuler, G., Lawson, L., McWilliam, A., Inaba,
K., Steinman, R. M., and Gordon, S. (1993). Identification of macrophages and
dendritic cells in the osteopetrotic (op/op) mouse. J Cell Sci 104 ( Pt 4), 1021-1029.
Witowski, J., Thiel, A., Dechend, R., Dunkel, K., Fouquet, N., Bender, T. O.,
Langrehr, J. M., Gahl, G. M., Frei, U., and Jorres, A. (2001). Synthesis of C-X-C and
C-C chemokines by human peritoneal fibroblasts: induction by macrophage-derived
cytokines. Am J Pathol 158, 1441-1450.
Wood, W., Turmaine, M., Weber, R., Camp, V., Maki, R. A., McKercher, S. R., and
Martin, P. (2000). Mesenchymal cells engulf and clear apoptotic footplate cells in
macrophageless PU.l null mouse embryos. Development 727, 5245-5252.
Wortis, H. H., Nehlsen, S., and Owen, J. J. (1971). Abnormal development of the
thymus in "nude" mice. J Exp Med 134, 681-692.
Wyburn, K., Wu, H., Yin, J., Jose, M., Eris, J., and Chadban, S. (2005). Macrophage-
derived interleukin-18 in experimental renal allograft rejection. Nephrol Dial
Transplant 20, 699-706.
204
Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X. F., and Achong, M.
K. (1998). IL-6 is an antiinflammatory cytokine required for controlling local or
systemic acute inflammatory responses. J Clin Invest 101, 311-320.
Yamashiro, S., Kamohara, H., Wang, J. M., Yang, D., Gong, W. H., and Yoshimura,
T. (2001). Phenotypic and functional change of cytokine-activated neutrophils:
inflammatory neutrophils are heterogeneous and enhance adaptive immune
responses. J Leukoc Biol 69, 698-704.
Yang, X., Ye, R., Kong, Q., Yang, Q., Dong, X., and Yu, X. (2004). CD40 is
expressed on rat peritoneal mesothelial cells and upregulates ICAM-1 production.
Nephrol Dial Transplant 19, 1378-1384.
Yano, S., Yanagawa, H., Nishioka, Y., Mukaida, N., Matsushima, K., and Sone, S.
(1996). T helper 2 cytokines differently regulate monocyte chemoattractant protein-1
production by human peripheral blood monocytes and alveolar macrophages. J
Immunol 157, 2660-2665.
Yao, V., McCauley, R., Cooper, D., Platell, C., and Hall, J. C. (2004a). Peritoneal
mesothelial cells produce cytokines in a murine model of peritonitis. Surg Infect
(Larchmt) 5, 229-236.
Yao, V., Platell, C., and Hall, J. C. (2004b). Peritoneal mesothelial cells produce
inflammatory related cytokines. ANZ J Surg 74, 997-1002.
Youinou, P., Jamin, C., and Lydyard, P. M. (1999). CD5 expression in human B-cell
populations. Immunol Today 20, 312-316.
Zachariadis, O., Cassidy, J. P., Brady, J., and Mahon, B. P. (2006). {gamma}{delta}
T Cells Regulate the Early Inflammatory Response to Bordetella pertussis Infection
in the Murine Respiratory Tract. Infect Immun 74, 1837-1845.
Zeillemaker, A. M., Mul, F. P., Hoynck van Papendrecht, A. A., Kuijpers, T. W.,
Roos, D., Leguit, P., and Verbrugh, H. A. (1995). Polarized secretion of interleukin-8
by human mesothelial cells: a role in neutrophil migration. Immunology 84, 227-232.
Zito, M. A., Koennecke, L. A., McAuliffe, M. J., McNally, B., van Rooijen, N., and
Heyes, M. P. (2001). Depletion of systemic macrophages by liposome-encapsulated
clodronate attenuates striatal macrophage invasion and neurodegeneration following
local endotoxin infusion in gerbils. Brain Res 892, 13-26.
Zlotnik, A., and Yoshie, O. (2000). Chemokines: a new classification system and
their role in immunity. Immunity 12, 121-127.
Zwacka, R. M., Zhang, Y., Halldorson, J., Schlossberg, H., Dudus, L., and
Engelhardt, J. F. (1997). CD4(+) T-lymphocytes mediate ischemia/reperfusion-
induced inflammatory responses in mouse liver. J Clin Invest 100, 279-289.
205
Zwirner, J., Werfel, T., Wilken, H. C., Theile, E., and Gotze, O. (1998).
Anaphylatoxin C3a but not C3a(desArg) is a chemotaxin for the mouse macrophage
cell line J774. Eur J Immunol 28, 1570-1577.
206
Appendix I: Published Papers resulting from work from this thesis:
1) Conditional Macrophage Ablation Demonstrates That Resident
Macrophages Initiate Acute Peritoneal Inflammation. Jean Francois
Cailhier, Marina Partolina, Srilatha Yuthoori, Shengji Wu, Kyung Ko,
Simon Watson, John Savill, Jeremy Hughes and Richard A. Lang. The
Journal ofImmunology, 2005, 174: 2336-2342.
URL: http://www.jimmunol.Org/cgi/content/full/174/4/2336.
2) Resident Pleural Macrophages Are Key Orchestrators ofNeutrophil
Recruitment in Pleural Inflammation. Jean Franfois Cailhier,
Deborah A. Sawatzky, Tiina Kipari, Kris Houlberg, Dave Walbaum,
Simon Watson, Richard A. Lang, Spike Clay, David Kluth, John Savill
and Jeremy Hughes. American Journal ofRespiratory and Critical
Care Medicine. Vol 173. pp. 540-547, (2006).
URL: http://ajrccm.atsjournals.Org/cgi/content/full/l 73/5/540.
Both manuscripts are included at the end of this thesis.
207
The Journal of Immunology
Conditional Macrophage Ablation Demonstrates That Resident
Macrophages Initiate Acute Peritoneal Inflammation1
Jean Francois Cailhier,2* Marina Partolina,2'3i Srilatha Vuthoori,2'4+ Shengji Wu,2+
Kyung Ko,5+ Simon Watson,* John Savill,* Jeremy Hughes,2'6* and Richard A. Lang2+
The role played by resident macrophages (M</>) in the initiation of peritoneal inflammation is currently unclear. We have used a
conditional Mr/j ablation strategy to determine the role of resident peritoneal M(fi in the regulation of neutrophil (PMN) recruit¬
ment in experimental peritonitis. We developed a novel conditional M</> ablation transgenic mouse (designated CDllbDTR) based
upon CDllb promoter-mediated expression of the human diphtheria toxin (DT) receptor. The murine DT receptor binds DT
poorly such that expression of the human receptor confers toxin sensitivity. Intraperitoneal injection of minute (nanogram) doses
of DT results in rapid and marked ablation of F4/80-positive M</» populations in the peritoneum as well as the kidney, and ovary.
In experimental peritonitis, resident M</> ablation resulted in a dramatic attenuation of PMN infiltration that was rescued by the
adoptive transfer of resident nontransgenic M</>. Attenuation of PMN infiltration was associated with diminished CXC chemokine
production at 1 h. These studies indicate a key role for resident peritoneal M<•/> in sensing perturbation to the peritoneal micro-
environment and regulating PMN infiltration. The Journal of Immunology, 2005, 174: 2336-2342.
Macrophages (M</>)7 are dispersed throughout the tissuesand have an important role in innate immunity (1),apoptotic cell clearance (2), development (3), and
morphogenesis (4, 5). Resident tissue Mr/' and dendritic cells are
regarded as sentinels of the innate immune system. Various strat¬
egies, such as M</> depletion induced by administration of liposo¬
mal clodronate (6), have been used to examine M</> function in
vivo. However, previous work using this method to study the role
of resident peritoneal Mc/> in experimental peritonitis has produced
conflicting results because they have suggested a key role (7), an
inhibitory role (8), or no role at all (8). In the current study, we
have used a conditional ablation strategy to clarify the role of
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resident Mc/j in the sensing of peritoneal injury and the regulation
of neutrophil (PMN) infiltration.
A conditional M</> ablation strategy has advantages over the
available naturally occurring and induced M(/'-deficient mutant
mice because the timing of M(/> elimination can be chosen. Despite
their limitations, nonconditional M</)-deficient mice have proven
valuable for analysis. For example, the Csjmop/Csfmop (osteo¬
petrosis) mouse is a naturally occurring mutant of the CSF-1 gene
and exhibits a M </> deficiency at a level that permits viability in
homozygotes (9). These mice have provided insight into M</> func¬
tion during development (3). In addition, mice targeted at the PU.l
locus exhibit multiple defects in development of hemopoietic lin¬
eages including a complete absence of tissue M</» (10, 11). Al¬
though PU.l mutation results in perinatal lethality, these mice
have been used to demonstrate that mesenchymal cells are able to
clear apoptotic cells during embryonic regression of interdigital
tissues (12).
Previous strategies used to eliminate specific cell types in a liv¬
ing organism include the generation of transgenic lines that ex¬
press diphtheria toxin A-chain (13, 14) or the ricin polypeptide
(15). However, even low levels of unanticipated transgene expres¬
sion can give unpredictable consequences (13). The alternative ab¬
lation strategy of killing thymidine kinase-expressing cells with
gancyclovir (16, 17) only permits the elimination of proliferating
cells. More recently, conditional M(/> ablation has been achieved
using transgenic expression of Fas under the control of the c-fins
promoter coupled with drug-inducible Fas dimerization to induce
cell death (18). Identification of the human receptor for diphtheria
toxin (DT) (also known as heparin-binding epidermal growth fac¬
tor (hbEGF) (19)) created an opportunity for a unique ablation
strategy. The murine form of hbEGF binds DT poorly, but mouse
cells can be rendered sensitive through transgenic expression of
human hbEGF. In transgenic mice expressing human hbEGF lin¬
eage specifically, cell ablation results following toxin injection. In
addition, DT is a protein synthesis inhibitor and kills both mitotic
and terminally differentiated cells. This strategy has recently been
used to generate transgenic mice in which hepatocytes (20) or
dendritic cells (21) may be conditionally ablated. In the current
0022-1767/05/S02.00
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report, we describe how we have used this strategy to generate a
conditional M</> ablation mouse to assess the role of resident peri¬
toneal Mr/) in the initiation of acute inflammation in experimental
sterile peritonitis induced by Brewer's thioglycolate (BTG). We
demonstrate that resident peritoneal M$ are essential for PMN
recruitment through Mr/>-dependent CXC chemokine production.
Materials and Methods
Transgenic construct
The CDllb promoter from coordinates —1704 to + 83 (22) was used to
drive expression of the human hbEGF cDNA (19). Splicing and polyade-
nylation signals were provided by a region of the human growth hormone
gene that had previously worked effectively with the CD1 lb promoter (22).
The fusion protein between hbEGF and GFP was generated by continuing
the open reading frame from the final residue of hbEGF with the first
residue of GFP.
Transgenic mice
The CDllb-DTR construct was used to generate transgenic mice on the
FVB/N background (23) using conventional techniques; transgene expres¬
sion was detected using an RT-PCR assay. The primer sequences used
were 5'-AAGATCCGCCACAACATCG for the forward primer and 5'-
GCAGCTCTAGGTTGGATTTCTG for the reverse primer. Because the
reverse primer sequence was taken from the base pairs flanking intron III
of hGFI, no PCR product could be amplified from genomic DNA.
Flow cytometry analysis
Bone marrow-derived M</> were prepared as previously described (4). Res¬
ident peritoneal cells were isolated by peritoneal lavage. Elicited peritoneal
M</> were lavaged from the peritoneal cavity 4 days after i.p. injection of 1
ml of 3% BTG (Difco). For flow cytometric analysis, —2 X 106 cells were
incubated for 10 min in FACS buffer containing rat anti-mouse FcR
blocker CD16/CD32 (Fc-yRIII/II). FITC- or PE-conjugated Abs at concen¬
trations suggested by the supplier were then added, and the mixture was
incubated at 4°C for 45-60 min. The cells were then washed and fixed in
2% formaldehyde before undergoing flow cytometry analysis. A fixed vol¬
ume of whole blood was obtained by tail vein bleed into 3.9% sodium
citrate. Blood was aliquoted into flow cytometry tubes, blocked, and
stained as for peritoneal lavage cells. One milliliter of FACSLysis buffer
(BD Biosciences) was then added to lyse erythrocytes, and samples were
spun and processed by flow cytometry. The Abs used were anti-CDUb
FITC conjugate (eBiosciences), anti-GRl PE (eBiosciences), anti-B220
(mouse CD45R) FITC and PE conjugates (BD Pharmingen), mouse anti-
CD3 PE conjugates (BD Pharmingen), and F4/80 allophycocyanin, FITC,
and PE conjugates (Caltag and Serotec). Annexin Vl rlt conjugate (US
Biological) and propidium iodide (PI; Sigma-Aldrich) were used to deter¬
mine the levels of apoptosis and necrosis. A known amount of fluorescent
Flow-Check fluorospheres (Beckman Coulter) was added to peritoneal la¬
vage samples before analysis, and the ratio of cells to beads was used to
calculate the absolute number of any cell type in peritoneal lavage fluid.
Analyses were performed using a FACScan or FACSCalibur instrument.
Immunolabeling of tissues
Organs were fixed in 4% formaldehyde in PBS at 4°C overnight, and par¬
affin-embedded tissue sections were prepared according to conventional
methods. Rehydrated sections were immersed in acetone for 10 min and
rinsed in PBS. and a limited trypsin (Sigma-Aldrich) digestion was per¬
formed for 20 min. Sections were then washed in PBS, and endogenous
peroxidase activity was quenched with a 30-min incubation in 0.3% H202
in methanol. Sections were then incubated with F4/80 mAb (Caltag Lab¬
oratories) at a 1/100 dilution. Further steps were performed according to
the recommendations of the manufacturer of the VECTASTAIN Elite ABC
(avidin/biotin complex) system used in the labeling (Vector Laboratories).
Sections were then washed in water, lightly counterstained with Mayer's
hematoxylin, dehydrated, and mounted.
Experimental peritonitis
Peritonitis was induced by i.p. injection of 1 ml of 3% BTG. Resident M</>
ablation was induced in transgenic mice by i.p. injection of DT (25 ng/g
body weight) 24 h before the administration of BTG, with DT-treated
FVB/N wild-type (WT) mice serving as control. Mice underwent perito¬
neal lavage at various time points following BTG injection. In some ex¬
periments, peritonitis was induced by the injection of 0.2 mg of zymosan
(Sigma-Aldrich) with peritoneal lavage being performed at 8 h. All exper¬
iments were performed in accordance with institutional and U.K. Home
Office guidelines.
Adoptive transfer ofperitoneal cells
Peritoneal lavage samples from groups of FVB/N WT mice were pooled,
spun, and either resuspended in I ml of sterile PBS (M(/>-rich peritoneal
cells) or plated on tissue culture plastic for 2 h to deplete M<|> by adhesion
(Mc/j-depleted peritoneal cells). A total of 97 ± 2.8% of M</> was removed
from the cell suspension. Four hours before induction of BTG peritonitis,
M</>-rich or M</>-dcpleted peritoneal cells suspended in 1 ml of PBS were
injected i.p. Experimental groups consisted of 1) CDllb-DTR transgenic
mice depleted of resident peritoneal Mi/> by prior administration of DT, 2)
DT-treated FVB/N WT mice, 3) Mcfi-depletcd mice reconstituted with M</>-
rich peritoneal cells, and 4) M</>-depleted mice reconstituted with M</>-
depleted peritoneal cells. Groups 1 and 2 were injected with 1 ml of PBS
4 h before BTG administration as an injection control for the adoptive cell
transfer procedure. Animals were sacrificed 8 h following the initiation of
peritonitis.
Chemokine studies
Mice underwent peritoneal lavage at 1 and 3 h following the i.p. injection
of BTG. Lavage fluid was centrifuged, aliquoted, and stored at -80°C until
analyzed by ELISA for MIP-2 and keratinocyte-derived chemokine (KC)
(R&D Systems). Chemokine production by peritoneal cell populations that
had been depleted of either M</> or mast cells (MC) was also determined in
vitro. Peritoneal cells were incubated with PE-conjugated anti-F4/80 Ab or
an Ab to the MC marker c-kit (CD117) to stain M</> or MC, respectively.
Peritoneal cells were then incubated with anti-PE-conjugated MACS mag¬
netic beads, and M</> or MC were removed by passing the cells over a
magnetic MACS column (Miltenyi Biotec). As a control, total peritoneal
cells were incubated with an isotype control Ab followed by magnetic
beads and subsequently passed over the magnetic MACS column. This
method resulted in >97% depletion of M</> or MC. Control peritoneal cells
and M(/>- or MC-depleted peritoneal cells were then plated in 48-well plates
(5 X 105 cells per well) and exposed to 1% BTG for 3 h. Peritoneal
cell-conditioned supematants were harvested, spun, and stored at -80°C
until analyzed by specific ELISA for MIP-2 and KC (R&D Systems).
Statistical analysis
The Student t test with a tailed distribution or ANOVA was used to analyze
data. A value of p < 0.05 was deemed statistically significant. Data are
presented as mean ± SE.
Results
Generation of transgenic mice
Conditional ablation transgenic mice were generated using an es¬
tablished strategy (21) and a construct (designated CDllb-DTR)
that used the CDllb promoter (22) to provide Mr/) expression
specificity. CDllb-DTR expresses the DT receptor (alternatively
named hbEGF (19)) (Fig. 1A) as a GFP fusion protein. The
hbEGF-GFP construct conferred sensitivity to DT in transiently
transfected murine cells indicating that it was functional (data not
shown).
Six transgenic lines were produced with the CDllb-DTR con¬
struct. Although the fluorescence signal from the hbEGF-GFP fu¬
sion protein was insufficient to permit detection of transgene ex¬
pression by FACS analysis, a RT-PCR assay indicated that four
lines exhibited detectable transgene expression in peritoneal cells
and spleen with line 34 exhibiting high expression (Fig. 1, B and
Q. WT and CD1 lb-DTR-34 bone marrow-derived M</> expressed
the M</>-specific gene F4/80 as expected (Fig. ID), indicating that
expression of the DT receptor was unlikely to have disrupted nor¬
mal Me/) differentiation. Transgene expression was also observed
in day 4 and 8 CD1 lb-DTR-34 bone marrow-derived M</> (Fig.
1E). Because line CD1 lb-DTR line 34 showed the highest levels
of transgene expression, further analysis was restricted to this line.
Transgenic M<f> are killed by DT in vitro and in vivo
Treatment of BTG-elicited peritoneal Mr/) from CD 1 lb-DTR-34
mice with concentrations of DT between 1 ng/ml to 1 mg/ml over
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FIGURE 1. Structure and expression of the CD 1 lb-DTR transgene. A,
Schematic of the CD11 b-DTR construct. The transcription start is indicated
by the right-facing arrow and exons by shaded boxes. The DTR-eGFP
fusion cDNA is inserted between the human CDllb promoter and the
human growth hormone (hGH) sequences that provides splicing and poly-
adenylation signals. Oligonucleotides eGFP and hGH used for RT-PCR
transcript detection are indicated by small arrows. B-E, RT-PCR expres¬
sion analysis performed on BTG-elicited peritoneal cells (B), spleen cells
(C), and bone-marrow derived M<f> (D and E). Transgene mRNA amplifi¬
cation pruducls were not evident in samples from WT mice or when re¬
verse transcriptase was omitted but was detected in line 34 peritoneal and
spleen cells (B and C). Line 34 bone-marrow derived M<j> also exhibited
normal expression of the Mef> marker F4/80 (D) and persistent transgene
expression (E).
a period of 48 h induced cell death at concentrations as low as 25
ng/ml. In contrast, Mcf> from WT mice or other transgenic lines
were resistant (data not shown). We then asked whether i.p. injec¬
tion ofDT ablated resident peritoneal Mtj> in vivo. DT was injected
at 25 ng/g mouse weight, and FACS analysis of peritoneal cells
was performed 24 h later. Normal numbers of resident peritoneal
M<|) (F4/80 positive, CDllb positive, and Ly6C/G negative) were
evident in WT mice receiving DT (Fig. 2A) as well as CD1 lb-
DTR-34 transgenic mice injected with either PBS (Fig. IB) or the
inactive form of the toxin DTmut (Fig. 2Q. However, CDllb-
DTR-34 transgenic mice showed an almost complete absence of
F4/80-positive peritoneal M<f> after a single dose of DT (Fig. 2D).
Administration of DT doses of 6.25 and 12.5 ng/g mouse weight
resulted in M<j> ablation of —72 and 82%, respectively, whereas
lower doses resulted in <50% ablation. We therefore chose to use
a dose of 25 ng/g body weight for the in vivo studies.
Time course of elimination in vivo
We then examined the kinetics of Mcj> ablation in the peritoneal
cavity following administration of a single dose of DT (25 ng/g
body weight). The appearance of apoptotic and necrotic cells was
monitored using Annexin VITK and PI staining, respectively. Peri¬
toneal lavages and flow cytometric analyses were conducted on a
series of mice 4, 6, 8, and 12 h after DT injection (Fig. 3). After
6 h, 65% of the peritoneal population was annexin V positive,
indicating a dramatic increase in early-stage apoptotic cells (Fig.
3A). The maximal numbers of Pl-positive cells occurred —2 h later
at 8 h after DT injection and represented —20% of the total peri¬
toneal cells (Fig. 36). The number of F4/80-positive cells was
nearly zero at 12 h (Fig. 3Q, and this corresponded to very low
levels of Pl-positive and annexin V-positive cells (A and 6). These
data suggest that DT induces sensitive cells to undergo apoptosis
and that some of these dying cells then undergo secondary necro¬
sis. All F4/80-positive cells were cleared by 12 h. Restoration of
the peritoneal M<j> population occurs by day 4 following a single
i.p. dose of DT (3.94 X 105 ± 1.7 X 105M<j>vs5.8 X 10s ± 1.3 X
10s; day 4 following DT treatment vs day 1 following PBS treat¬
ment; n = 5 per group, p > 0.05).
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FIGURE 2. Flow cytometric analysis of peritoneal cell M<j> killing by
DT. A-D, Cells were removed from the peritoneal cavity by peritoneal
lavage and labeled with PE-conjugated F4/80 Ab, and flow cytometric
analysis was performed. A, WT mice injected with DT (25 ng/g body
weight) show a normal percentage of peritoneal Mcf>. B and C, CDllb-
DTR-34 mice receiving either PBS (B) or DTmut (C) have normal F4/80
profiles. D, In contrast, CDllb-DTR-34 mice treated with active DT show
complete absence of F4/80-positive cells. £, In WT mice, injection of DT
at 25 ng/g mouse weight does not affect either the small population of
CD3+ T cells (upper-left quadrant) or the larger population of F4/80+ Mc|)
{lower-right quadrant) in the peritoneal cavity. F, CDllb-DTR-34 mice
receiving DT exhibit elimination of the F4/80+ population, whereas the
CD3+ cells remain unaffected.
Specificity of M(f> elimination in vivo
To test the specificity of M<j> elimination, we examined CD3+ T
cells in spleen and peritoneal cavity and B220+ B cells in the
spleen. In this case, we injected two doses of DT at 25 ng/g at 48-h
intervals and assessed ablation 24 h later. The F4/80-positive peri¬
toneal population was unaffected in WT mice (Fig. 2E, lower-right
quadrant), but was eliminated in CD1 lb-DTR-34 animals (G, low¬
er-right quadrant). Despite complete peritoneal M<j> elimination in
CDllb-DTR-34 animals, the peritoneal CD3+ T cells were
present in both WT and transgenic animals injected with DT (Fig.
2, E and F, upper-left quadrants). The relative increase in CD3-
positive and double-negative cells in the DT-treated CDllb-
DTR-34 animals is due to the plotting of equal numbers of detec¬
tion events in the FACS analyses. B220+ and CD3+ populations
in spleen were unaffected in either WT or CDllb-DTR-34 mice
receiving two doses of DT (data not shown).
Because CD1 lb is expressed on both granulocytes and Mcj>, we
asked whether both of these cell types were sensitive to DT.
CDllb-DTR-34 mice were injected with BTG. DT (25 ng/g body
weight) or PBS was injected 8 h after initiation of peritonitis with
peritoneal lavage being performed 12 h later. Despite 90% Mcj>
ablation (0.5 X 106 ± 0.15 X 106 vs 4.8 X 106 ± 0.23 X 106; DT
injection vs PBS; p < 0.005), there was no difference in PMN
number (2.3 X 106 ± 0.22 X 10s vs 1.6 X 106 ± 0.39 X 106; DT
injection vs PBS; p > 0.05). In addition, flow cytometric analysis
of whole blood performed 24 h following DT administration in¬
dicated that circulating PMN numbers were unaffected by DT ad¬
ministration (1.02 X 106 ± 0.18 X 106 PMNs/ml whole blood vs










































FIGURE 3. Time course of peritoneal M<f depletion. Cells were re¬
moved from the peritoneal cavity by peritoneal lavage. Mice were either
injected with a single dose of DT (gray lines) or DT""" (black lines) at 25
ng/g mouse weight i.p., and the resident peritoneal population was assessed
for the appearance of annexin V-positive cells (A), for labeling of cells with
PI (B), and for presence of the M</> marker F4/80 (C). Flow cytometric
analysis identified the labeled proportion of total cells over a 12-h time
course following DT injection.
0.97 X 106 ± 0.22 X 106; DT injection vs PBS; p > 0.05). In
contrast. DT administration induced significant depletion of circu¬
lating monocytes (0.117 X 10® ± 0.059 X 106 monocytes/ml
whole blood vs 0.52 X
p < 0.05).
10° ± 0.073 X 10®; DT injection vs PBS;
Differential deletion of M<1> populations
We also asked whether DT injection could eliminate M</> in distant
organs. Two doses of DT (25 ng/g) were administered IP at 48-h
intervals, and the presence of F4/80-positive Mr/) in kidney, liver,
and lung was analyzed 24 h later and in the ovary 16 h later (Fig.
4). The ovary was examined at 16 h, because there was evidence
of some patchy ovarian necrosis present at 20 h. WT mice injected
with DT and CD1 lb-DTR-34 homozygote mice injected with DT-
mut
were unaffected (Fig. 4, top two rows). Both kidney and ovary
of CD 1 lb-DTR-34 homozygote mice injected with DT exhibited
an absence of F4/80+ cells. In the kidney, mesangial and intersti¬
tial Mr/) were ablated in the absence of overt renal injury. How¬
ever, hepatic sinusoidal Mr/) and alveolar Mr/> were unaffected,
indicating that not all populations of tissue Mr/) were susceptible.
However, the rapid elimination of Mr/) populations in the perito¬
neal cavity and kidney while leaving other cell populations intact
establishes the basic validity of this approach to conditional cell
ablation.
Resident A7r/> ablation reduces PMN influx and CXC chemokine
responses during experimental peritonitis
We used the conditional ablation strategy to investigate the role of
resident tissue peritoneal Mr/> in sensing perturbation of the mi-
croenvironment and subsequent initiation of acute peritoneal in¬
flammation and PMN recruitment in experimental peritonitis. Res¬
ident Mr/) ablation markedly attenuated PMN infiltration following
the administration of 3% BTG (Fig. 54). We also performed Mr/)
repletion studies with either Mt/>-rich or Mr/)-depleted peritoneal
cells derived from WT mice. Reconstitution of DT-treated CD1 lb-
DTR-34 homozygote mice with Mr/>-rich peritoneal cells 4 h be¬
fore BTG treatment resulted in complete restoration of peak PMN
infiltration at 8 h. In contrast, the administration of Mc/>-depIeted
peritoneal cells was ineffective (Fig. 5B). Previous work suggested
that the nature of the inflammatory stimulus may determine the
involvement of M</> in experimental peritonitis (8), and we there¬
fore performed M</> depletion studies in zymosan peritonitis. We
also found that depletion of resident peritoneal M</) resulted in a
significant reduction in PMN infiltration 8 h following the induc¬
tion of zymosan peritonitis (2.6 X 10® ± 8.8 X I05 PMNs vs
5.4 X 10® ± 3.7 X 105; DTR plus DT vs FVB/N WT controls plus
DT; n = 6 per group; p < 0.05).
In this model, we found peak levels of the PMN CXC chemo-
kines MIP-2 and KC at the 1-h time point. Resident peritoneal M</)
FIGURE 4. Effect of DT on tissue M</> populations.
Micrographs showing the effect of DT treatment of WT
mice (top row), dt"1"1 treatment of CDllb-DTR mice
(middle row), and DT treatment of CDllb-DTR mice
(bottom row) upon the presence of F4/80-positive M</> in
liver (left column), lung (center left column), kidney
(center right column), and ovary (right column). Ani¬
mals received two doses of DT or DTmul delivered at
48-h intervals. Liver, lung, and kidney were assessed
24 h after the second DT injection, whereas ovary was
assessed at 16 h.
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FIGURE 5. Resident M<j> ablation attenuates peritoneal inflammation.
WT and CDllb-DTR mice were injected i.p. with DT (25 ng/g body
weight). One milliliter of 3% BTG was injected i.p. 24 h later with mice
undergoing peritoneal lavage at various time points. A, Peritoneal cells
were stained for the PMN marker GR1. Resident peritoneal M</< ablation
induced a marked blunting of PMN infiltration of the peritoneal cavity. B,
WT and three groups of CD1 lb-DTR mice were injected with DT (25 ng/g
body weight). Four hours before i.p. injection of 3% BTG, two groups of
M<i>-depleted CDllb-DTR mice were reconstituted with either M<f>rich
peritoneal cells (M(j>R) or M<j>-depleted peritoneal cells (M<j>D). Adminis¬
tration of PBS served as control to the remaining groups. Mice underwent
peritoneal lavage 8 h following administration of 3% BTG, and peritoneal
cells were stained for GR1. *, p < 0.05.
ablation before the initiation of BTG peritonitis markedly reduced
the elevation in MIP-2 levels (148.5 ± 34.8 vs 1762.1 ± 153.5
pg/ml; M<j>-depleted mice vs nondepleted mice: p < 0.00001).
There was a slight, albeit statistically significant, difference in the
much lower levels of MIP-2 between DT-treated and control mice
at 3 h (204 ± 54 vs 74 ± 8 pg/ml; M<j>-depleted mice vs nonde¬
pleted mice; p < 0.05). This suggests that the production of MIP-2
in vivo is predominantly M$ dependent. In addition, a 50% re¬
duction in the level of KC was evident in M<j>-depleted mice at the
1-h time point (1408.2 ± 322.5 vs 2467.5 ± 264.9 pg/ml; M$-
depleted mice vs nondepleted mice; p < 0.05). Interestingly, the
levels of KC levels at 3 h are higher in M<(>-depleted mice com¬
pared with control mice (1477 ± 400 vs 74 ± 8 pg/ml; M(j>-
depleted mice vs nondepleted mice; p < 0.01), thereby suggesting
a source of KC other than resident M<j>.
CXC chemokine responses are M<f> dependent in vitro
Previous studies of peritoneal and dermal inflammation have im¬
plicated the MC as playing an important role in the initiation of
PMN infiltration (8, 24). We therefore performed in vitro studies to
determine the production of PMN chemokines by BTG-stimulated
peritoneal cell populations that had been depleted of M<j> or MC.
Control peritoneal cells produced significant levels of MIP-2 and
KC, which was not affected by MC depletion (Fig. 6). However,
chemokine levels were dramatically reduced following the deple¬
tion of M<j>, thereby indicating that chemokine production was
completely M<j> dependent with no involvement of MC (Fig. 6).
FIGURE 6. CXC chemokine production in response to BTG stimula¬
tion is M<f> dependent and MC independent in vitro. Peritoneal cells were
depleted of either M<f) or MC by incubation with PE-conjugated anti-F4/80
or anti-c-faf (CD 117) followed by incubation with anti-PE-conjugated
magnetic beads and passage over a magnetic column (>97% depletion of
Mtj> or MC). Incubation of total peritoneal cells with an isotype control Ab
followed by magnetic beads and passage over the magnetic column served
as control. Cells were then plated in 48-well plates (5 X 105 cells per well)
and exposed to 1% BTG for 3 h. Peritoneal cell-conditioned supernatants
were harvested, spun, and analyzed by specific ELISA for MIP-2 and KC.
*, p < 0.005.
Discussion
Previous analyses (20, 21) and the experiments we describe here
show that expression of human hbEGF (19) in mouse cells can
confer sensitivity to DT in vivo, and that, as a consequence, in¬
jection of DT will kill cells that express hbEGF. Our data indicate
that M(f> populations in the peritoneal cavity and kidney can be
rapidly killed or eliminated while leaving other cell populations
intact, and this establishes the basic validity of this approach to
conditional cell ablation. We noted that hepatic and alveolar M<j>
populations were unaffected, and it may be the case that a higher
dose of DT may have ablated these cells. However, we found that
mice could become unwell with doses of DT >25 ng/g body
weight, and we therefore did not use doses >25 ng/g body weight
in this study. It is pertinent that, despite PMN expression of
CD1 lb, the administration of DT did not induce the death of re¬
cruited or circulating PMNs, indicating that PMNs are insensitive
to DT, potentially as a result of their lower level of protein
synthesis.
We used the conditional ablation strategy to investigate the role
of resident peritoneal M<j> in the initiation of acute peritoneal in¬
flammation following the administration of BTG. Previous work
has indicated that leukotrienes derived from resident peritoneal
M(|> are involved in the development of early vascular permeability
in sterile peritonitis (25). Although early work in rat models of
peritonitis implicated the resident peritoneal M<j> in the orchestra¬
tion of PMN recruitment (26-28), more recent studies have pro¬
duced conflicting results (7, 8). Indeed, studies by Ajuebor et al.
(8) suggest that residentM$ depletion inhibits PMN influx in LPS-
induced inflammation, has no effect in BTG peritonitis, and aug¬
ments PMN influx in zymosan peritonitis. In the latter model, it is
proposed that Mr/>-derived IL-10 inhibits PMN recruitment. Con¬
versely, work by Knudsen et al. (7) using clodronate-induced de¬
pletion of peritoneal M<j> in a rat model of sterile peritonitis dem¬
onstrated that PMN infiltration was M(j> dependent.
In this study, administration of DT resulted in a dramatic 98%
M<j> ablation that markedly blunted PMN infiltration, thereby in¬
dicating a key role for the resident M<j> in the orchestration of acute
peritoneal inflammation in this experimental model. It is important
to note that the reduced PMN infiltration in DT-treated mice was
not attributable to a systemic neutropenia, because PMNs were not
sensitive to DT and the number of circulating PMNs in DT-treated
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mice was comparable with that of PBS-treated mice at 24 h. The
importance of the resident M<j> was reinforced by experiments in¬
volving the adoptive transfer of nontransgenic peritoneal McJ) fol¬
lowing DT-mediated Mt/j ablation and before the initiation of peri¬
tonitis. The presence or absence of M<t in the transferred
peritoneal cell population directly correlated with the restoration of
the PMN influx, thereby suggesting that the M<f> exerts a critical
role in this process. In addition, we found that depletion of resident
M(f> also significantly reduced PMN infiltration in zymosan peri¬
tonitis, thereby suggesting that the sensing function of the resident
M</) may be stimulus independent.
The magnitude of the M<j> depletion may explain the apparent
discrepancy between these results and the study by Ajuebor et al.
(8). Administration of a single dose of DT induced 98% M$ ab¬
lation, whereas three doses of liposomal clodronate resulted in
>85% M<j> depletion in the study by Ajuebor et al. (8). M<j> are a
potent source of chemokines and cytokines, and it may be the case
that, in certain circumstances, a relatively small population of re¬
sidual M</> may exert significant biological effects. Although ad¬
ministration of liposomal clodronate may exert marked biological
effects despite depletion of only ~80% of M</> (29), it may be
necessary to deplete almost all peritoneal M<j> to delineate their
roles as sentinel cells.
Although peritoneal M<j> may produce myriad mediators capable
of recruiting PMNs (30, 31), we examined the effect of M<j> abla¬
tion upon the level of CXC chemokines in this model. Our data
suggest that the initiation of PMN infiltration is mediated by res¬
ident peritoneal M^-dependent production of chemokines previ¬
ously documented to play a role in orchestrating PMN recruitment
in BTG peritonitis (32, 33) and in other inflammatory situations
(34-36). MC are also a rich source of proinflammatory and vaso¬
active mediators and have been documented to play an important
role in PMN recruitment during inflammation of the peritoneum
(8) as well as other sites such as the skin (24).
We found that resident M<j> ablation markedly reduced the peak
level of M1P-2 and significantly blunted the level of KC at 1 h.
However, partial inhibition (50%) of KC production at 1 h and the
persistent elevation of KC at 3 h in M<j>-depleted mice suggest that
KC may be produced by other cells within the peritoneum. The
persistent elevation of KC also suggests that M<j> may play a role
in the negative regulation of KC production by non-Mcj> cells. In
this context, it is pertinent that our in vitro data indicate that both
KC and MIP-2 production by peritoneal cells obtained by perito¬
neal lavage is almost entirely dependent upon M<j>, because peri¬
toneal cells depleted of M(j> produced minimal levels of chemo¬
kines. These findings suggest that peritoneal cells retrievable by
peritoneal lavage are not the source of KC detected in our in vivo
study. This interpretation of the data is consistent with recent work
in a wound model (37) demonstrating MIP-2 expression by in¬
flammatory cells and KC expression by resident tissue cells such
as endothelial cells and fibroblasts. Peritoneal mesothelial cells
undoubtedly participate in peritoneal inflammation and can pro¬
duce chemokines and cytokines (38), and it may be the case that
mesothelial cells contribute to the KC production evident in this
study. Despite this, however, we found that PMN infiltration is still
markedly blunted despite the persistent presence of KC at 3 h.
We also examined the potential interaction between M<j> and
MC by performing in vitro studies of peritoneal cells that had been
depleted of M<j> or MC before stimulation with BTG. Interestingly,
depletion of MC had no significant effect upon the production of
KC and MIP-2 following BTG stimulation, suggesting that che-
mokine production in this model was M(j> dependent and MC
independent.
In conclusion, this work has used a novel model of conditional
Mcj> ablation to dissect the role of resident peritoneal M<j> in the
initiation of acute peritoneal inflammation. Our data indicate a key
role for the resident M<j> in sensing peritoneal irritation and or¬
chestrating PMN infiltration in BTG and zymosan peritonitis. This
proinflammatory function is predominantly mediated by produc¬
tion of the potent PMN CXC chemokine MIP-2 and, to a lesser
extent, KC. Although previous work has implicated the involve¬
ment of other cells such as MC, our study suggests that resident
M$ are critically important producers of PMN chemokines and act
to orchestrate PMN recruitment in murine BTG peritonitis. We
also anticipate that CD1 lb-DTR transgenic mice will be valuable
for studying other M(j> functions in vivo in a variety of different
biological contexts. The option of being able to choose the time
and, with local toxin injection, perhaps the locality of ablation
offers a number of advantages over other cell ablation systems.
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Resident Pleural Macrophages Are Key Orchestrators
of Neutrophil Recruitment in Pleural Inflammation
Jean Francois Cailhier*, Deborah A. Sawatzky*, Tiina Kipari, Kris Houlberg, Dave Walbaum, Simon Watson,
Richard A. Lang, Spike Clay, David Kluth, John Savill, and Jeremy Hughes
Phagocyte Laboratory, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom; and
Division of Developmental Biology, Department of Ophthalmology, Children's Hospital Research Foundation, Cincinnati, Ohio
Rationale: The role played by resident pleural macrophages in the
initiation of pleural inflammation is currently unclear.
Objective: To evaluate the role of resident pleural macrophages in
the initiation of inflammation.
Methods: We have used a conditional macrophage ablation strategy
to determine the role of resident pleural macrophages in the regula¬
tion of neutrophil recruitment in a murine model of experimental
pleurisy induced by the administration of carrageenan and formalin-
fixed Staphylococcus aureus.
Measurements and Main Results: Conditional macrophage ablation
mice express the human diphtheria toxin receptor under the control
of the CD1 lb promoter such that the administration of diphtheria
toxin induces ablation of nearly 97% of resident macrophages.
Ablation of resident pleural macrophages before the administration
of carrageenan or S. aureus dramatically reduced neutrophil influx
into the pleural cavity. In the carrageenan model, the reduction in
neutrophil infiltration was associated with marked early reduction
in the level of macrophage inflammatory protein 2 as well as re¬
duced levels of various cytokines, including tumor necrosis factor a,
interleukin 6, and interleukin 10. Adoptive transfer of nontransgenic
macrophages partially restored neutrophil infiltration.We also stim¬
ulated macrophage-depleted and nondepleted pleural cell popula¬
tions with carrageenan in vitro and determined the production of
chemokines and cytokines. Chemokine and cytokine production
was markedly reduced by macrophage depletion, reinforcing the
role of resident pleural macrophages in the generation of mediators
that initiate acute inflammation.
Conclusion: These studies indicate a critical role for resident pleural
macrophages in sensing perturbation to the local microenviron-
ment and orchestrating subsequent neutrophil infiltration.
Keywords: inflammation; macrophage; pleural diseases
The pleural membranes and associated cells are important be¬
cause they are metabolically active and act as a barrier to invad¬
ing pathogens by generating an innate and adaptive immunologic
response. The pleural cavity is lined with mesothelium and con¬
tains resident macrophages (M<j>), mast cells, and lymphocytes
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(1, 2). During pleural inflammation, it has been reported that
mesothelial cells are predominantly responsible for the secre¬
tion of C-X-C chemokines, such as interleukin 8 (IL-8), and
C-C chemokines, such as macrophage inflammatory protein la
(MlP-la) and macrophage chemoattractant protein 1 (MCP-1),
which act to recruit neutrophils (polymorphonuclear leukocytes
[PMNs]) and mononuclear cells (3-6). In addition, a recent study
demonstrated that activated pleural fibroblasts may also be a
source of C-X-C and C-C chemokine production (7).
Previous work suggested that the initiation of inflammation
is dependent on endogenous IL-6 secretion that subsequently
stimulates the additional production of tumor necrosis factor a
(TNF-a) and IL-1J3 from resident pleural cells (8). In contrast,
increased IL-ip levels have been reported to precede elevated
IL-6 levels (9), thereby suggesting that IL-ip might induce IL-6
production. There is no doubt that TNF-a and IL-ip are key
cytokines in the development of pleural inflammation because
they act to enhance IL-8 and MCP-1 production from mesothe¬
lial cells (3,5,10-12). In addition, studies using function-blocking
antibodies suggest that activated resident M<|> could be responsi¬
ble for this TNF-a and IL-ip secretion (10, 12).
Carrageenan-induced pleurisy is a well-established model of
acute inflammation (13) and is characterized by a rapid influx
of PMNs followed by mononuclear cell infiltration (14,15). This
model is often used to assess the antiinflammatory effects of
pharmaceutical agents (16-20) and to assess the in vivo impor¬
tance of established inflammatory mediators (21-23). Although
the neutrophil influx evident in this model is generally used
as an experimental readout of acute inflammation, there are
data indicating that neutrophils are involved in the release of
injurious enzymes and modulation of vascular permeability in
carrageenan-mediated pleural inflammation (24, 25).
To date, there has been little study of the role of the resident
pleural M(|> in the initiation of inflammation and orchestration
of PMN recruitment. Previous work demonstrated a reduced
eosinophil influx after administration of LPS to mice that had
been previously treated with diphosphonate-containing lipo¬
somes to deplete resident pleural M(J) (26). Although this suggests
that resident pleural M<)> may play a key role in the initiation
of pleural inflammatory responses, there are no definitive data
available for PMN infiltration and proinflammatory cytokine
production.
This study used transgenic mice expressing the human diph¬
theria toxin receptor (DTR) under the CD1 lb promoter (desig¬
nated CDllb-DTR mice) (27) to examine the role of resident
pleural Ni<J> in carrageenan-induced pleurisy. Administration of
diphtheria toxin (DT) to CDllb-DTR mice results in rapid
depletion of resident pleural M(|). Our data indicate that ablation
of resident pleural M<|) markedly blunted both PMN recruitment
and the levels of key chemokines and cytokines. In addition,
resident Mc|> ablation markedly reduced the acute PMN infiltra¬
tion that followed the instillation of fixed, killed Staphylococcus
aureus. This study demonstrates that resident pleural M<(> play
an essential role in the orchestration of pleural PMN recruitment
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in pleural inflammation induced by carrageenan and fixed, killed
S. aureus.
METHODS
Macrophage Ablation and Pleurisy Induction
Mice were housed in the University of Edinburgh animal facilities and
experiments were performed in accordance with institutional and U.K.
Home Office guidelines. CDllb-DTR transgenic mice were generated
as previously described and were on an FVB/N background (27). Resi¬
dent pleural Mp were ablated in homozygous CDllb-DTR mice by
intraperitoneal injection of DT (25 ng/g body weight) 24 h before the
administration of carrageenan. DT-treated FVB/N wild-type (WT) mice
served as control animals. Carrageenan-induced pleurisy was induced
as described previously (28). \-Carrageenan (0.1 ml of a 1% solution)
was injected into the pleural cavity. Animals were culled at various
time points after pleurisy developed. In addition, 3 X 106 formalin-
fixed, lluorescently labeled S. aureus (Sigma, Dorset, UK) were injected
into the pleural cavity of CDllb-DTR mice and FVB/N WT mice
24 h after administration of DT or phosphate-buffered saline (PBS).
Animals were culled 4 h later.
Cell Processing and Analysis
Pleural cavities were washed with 1 ml of 3.15% (weight/volume)
sodium citrate (Sigma, Dorset, UK) in saline. We performed flow cyto¬
metric analysis of pleural lavage and circulating blood as described
previously (27). The antibodies used were anti-CDllb fluorescein iso-
thiocyanate, anti-GRl phycoerythrin (PE) and anti-c-kit PE (all from
eBiosciences, London, UK), anti-B220 (mouse CD45R) PE and mouse
anti-CD3 PE (both from Pharmingen, San Diego, CA), and F4/80 allo-
phycocyanin (APC) and F4/80 PE (both from Caltag, Botolph Claydon,
UK). Cell number was determined as described previously (27).
Adoptive Transfer of Pleural Cell Populations
Pleural lavages from groups of naive FVB/N WT mice were incubated
with PE-conjugated anti-F4/80 antibody to stain Mp and then incubated
with anti-PE conjugated magnetic cell sorting (MACS) magnetic beads
(Miltenyi Biotech Ltd., UK). MP were removed by passing the cells
over a magnetic MACS column (27). As a control, pleural cells were
incubated with an isotypc control antibody and then processed as pre¬
viously stated. Thismethod removed 98.2 ± 0.7% of the M<|>. In addition,
resident pleural Mp were purilied by negative selection after incubation
of pleural cells with PE-conjugatcd anti-B220, anti-c-kit, and anti-CD3
antibodies followed by incubation with anti-PE-conjugated MACS
magnetic beads and passage through the magnetic MACS column;
isolated Mp were 90% pure. Purified Mp and the Mp-depleted and Mp
nondcpleted pleural cell populations were resuspended in 1 % carra-
gecnan and administered into the pleural cavity of each mouse. Groups
therefore consisted of (/) DT-trcated CDllb-DTR transgenic mice
depleted of resident pleural Mp, (2) DT-treated FVB/N WT mice, (3)
Mp-depleted mice reconstituted with a nondepleted Mp-rich pleural
cell population, (4) Mp-depleted mice reconstituted with a Mp-depletcd
pleural cell population, and (5) Mp-deplcted mice reconstituted with
a population of pleural Mp purified by negative selection. As a control,
the effect of cell transfer alone was assessed by reconstituting
Mp-depleted mice with either nondepleted Mp-rich pleural cells or
purilied Mp alone in the absence of any additional stimulus. Animals
were killed 6 h after induction of pleurisy.
Chemokine Studies
Mice underwent pleural lavage at 1, 3, 6, 24, and 72 h after administra¬
tion of carrageenan. Lavage fluid was centrifuged and stored at —80°C
until analyzed by specific ELISA for MIP-2, keratinocyte-derived
chemokine (KC), and TNF-a (R&D Systems, Abingdon, UK). Cytome¬
tric bead array (BD Biosciences, Oxford, UK) was also used to deter¬
mine the concentration of IL-6, IL-10, IL-12p70, IFN-y, and MCP-1,
with samples being processed as described previously (29). Chemokinc
and cytokine production by intact pleural cell populations or Mp-de-
pleted pleural cell populations stimulated with carrageenan in vitro was
also determined: Mp depletion was achieved using the MACS magnetic
column and resulted in more than 98% Mp depletion. Control pleural
cells and Mp-depleted pleural cells were plated in 48-well plates and
exposed to 0.25% carrageenan for 6 h. In control experiments, cell
preparations were exposed to medium alone. Pleural cell-conditioned
supernatants were analyzed as above. No bioassays were undertaken.
Statistical Analysis
One-way analysis of variance with a Bonferroni multiple comparison
post hoc test, with a 95% confidence interval, or a Student's t lest was
used as appropriate. Statistical analysis including correlation analysis
was performed using GraphPad Prism software (San Diego, CA). The
significance level was set at p < 0.05. Data are presented as mean ± SEM.
RESULTS
Transgenic Pleural Resident Mp Are Ablated by DT In Vivo
There was no difference in the number of pleural Mp, B cells,
T cells, or mast cells between CDllb-DTR and FVB/N control
mice (data not shown). Flow cytometric analysis of pleural cells
was performed 24 h after the injection of DT (25 ng/g mouse
body weight). CDllb-DTR transgenic mice exhibited almost
complete ablation (96.1% ± 0.8) of F4/80-positive pleural Mp
after a single dose of DT (Figure 1). In addition, flow cytometric
analysis of whole blood performed 24 h after DT administration
indicated a significant 88% reduction in circulating monocyte
numbers (1.17 X 105 ± 5.9 X 104 monocytes/ml whole blood vs.
5.23 X 10s ± 7.3 X 104, DT injection vs. control; p < 0.05).
Circulating monocyte and pleural macrophage numbers re¬
mained markedly reduced for 48 h after the administration of
DT with recovery of monocyte/macrophage numbers evident at
72 h (data not shown). However, no reduction in the number
of circulating PMNs was evident 24 h after DT administration
(10.1 x 105 ± 1.9 X 105 PMNs/ml whole blood vs. 4.7 X 10s ±
0.8 X 105, DT injection vs. control; p < 0.05). In addition, no
difference in circulating PMN number was evident 6, 48, or 72 h
after the administration of DT, indicating an absence of any
initial neutropenia or delayed effects (6 h: 7.9 X 105 ± 1.2 X 105
PMNs/ml whole blood vs. 5.0 X 10s ± 1.4 X 105, DT injection vs.
control; p > 0.05; 48 h: 4.0 x 105 ± 0.6 X 105 PMNs/ml whole
blood vs. 4.9 X 105 ± 0.1 X 10s, DT injection vs. control; p >
0.05; 72 h: 2.9 X 105 ± 1.4 X 105 PMNs/ml whole blood vs. 4.4 X
10s ± 0.3 X 105, DT injection vs. control; p > 0.05). We did,
however, note a significant reduction in the number of B cells
and mast cells within the pleural cavity 24 h after the administra¬
tion of DT although T-cell numbers were unaffected (B cells:
8.1 X 104 ± 5.7 X 104 vs. 32.9 X 104 ± 8.8 X 104, DT vs. control;
p < 0.05; mast cells: 6.1 X 102 ± 0.1 X 102 vs. 67.8 X 102 ±
18.2 x 102, DT vs. control; p < 0.05). Interestingly, the depletion
of pleural Mp is almost complete at 6 h at which time no signifi¬
cant difference in the number of B lymphocytes or mast cells
was evident. The loss of B cells and mast cells may be a conse¬
quence of the secondary necrosis of apoptotic macrophages that
may occur in the absence of a population of viable macrophages
to phagocytose the dying cells. Also, a subset of B lymphocytes
and mast cells may express CD1 lb and this may account for the
reduced numbers seen after the administration of DT (30-32).
Pleural Resident Mp Ablation Reduces PMN Influx in
Carrageenan-induced Pleurisy
We used the conditional Mp ablation strategy to investigate the
role of resident pleural Mp in initiating PMN recruitment after
the administration of carrageenan. PMN infiltration after the
administration of 1 % carrageenan was markedly attenuated at
all experimental time points after resident Mp ablation (Figure 2).
It is particularly noteworthy that the early time points of 6 and
24 h demonstrated a dramatic difference between groups. Although
PMN infiltration in CDllb-DTR mice did reach approximately






Figure 7. Administration of DT 24 h before performing pleural lavage
results in ablation of pleural F4/80-positive macrophages (M<J>). CD11 b-
DTR and FVB/N wild-type (WT) mice were treated with diphtheria toxin
(DT) intraperitoneal^ at a dose of 25 ng/g body weight. Pleural lavage
was performed 24 h later. Cells were stained for the M<j> surface marker
F4/80 and analyzed by flow cytometry. (A) Representative flow cytome¬
try dotplot indicating that over 50% of pleural cells retrievable by pleural
lavage 24 h after DT administration in FVB/N mice are F4/80 positive.
(B) Administration of DT results in marked ablation of resident
F4/80 positive pleural Mp in CDIIb-DTR mice. DT administration
ablated 96.1 ± 0.8% of the resident M(|) population compared with
baseline M(|) numbers (n = 9 mice, p < 0.0001). APC = allophycocyanin.
50% of control levels at the later time points of 72 h, this
was still significantly less than DT-treated nontransgenic FVB/N
WT mice.
Adoptive Transfer of Nontransgenic Purified M(j> or
M<j)-rich Pleural Cell Populations Partially Restores
PMN Influx in M<|)-ablated CDIIb-DTR Mice after
Carrageenan Administration
To further analyze the role of resident pleural Mc|> in the initiation
of acute pleural inflammation, we also performed M<j> repletion
studies using the adoptive transfer of either M<j>-rich or M<|>-
depleted pleural cell populations derived from DT-insensitive
nontransgenic FVB/N WT mice. In these experiments, the adop¬
tive transfer of M(|>-rich pleural cell populations restored M(|>
number to approximately 50% of the M(|> number normally pres¬
ent in pleural lavage fluid. Flowever, despite the fact that M(J)
reconstitution of DT-treated CD1 lb-DTR mice was incomplete,
Figure 2. Resident M(J> ablation 24 h before administration of carra¬
geenan blunts neutrophil (PMN) recruitment. 0.1 ml of 1% carrageenan
was administered to CDIIb-DTR and FVB/N WT mice 24 h after DT
treatment. Pleural lavage was performed at 0, 6, 24, and 72 h after
carrageenan administration. Lavaged cells were stained for GR1 and
counted by flow cytometry (*p < 0.05 vs. CD11 b-DTR group; n = 4-5
mice/group).
the administration of M(|)-rich pleural cells concurrently with
carrageenan significantly increased PMN infiltration at 6 h
(Figure 3). The partial restoration of peak PMN infiltration was
approximately 35% of levels present in control DT-treated FVB/
N WT mice at the same time point. In contrast, administration
of M<J>-depleted pleural cells concurrently with carrageenan
made no significant impact on PMN infiltration compared with
M<)>-depleted CD1 lb-DTR mice (Figure 3). Interestingly, a sig¬
nificant correlation (R2 = 0.9979) was found between the M(j)
number present in the pleural space at the initiation of inflam¬
mation and the number of infiltrating PMNs present at 6 h. We
also reconstituted DT-treated CD1 lb-DTR mice with purified
M<j> (90% pure) concurrently with the administration of carra¬
geenan and this resulted in a comparable PMN influx to that
evident after reconstitution with M<j)-rich pleural cells. It should
be noted that, although DT-induced M<|> ablation is associated
with a reduction of B-cell and mast cell number, the administra¬
tion of M<|)-depleted pleural cells comprising B cells, mast cells,
and T cells had no significant impact on PMN infiltration. Last,
the adoptive transfer of a control population of M<])-rich pleural
cells or purified M<f> was noninflammatory (Figure 3).
M(|)-dependent Chemokine and Cytokine Responses during
Carrageenan-induced Pleurisy
In this model, we found peak levels of the PMN C-X-C chemo-
kines MIP-2 and KC at the 1- and 3-h time points, respectively.
Ablation of resident pleural Mt}> before administration of
carrageenan markedly reduced MIP-2 levels at both 1 and 3 h
(Figure 4A), thereby suggesting that the early production of
MIP-2 in vivo is predominantly M<j> dependent. Interestingly,
however, M<)>-ablated mice exhibited a delayed and significantly
blunted MIP-2 response. It is of interest that very few McJ)
(< 30,000) are present within the pleural cavity of DT-treated
CD1 lb-DTR mice at the 6-h time points, suggesting that the
delayed MIP-2 response may be derived from production by
local cells, such as mesothelial cells and others. MIP-2 levels are
very low at the 24-h time point and beyond in both experimental
groups. In contrast to the MIP-2 data, a very modest, albeit
statistically significant, reduction in KC levels was evident in
M(j)-depleted mice at the 1-, 3-, and 6-h time points (Figure 4B),
but no differences were evident thereafter, suggesting that cells
other than M<j) may be responsible for production of this chemo¬
kine. The fact that ablation of resident pleural M<j) dramatically
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Figure 3. Adoptive transfer of
Mp-rich pleural cells and puri¬
fied pleural macrophages par¬
tially restores PMN infiltration
in carrageenan-induced pleu¬
risy. FVB/N WT and six groups
of CD11 b-DTR mice were in¬
jected with DT (25 ng/g body
weight) 24 h before carra-
geenan injection. Three groups
of Mp-depleted CD11 b-DTR
mice were reconstituted with
(7) purified M<() isolated by
negative selection (90% pure,
designated Mp), (2) Mp-rich
pleural cells (designated MpR),
or(3) Mp-depleted pleuralcells
(designated MpD) at the same
time as the administration of
carrageenan. Mice underwent pleural lavage 6 h after the induction of inflammation. Controls comprised the adoptive transfer of either (7) purified
Mp or (2) Mp-rich pleural cell populations to DT-treated CD11 b-DTR mice in the absence of carrageenan. DT-treated CD11 b-DTR mice exhibited
a marked reduction in PMN infiltration in response to carrageenan, whereas reconstitution of Mp-depleted mice with either purified Mp or a Mp-
rich pleural cell population partially restored PMN infiltration. The adoptive transfer of an Mp-depleted pleural cell population did not increase
PMN infiltration. The adoptive transfer of either purified Mp or an Mp-rich pleural cell population alone did not induce significant PMN infiltration
compared with DT-treated CD11 b-DTR mice (n = 8-10 mice/group; *p < 0.05 vs. DT-treated CD11 b-DTR mice that received carrageenan).
FVB/N+
DT+CAR
CDllb-DTR CDllb-DTR CDllb-DTR CDllb-DTR CDllb-DTR CDllb-DTR CDllb-DTR
+DT+M(t> +DT+Mq>R +DT+M<j>D DT+CAR DT+M<j> DT+MpR +DT
+CAR +CAR +CAR
blunted PMN infiltration suggests that early PMN influx is very
dependent on resident Mp production of MIP-2. The ablation
of resident pleural Mp did not exert marked effects on the pro¬
duction of MCP-1 as levels were only reduced by approximately
36% at the 3-h time point (Figure 4C), suggesting a source other
than Mp.
Analysis of the levels of cytokines in pleural lavage samples
indicated a key role for resident Mp in the early production of
the cytokines TNF-a, IL-6, and IL-10. Mp ablation resulted in
greater than 90% reduction in TNF-a and IL-6 levels, with a
less dramatic but significant inhibitory effect on IL-10 levels
(Figure 5). IL-12 levels were also reduced with Mp ablation at
24 h (data not shown). Despite these important differences in
these cytokines, IFN-y levels were comparable between DT-
treated CDllb-DTR and FVB/N control mice at each time point
(data not shown), suggesting a source other than resident Mp.
Chemokine and Cytokine Responses of Pleural Cell
Populations In Vitro Are Mp Dependent
Because pleural mesothelial cells may be an important source
of chemokines, we performed additional in vitro studies to deter¬
mine the production of chemokines and cytokines by carrageenan-
stimulated pleural cell populations that had been depleted of
Mp. Immunomagnetic Mp depletion using antibodies for the Mp
specific marker F4/80 resulted in 98% depletion of Mp from
pleural cell populations, whereas B-cell and mast cell numbers
were comparable between groups (data not shown). Stimulation
of control Mp-rich pleural cell populations for 6 h with carra¬
geenan resulted in significant production of MIP-2 and KC
(Figure 6). In contrast, no significant chemokine production was
evident after stimulation of pleural cell populations depleted of
residentMp but containing B cells, T cells, and mast cells, thereby
indicating that production of these PMN C-X-C chemokines
in vitro was completely Mp dependent. Limited production of
MCP-1 was evident in vitro but this was also significantly reduced
by depletion of resident Mp (25.3 ± 5.3 vs. 7.1 ± 4.7 pg/ml,
Mp-rich pleural cells vs. Mp-depleted pleural cells; p < 0.05).
Analysis of in vitro cytokine production demonstrated that resi¬
dent Mp were key cytokine producers, because Mp depletion
before carrageenan stimulation resulted in a reduction of 63, 67,
and 92% in the production of TNF-a, IL-10, and IL-6, respec¬
tively (Figure 7).
Pleural Resident Mp Ablation Reduces PMN Influx in
Response to 5. aureus
Although the carrageenan model of pleurisy is a useful model
of inflammation and has been used by many investigators to
dissect inflammatory pathways, we sought evidence that resident
Mp were involved in models of inflammation that were more
closely related to clinical disease. We initially used the model
of intrapleural LPS instillation, but this resulted in a very low
level of PMN infiltration compared with carrageenan. We there¬
fore instilled formalin-fixed, fluorescently labeled S. aureus into
the pleural cavity and this induced a marked PMN infiltrate at
the 4-h time point (> 1.5 X 106 PMNs). The ablation of resident
Mp significantly reduced PMN infiltration after the administration
of S. aureus (Figure 8). We also found comparable PMN infiltra¬
tion in DT-treated FVB/N WT mice and PBS-treated CDllb-
DTR mice, indicating that insertion of the transgene had no
significant effect on the generation of acute inflammatory re¬
sponses (Figure 8A), with comparable findings evident after
the administration of carrageenan (data not shown). Cytospin
preparations of pleural lavage cells indicated prominent inges¬
tion of S. aureus particles by Mp in DT-treated FVB/NWT mice
(Figure 8B) with very limited uptake by PMNs. In contrast, in
the absence of Mp, DT-treated CDllb-DTR mice exhibited
marked ingestion of S. aureus particles by PMNs (Figure 8B).
DISCUSSION
We used a conditional macrophage ablation strategy to dissect
the role of the resident pleural Mp in the initiation of pleural
inflammation and PMN recruitment in carrageenan-induced
pleurisy. Carrageenan induces inflammatory responses that are
likely to be involved in human disease such as tuberculosis,
which is a cause of significant morbidity and mortality. We also
examined the effect of Mp ablation before the administration of
fixed S. aureus, a model with direct clinical relevance. Although
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Figure 4. Resident M(|) ablation attenuates chemokine production in
carrageenan-induced pleurisy. CD11 b-DTR and FVB/N WT mice were
injected with DT (25 ng/g body weight) 24 h before administration of
carrageenan. Pleural lavage was performed 1, 3, 6, 24, and 72 h after the
induction of pleurisy. The levels of macrophage inflammatory protein 2
(MIP-2; A) and keratinocyte-derived chemokine (KC; B) were deter¬
mined in the pleural lavage supernatant by specific ELISA. The level of
macrophage chemoattractant protein 1 (MCP-1; C) in the pleural lavage
supernatant was determined by cytometric bead array (CBA) analysis
(*p < 0.05 vs. CD11 b-DTR group; n = 5 mice/group).
the resident pleural M<j> can secrete chemokines and cytokines,
their role in pleurisy is currently unclear. Pleural mesothelial
cells also have the capacity to secrete various chemokines (3, 6,
7,12, 33, 34). In addition, some studies have identified resident
pleural M<j)-derived proinflammatory cytokines such as TNF-a
that are essential for the secretion ofC-X-C and C-C chemokines
from pleural mesothelial cells (3, 5, 8, 10-12, 33), suggesting
important cross-talk between different pleural cells.
The first major finding of this study is that the administration
of DT to CDllb-DTR transgenic mice results in the rapid and
effective ablation of resident pleural M<j), with greater than 96%
of resident pleural M<)> being depleted 24 h after DT treatment.
This is comparable with our previous work studying peritoneal
inflammation (27). Interestingly, despite PMN expression of
CDllb, the administration of DT did not induce the death of
circulating PMNs, indicating that PMNs are insensitive to DT,
potentially as a result of their lower level of protein synthesis.
Figure 5. Resident M<j> ablation attenuates cytokine production in
carrageenan-induced pleurisy. CD11 b-DTR and FVB/N WT mice were
injected with DT (25 ng/g body weight) 24 h before carrageenan injec¬
tion. Pleural lavage was performed 1, 3, 6, 24, and 72 h after the induction
of pleurisy. The level of tumor necrosis factor a (TNF-a; A) in the pleural
lavage supernatant was determined by specific ELISA, whereas the levels
of interleukin 6 (IL-6; B) and IL-10 (C) were determined by CBA analysis
(*p < 0.05 vs. CD11 b-DTR group; n = 5 mice/group).
The second major finding of this study is that resident pleural
M<|) ablation dramatically blunted early PMN infiltration into
the pleural cavity, indicating an important role for resident pleu¬
ral M<|> in initiating acute pleural inflammation. The administra¬
tion of DT did not affect the numbers of circulating PMNs,
thereby excluding this potential cause for diminished PMN infil¬
tration of the pleural cavity. We performed M(|> repletion studies
involving the adoptive transfer of nontransgenic pleural cell pop¬
ulations to M(j)-depleted mice concurrent with the induction of
pleurisy. The adoptive transfer of pleural cell populations de¬
pleted of M<() by magnetic immunodepletion had no significant
effect on PMN recruitment; PMN numbers were comparable to
those evident in control M(|>-depleted mice. In contrast, adoptive
transfer of either pleural cell populations containing M<|> or a
population of purified M(j> significantly increased pleural PMN
infiltration, reinforcing the key role of resident pleural M(j>.
Adoptive transfer of pleural cells was unable to restore Mcj)
numbers to normal values and this may explain the partial resto¬
ration of PMN infiltration compared with DT-treated FVB/N
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Figure 6. In vitro production of MIP-2 and KC aftercarrageenan stimula¬
tion is Mp dependent. Resident pleural cells were harvested and immu-
nodepleted of resident pleural M<|> by passage over a magnetic column.
Equivalent numbers of cells were plated and stimulated with 0.25%
carrageenan or normal medium for 6 h. Supernatants were harvested
and analyzed by specific ELISA for MIP-2 and KC (*p < 0.05 vs. all cells
with medium; n = 4 wells/condition).
number of pleural M<(> at the initiation of disease and the number
of infiltrating PMNs at 6 h after carrageenan administration
strongly supports a key proinflammatory role for resident pleural
M<|>. It is possible that carrageenan pleurisy may be partially
dependent on the proinflammatory actions of recruited mono¬
cytes, unlike experimental peritonitis where acute PMN infiltra¬
tion is monocyte independent (27). Our data indicate a profound
effect of M<]> depletion on PMN recruitment at the early time
point of 6 h and because monocyte recruitment occurs signifi¬
cantly later in the carrageenan model it is likely that monocyte
recruitment will be very limited at this early time point. Thus,
a reduction inmonocyte recruitment in DT-treated CD11 b-DTR
mice is unlikely to be involved in the early reduction in PMN
infiltration in these studies, although recruited monocytes may
play a role in PMN infiltration at later time points.
Although defective PMN migration consequent on exposure
to DT is an alternative explanation for these findings, our previ¬
ous work in experimental peritonitis indicated that reconstitu-
tion of M4>-depleted mice with nontransgenic M<j> was able to
fully restore PMN infiltration in response to thioglycollate (27).
In addition, intrapleural administration of the chemokine MIP-2
to M<j)-depleted CDllb-DTR mice resulted in significant PMN
infiltration (3.2 X 105 ± 0.9 X 105 PMNs/ml at 4 h after the
intrapleural administration of 30 ng MIP-2), suggesting that
PMN migration is not defective under these experimental
conditions.
In these experiments, DT administration and the subsequent
induction of widespread M<|> death did affect the numbers of
pleural B cells and mast cells. However, despite this potentially
confounding issue, several factors support the prominent role
of the pleural M(|) in the carrageenan model. First, data from
in vitro experiments indicate a dramatic reduction in chemokine
and cytokine production after M<)> depletion from resident pleu¬
ral cell populations. In these studies, pleural cells were labeled
with a PE-conjugated antibody to the specific MP marker F4/80
before immunomagnetic depletion, and F4/80 is not expressed
by B cells ormast cells. Second, adoptive transfer of M(|)-depleted
pleural cells comprising B cells, T cells, and mast cells did not
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Figure 7. In vitro production of the cytokines TNF-a, IL-10, and IL-6
after carrageenan stimulation is Mp dependent. Resident pleural cells
were harvested and immunodepleted of resident pleural Mp by passage
over a magnetic column. Equivalent numbers of cells were stimulated
with 0.25% carrageenan or normal medium for 6 h. Supernatants were
harvested and analyzed by specific EUSA for TNF-a and by CBA for
IL-10 and IL-6 (*p < 0.05 all cells vs. Mp-depleted for their respective
condition, i.e., M<j) with medium or Mp with carrageenan). n = 4 wells/
condition.
tration. In contrast, adoptive transfer of M<|>-rich pleural cells or
purified M(|> isolated by negative selection significantly increased
PMN infiltration in response to carrageenan administration.
Last, previous work suggests that mast cells do not play a signifi¬
cant role in the carrageenan pleurisy model (35, 36).
We then examined the effect of resident pleural M(|> ablation
on the level of C-X-C chemokines in this model. Resident pleural
M<|) ablation markedly reduced MIP-2 levels in the pleural exu¬
date but had a lesser, albeit significant, inhibitory effect on KC
levels. In vitro study of M<t>-replete or Mp-depleted pleural cell
populations indicated that M<J) are a key source of chemokines
because M<|>-depleted pleural cell populations produced minimal
amounts of the chemokines MIP-2 and KC. Interestingly, these
in vitro studies demonstrated comparable production of MIP-2
and KC, whereas analysis of pleural lavage fluid indicated that
KC levels were approximately two- to threefold higher than
MIP-2 levels in vivo. These data are comparable to our previous
studies of thioglycollate peritonitis (27) and suggest that other
cells within the pleural cavity, such as mesothelial cells, may be
an important source of KC in vivo. The suggestion that pleural
cells, other than those retrievable by pleural lavage, represent
a significant source of KC is consistent with recent work in a
wound model of inflammation (37) that demonstrated MIP-2
expression by inflammatory cells while KC was predominantly
expressed by resident tissue cells, such as endothelial cells and
fibroblasts. Pleural mesothelial cells undoubtedly participate in
pleural inflammation and our data suggest that mesothelial cells
actively contribute to KC production. It should be stressed, how¬
ever, that marked inhibition of PMN recruitment was evident
at early time points in the presence of relatively preserved KC
levels suggesting that MIP-2 is more important in vivo in this
model. Also, pleural cell populations stimulated with carra¬
geenan in vitro produced relatively low levels of the C-C chemo¬
kine MCP-1 compared with the levels found in vivo, suggesting
a prominent role for mesothelial cells in MCP-1 production
in vivo and subsequent mononuclear cell recruitment. Our data
are therefore also in accordance with previous reports high¬
lighting the importance of pleural mesothelial cells (3, 6, 38).
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Our data also indicate that resident pleural M<|> are critically
involved in the generation of cytokines because TNF-a, IL-10,
and IL-6 levels in pleural exudates were significantly reduced in
CD11 b-DTR mice treated with DT. Also, carrageenan-stimulated
pleural cell populations exhibited a significant reduction in cytokine
levels in vitro after magnetic immunodepletion of pleural M<J>.
Our studies raise the question as to why there was no significant
PMN infiltration in response to significant KC production. Perti¬
nent previous work studying the effect of function-blocking anti¬
bodies to either MIP-2 or KC in thioglycollate peritonitis indi¬
cates that inhibition of either chemokine individually results in
marked (> 70%) inhibition of PMN infiltration with inhibition
of both chemokines giving little additional effect (39, 40). We
did not perform in vitro PMN chemotaxis assays to assess the
chemotactic activity of pleural lavage lluid from M<)>-depleted
and control mice with pleurisy because the preparation of pure
populations of nonactivated murine neutrophils is problematic.
In addition, our previous studies indicate that experiments in-
4 —
Figure 8. Resident M(|i ablation 24 h before the administration of forma¬
lin-fixed Staphylococcus aureus significantly blunts PMN recruitment,
(4) A total of 3 x 106 formalin-fixed, fluorescently labeled 5. aureus
were Instilled Into the pleural cavity of CD11 b-DTR and FVB/N WT mice
24 h after DT treatment with phosphate buffered saline (PBS)-treated
CD11 b-DTR serving as an additional control, Pleural lavage was per¬
formed at 4 h after the administration of S, aureus, Lavaged cells were
stained for GR1 and counted by flow cytometry (*p < 0,05 vs, DT-
treated CD11 b-DTR group; n * 4 mice/group). (B) Photomicrographs
of Dlffqulck-stalned (A and C) or Hoechst-stalned (B and D) cytospin
preparations of pleural lavage cells from either DT-treated FVB/N WT
mice (A and B) or DT-treated CD11 b-DTR mice (C and D) 4 h after the
administration of 3 x 106 formalin-fixed, fluorescently labeled 5, aureus,
PMNs may be readily distinguished from Mb by their smaller size and
the characteristic lobulated or circular nuclear morphology, Note that
In B, the cell Indicated with an arrow Is the only M<J> present In the field
and exhibits a large, rounded nucleus, whereas the remaining smaller
PMNs exhibit a polylobular nuclear morphology. There are no Mb pres¬
ent In C and D, Prominent Ingestion of 5, aureus particles by Mb Is
evident In control DT-treated FVB/N WT mice (examples shown with
arrows In A and B), with very limited uptake by PMNs. In contrast, In
the absence of Mb, DT-treated CD11 b-DTR mice exhibit marked Inges¬
tion of 5. aureus particles by PMNs (examples shown with arrows In C
and D),
volving the adoptive transfer of lavage lluid are confounded by
the resultant dilution of chemokines and cytokines. However,
the dramatic reduction in the levels of intrapleural cytokines in
M<|)-depleted mice may contribute to the defective PMN infiltra¬
tion via modulation of local endothelial cell expression of adhe¬
sion molecules involved in PMN diapedesis, Although many
mediators, including cytokines, nitric oxide, complement pro¬
teins, and prostaglandins, are involved in acute inflammatory
processes and leukocyte recruitment, our findings indicate that
resident Mt(t play a key role in orchestrating PMN influx in
carrageenan pleurisy. In addition, our limited experiments per¬
formed In mice administered killed S, aureus indicated that Mb
depletion markedly reduces staphylococcal-induced PMN infil¬
tration. Also, prominent Mb ingestion of S, aureus was evident
in control DT-treated FVB/N mice and this reinforces the key
role for resident Mb as sentinel cells that act to recognize and
clear proinflammatory pathogens and particulate material.
In conclusion, this study used a transgenic model of condi¬
tional Mb ablation to demonstrate a key role for the resident
pleural Mb in sensing pleural irritation and orchestrating PMN
infiltration in carrageenan-induced pleurisy. This proinflamma¬
tory function is predominantly mediated by production of the
potent PMN C-X-C chemokine MIP-2 and proinflammatory cy¬
tokines such as TNF-a and IL-6 that can promote the production
of the PMN C-X-C chemokine KC by mesothelial cells. Our
study suggests that resident Mb are critically important produc¬
ers of PMN chemokines and proinflammatory cytokines and act
to orchestrate PMN recruitment in murine carrageenan-induced
pleurisy.
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